[
    {
        "real_row": {
            "pubmed_id": 10101,
            "papername": "Advances in Migraine Treatment",
            "authors": "Smith, John; Doe, Jane",
            "publication_date": "2023-01-15",
            "journal": "Journal of Neurology",
            "disease": "Migraine",
            "medication_group": "Randomised group",
            "therapy_or_medication": "Erenumab",
            "medical_outcome": "Discontinuation",
            "result": "15.0%",
            "outcome_category": "Adverse Events and Side Effects",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 5,
            "pubmed_id": 10101,
            "paper": "Advances in Migraine Treatment",
            "authors": "Smith, John; Doe, Jane",
            "journal": "Journal of Neurology",
            "publication_date": "2023-01-15",
            "disease": "Migraine",
            "medication_group": "Adults with chronic migraine",
            "therapy_or_medication": "Erenumab",
            "medical_outcome": "Medication discontinuation rate due to adverse events",
            "result": "15.0%",
            "outcome_category": "Adverse Events and Side Effects",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0000001192092896,
            "medication_group_correct": 0.4428704082965851,
            "therapy_or_medication_correct": 0.9999997615814209,
            "medical_outcome_correct": 0.6999533772468567,
            "result_correct": 1.0,
            "outcome_category_correct": 0.9999999403953552,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 6.142823427915573
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 5,
                    "pubmed_id": 10101,
                    "paper": "Advances in Migraine Treatment",
                    "authors": "Smith, John; Doe, Jane",
                    "journal": "Journal of Neurology",
                    "publication_date": "2023-01-15",
                    "disease": "Migraine",
                    "medication_group": "Adults with chronic migraine",
                    "therapy_or_medication": "Erenumab",
                    "medical_outcome": "Medication discontinuation rate due to adverse events",
                    "result": "15.0%",
                    "outcome_category": "Adverse Events and Side Effects",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.4428704082965851,
                    "therapy_or_medication_correct": 0.9999997615814209,
                    "medical_outcome_correct": 0.6999533772468567,
                    "result_correct": 1.0,
                    "outcome_category_correct": 0.9999999403953552,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.142823427915573
                }
            },
            {
                "pred_row": {
                    "id": 6,
                    "pubmed_id": 10101,
                    "paper": "Advances in Migraine Treatment",
                    "authors": "Smith, John; Doe, Jane",
                    "journal": "Journal of Neurology",
                    "publication_date": "2023-01-15",
                    "disease": "Migraine",
                    "medication_group": "Adults with chronic migraine",
                    "therapy_or_medication": "Erenumab",
                    "medical_outcome": "at least a 50% reduction in MMD",
                    "result": "47.3%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.4428704082965851,
                    "therapy_or_medication_correct": 0.9999997615814209,
                    "medical_outcome_correct": 0.5218052268028259,
                    "result_correct": 0.8516725301742554,
                    "outcome_category_correct": 0.6407684087753296,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.457116276025772
                }
            },
            {
                "pred_row": {
                    "id": 7,
                    "pubmed_id": 10101,
                    "paper": "Advances in Migraine Treatment",
                    "authors": "Smith, John; Doe, Jane",
                    "journal": "Journal of Neurology",
                    "publication_date": "2023-01-15",
                    "disease": "Migraine",
                    "medication_group": "Adults with chronic migraine",
                    "therapy_or_medication": "Topiramate",
                    "medical_outcome": "Medication discontinuation rate due to adverse events",
                    "result": "22.0%",
                    "outcome_category": "Adverse Events and Side Effects",
                    "outcome_evaluation": "significantly worse"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.4428704082965851,
                    "therapy_or_medication_correct": 0.5977753400802612,
                    "medical_outcome_correct": 0.6999533772468567,
                    "result_correct": 0.96861732006073,
                    "outcome_category_correct": 0.9999999403953552,
                    "outcome_evaluation_correct": 0.790851891040802,
                    "score": 5.50006839632988
                }
            },
            {
                "pred_row": {
                    "id": 8,
                    "pubmed_id": 10101,
                    "paper": "Advances in Migraine Treatment",
                    "authors": "Smith, John; Doe, Jane",
                    "journal": "Journal of Neurology",
                    "publication_date": "2023-01-15",
                    "disease": "Migraine",
                    "medication_group": "Adults with chronic migraine",
                    "therapy_or_medication": "Topiramate",
                    "medical_outcome": "at least a 50% reduction in MMD",
                    "result": "34.1%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly worse"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.4428704082965851,
                    "therapy_or_medication_correct": 0.5977753400802612,
                    "medical_outcome_correct": 0.5218052268028259,
                    "result_correct": 0.9138594269752502,
                    "outcome_category_correct": 0.6407684087753296,
                    "outcome_evaluation_correct": 0.790851891040802,
                    "score": 4.907930821180344
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 10101,
            "papername": "Advances in Migraine Treatment",
            "authors": "Smith, John; Doe, Jane",
            "publication_date": "2023-01-15",
            "journal": "Journal of Neurology",
            "disease": "Migraine",
            "medication_group": "Randomised group",
            "therapy_or_medication": "Erenumab",
            "medical_outcome": "Reduction in MMD",
            "result": "47.3%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 6,
            "pubmed_id": 10101,
            "paper": "Advances in Migraine Treatment",
            "authors": "Smith, John; Doe, Jane",
            "journal": "Journal of Neurology",
            "publication_date": "2023-01-15",
            "disease": "Migraine",
            "medication_group": "Adults with chronic migraine",
            "therapy_or_medication": "Erenumab",
            "medical_outcome": "at least a 50% reduction in MMD",
            "result": "47.3%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0000001192092896,
            "medication_group_correct": 0.4428704082965851,
            "therapy_or_medication_correct": 0.9999997615814209,
            "medical_outcome_correct": 0.8218579888343811,
            "result_correct": 1.0,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 6.264728218317032
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 5,
                    "pubmed_id": 10101,
                    "paper": "Advances in Migraine Treatment",
                    "authors": "Smith, John; Doe, Jane",
                    "journal": "Journal of Neurology",
                    "publication_date": "2023-01-15",
                    "disease": "Migraine",
                    "medication_group": "Adults with chronic migraine",
                    "therapy_or_medication": "Erenumab",
                    "medical_outcome": "Medication discontinuation rate due to adverse events",
                    "result": "15.0%",
                    "outcome_category": "Adverse Events and Side Effects",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.4428704082965851,
                    "therapy_or_medication_correct": 0.9999997615814209,
                    "medical_outcome_correct": 0.6591523885726929,
                    "result_correct": 0.8516725301742554,
                    "outcome_category_correct": 0.6407684087753296,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.594463437795639
                }
            },
            {
                "pred_row": {
                    "id": 6,
                    "pubmed_id": 10101,
                    "paper": "Advances in Migraine Treatment",
                    "authors": "Smith, John; Doe, Jane",
                    "journal": "Journal of Neurology",
                    "publication_date": "2023-01-15",
                    "disease": "Migraine",
                    "medication_group": "Adults with chronic migraine",
                    "therapy_or_medication": "Erenumab",
                    "medical_outcome": "at least a 50% reduction in MMD",
                    "result": "47.3%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.4428704082965851,
                    "therapy_or_medication_correct": 0.9999997615814209,
                    "medical_outcome_correct": 0.8218579888343811,
                    "result_correct": 1.0,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.264728218317032
                }
            },
            {
                "pred_row": {
                    "id": 7,
                    "pubmed_id": 10101,
                    "paper": "Advances in Migraine Treatment",
                    "authors": "Smith, John; Doe, Jane",
                    "journal": "Journal of Neurology",
                    "publication_date": "2023-01-15",
                    "disease": "Migraine",
                    "medication_group": "Adults with chronic migraine",
                    "therapy_or_medication": "Topiramate",
                    "medical_outcome": "Medication discontinuation rate due to adverse events",
                    "result": "22.0%",
                    "outcome_category": "Adverse Events and Side Effects",
                    "outcome_evaluation": "significantly worse"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.4428704082965851,
                    "therapy_or_medication_correct": 0.5977753400802612,
                    "medical_outcome_correct": 0.6591523885726929,
                    "result_correct": 0.891029953956604,
                    "outcome_category_correct": 0.6407684087753296,
                    "outcome_evaluation_correct": 0.790851891040802,
                    "score": 5.022448509931564
                }
            },
            {
                "pred_row": {
                    "id": 8,
                    "pubmed_id": 10101,
                    "paper": "Advances in Migraine Treatment",
                    "authors": "Smith, John; Doe, Jane",
                    "journal": "Journal of Neurology",
                    "publication_date": "2023-01-15",
                    "disease": "Migraine",
                    "medication_group": "Adults with chronic migraine",
                    "therapy_or_medication": "Topiramate",
                    "medical_outcome": "at least a 50% reduction in MMD",
                    "result": "34.1%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly worse"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.4428704082965851,
                    "therapy_or_medication_correct": 0.5977753400802612,
                    "medical_outcome_correct": 0.8218579888343811,
                    "result_correct": 0.931214451789856,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.790851891040802,
                    "score": 5.5845703184604645
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 10101,
            "papername": "Advances in Migraine Treatment",
            "authors": "Smith, John; Doe, Jane",
            "publication_date": "2023-01-15",
            "journal": "Journal of Neurology",
            "disease": "Migraine",
            "medication_group": "Randomised group",
            "therapy_or_medication": "Topiramate",
            "medical_outcome": "Discontinuation",
            "result": "22.0%",
            "outcome_category": "Adverse Events and Side Effects",
            "outcome_evaluation": "significantly worse"
        },
        "pred_row": {
            "id": 7,
            "pubmed_id": 10101,
            "paper": "Advances in Migraine Treatment",
            "authors": "Smith, John; Doe, Jane",
            "journal": "Journal of Neurology",
            "publication_date": "2023-01-15",
            "disease": "Migraine",
            "medication_group": "Adults with chronic migraine",
            "therapy_or_medication": "Topiramate",
            "medical_outcome": "Medication discontinuation rate due to adverse events",
            "result": "22.0%",
            "outcome_category": "Adverse Events and Side Effects",
            "outcome_evaluation": "significantly worse"
        },
        "best_similarity": {
            "disease_correct": 1.0000001192092896,
            "medication_group_correct": 0.4428704082965851,
            "therapy_or_medication_correct": 1.0,
            "medical_outcome_correct": 0.6999533772468567,
            "result_correct": 1.0000001192092896,
            "outcome_category_correct": 0.9999999403953552,
            "outcome_evaluation_correct": 1.0,
            "score": 6.142823964357376
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 5,
                    "pubmed_id": 10101,
                    "paper": "Advances in Migraine Treatment",
                    "authors": "Smith, John; Doe, Jane",
                    "journal": "Journal of Neurology",
                    "publication_date": "2023-01-15",
                    "disease": "Migraine",
                    "medication_group": "Adults with chronic migraine",
                    "therapy_or_medication": "Erenumab",
                    "medical_outcome": "Medication discontinuation rate due to adverse events",
                    "result": "15.0%",
                    "outcome_category": "Adverse Events and Side Effects",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.4428704082965851,
                    "therapy_or_medication_correct": 0.5977753400802612,
                    "medical_outcome_correct": 0.6999533772468567,
                    "result_correct": 0.96861732006073,
                    "outcome_category_correct": 0.9999999403953552,
                    "outcome_evaluation_correct": 0.790851891040802,
                    "score": 5.50006839632988
                }
            },
            {
                "pred_row": {
                    "id": 6,
                    "pubmed_id": 10101,
                    "paper": "Advances in Migraine Treatment",
                    "authors": "Smith, John; Doe, Jane",
                    "journal": "Journal of Neurology",
                    "publication_date": "2023-01-15",
                    "disease": "Migraine",
                    "medication_group": "Adults with chronic migraine",
                    "therapy_or_medication": "Erenumab",
                    "medical_outcome": "at least a 50% reduction in MMD",
                    "result": "47.3%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.4428704082965851,
                    "therapy_or_medication_correct": 0.5977753400802612,
                    "medical_outcome_correct": 0.5218052268028259,
                    "result_correct": 0.891029953956604,
                    "outcome_category_correct": 0.6407684087753296,
                    "outcome_evaluation_correct": 0.790851891040802,
                    "score": 4.885101348161697
                }
            },
            {
                "pred_row": {
                    "id": 7,
                    "pubmed_id": 10101,
                    "paper": "Advances in Migraine Treatment",
                    "authors": "Smith, John; Doe, Jane",
                    "journal": "Journal of Neurology",
                    "publication_date": "2023-01-15",
                    "disease": "Migraine",
                    "medication_group": "Adults with chronic migraine",
                    "therapy_or_medication": "Topiramate",
                    "medical_outcome": "Medication discontinuation rate due to adverse events",
                    "result": "22.0%",
                    "outcome_category": "Adverse Events and Side Effects",
                    "outcome_evaluation": "significantly worse"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.4428704082965851,
                    "therapy_or_medication_correct": 1.0,
                    "medical_outcome_correct": 0.6999533772468567,
                    "result_correct": 1.0000001192092896,
                    "outcome_category_correct": 0.9999999403953552,
                    "outcome_evaluation_correct": 1.0,
                    "score": 6.142823964357376
                }
            },
            {
                "pred_row": {
                    "id": 8,
                    "pubmed_id": 10101,
                    "paper": "Advances in Migraine Treatment",
                    "authors": "Smith, John; Doe, Jane",
                    "journal": "Journal of Neurology",
                    "publication_date": "2023-01-15",
                    "disease": "Migraine",
                    "medication_group": "Adults with chronic migraine",
                    "therapy_or_medication": "Topiramate",
                    "medical_outcome": "at least a 50% reduction in MMD",
                    "result": "34.1%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly worse"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.4428704082965851,
                    "therapy_or_medication_correct": 1.0,
                    "medical_outcome_correct": 0.5218052268028259,
                    "result_correct": 0.9321476221084595,
                    "outcome_category_correct": 0.6407684087753296,
                    "outcome_evaluation_correct": 1.0,
                    "score": 5.53759178519249
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 10101,
            "papername": "Advances in Migraine Treatment",
            "authors": "Smith, John; Doe, Jane",
            "publication_date": "2023-01-15",
            "journal": "Journal of Neurology",
            "disease": "Migraine",
            "medication_group": "Randomised group",
            "therapy_or_medication": "Topiramate",
            "medical_outcome": "Reduction in MMD",
            "result": "34.1%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly worse"
        },
        "pred_row": {
            "id": 8,
            "pubmed_id": 10101,
            "paper": "Advances in Migraine Treatment",
            "authors": "Smith, John; Doe, Jane",
            "journal": "Journal of Neurology",
            "publication_date": "2023-01-15",
            "disease": "Migraine",
            "medication_group": "Adults with chronic migraine",
            "therapy_or_medication": "Topiramate",
            "medical_outcome": "at least a 50% reduction in MMD",
            "result": "34.1%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly worse"
        },
        "best_similarity": {
            "disease_correct": 1.0000001192092896,
            "medication_group_correct": 0.4428704082965851,
            "therapy_or_medication_correct": 1.0,
            "medical_outcome_correct": 0.8218579888343811,
            "result_correct": 1.0,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 1.0,
            "score": 6.264728635549545
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 5,
                    "pubmed_id": 10101,
                    "paper": "Advances in Migraine Treatment",
                    "authors": "Smith, John; Doe, Jane",
                    "journal": "Journal of Neurology",
                    "publication_date": "2023-01-15",
                    "disease": "Migraine",
                    "medication_group": "Adults with chronic migraine",
                    "therapy_or_medication": "Erenumab",
                    "medical_outcome": "Medication discontinuation rate due to adverse events",
                    "result": "15.0%",
                    "outcome_category": "Adverse Events and Side Effects",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.4428704082965851,
                    "therapy_or_medication_correct": 0.5977753400802612,
                    "medical_outcome_correct": 0.6591523885726929,
                    "result_correct": 0.9138594269752502,
                    "outcome_category_correct": 0.6407684087753296,
                    "outcome_evaluation_correct": 0.790851891040802,
                    "score": 5.045277982950211
                }
            },
            {
                "pred_row": {
                    "id": 6,
                    "pubmed_id": 10101,
                    "paper": "Advances in Migraine Treatment",
                    "authors": "Smith, John; Doe, Jane",
                    "journal": "Journal of Neurology",
                    "publication_date": "2023-01-15",
                    "disease": "Migraine",
                    "medication_group": "Adults with chronic migraine",
                    "therapy_or_medication": "Erenumab",
                    "medical_outcome": "at least a 50% reduction in MMD",
                    "result": "47.3%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.4428704082965851,
                    "therapy_or_medication_correct": 0.5977753400802612,
                    "medical_outcome_correct": 0.8218579888343811,
                    "result_correct": 0.931214451789856,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.790851891040802,
                    "score": 5.5845703184604645
                }
            },
            {
                "pred_row": {
                    "id": 7,
                    "pubmed_id": 10101,
                    "paper": "Advances in Migraine Treatment",
                    "authors": "Smith, John; Doe, Jane",
                    "journal": "Journal of Neurology",
                    "publication_date": "2023-01-15",
                    "disease": "Migraine",
                    "medication_group": "Adults with chronic migraine",
                    "therapy_or_medication": "Topiramate",
                    "medical_outcome": "Medication discontinuation rate due to adverse events",
                    "result": "22.0%",
                    "outcome_category": "Adverse Events and Side Effects",
                    "outcome_evaluation": "significantly worse"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.4428704082965851,
                    "therapy_or_medication_correct": 1.0,
                    "medical_outcome_correct": 0.6591523885726929,
                    "result_correct": 0.9321476221084595,
                    "outcome_category_correct": 0.6407684087753296,
                    "outcome_evaluation_correct": 1.0,
                    "score": 5.674938946962357
                }
            },
            {
                "pred_row": {
                    "id": 8,
                    "pubmed_id": 10101,
                    "paper": "Advances in Migraine Treatment",
                    "authors": "Smith, John; Doe, Jane",
                    "journal": "Journal of Neurology",
                    "publication_date": "2023-01-15",
                    "disease": "Migraine",
                    "medication_group": "Adults with chronic migraine",
                    "therapy_or_medication": "Topiramate",
                    "medical_outcome": "at least a 50% reduction in MMD",
                    "result": "34.1%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly worse"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.4428704082965851,
                    "therapy_or_medication_correct": 1.0,
                    "medical_outcome_correct": 0.8218579888343811,
                    "result_correct": 1.0,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 1.0,
                    "score": 6.264728635549545
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 20202,
            "papername": "Diabetes Management Innovations",
            "authors": "Lee, Alice; Kim, Young",
            "publication_date": "2022-03-04",
            "journal": "Endocrinology Today",
            "disease": "Diabetes",
            "medication_group": "Metformin group",
            "therapy_or_medication": "Metformin",
            "medical_outcome": "Reduction in A1C",
            "result": "1.2%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "no significant differences"
        },
        "pred_row": {
            "id": 9,
            "pubmed_id": 20202,
            "paper": "Diabetes Management Innovations",
            "authors": "Lee, Alice; Kim, Young",
            "journal": "Endocrinology Today",
            "publication_date": "2022-03-04",
            "disease": "Type 2 Diabetes",
            "medication_group": "No group specified",
            "therapy_or_medication": "Metformin",
            "medical_outcome": "A1C reduction",
            "result": "1.2%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly worse"
        },
        "best_similarity": {
            "disease_correct": 0.733036458492279,
            "medication_group_correct": 0.5247234106063843,
            "therapy_or_medication_correct": 0.9999998807907104,
            "medical_outcome_correct": 0.7979474067687988,
            "result_correct": 1.0,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 0.5732789039611816,
            "score": 5.628986179828644
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 9,
                    "pubmed_id": 20202,
                    "paper": "Diabetes Management Innovations",
                    "authors": "Lee, Alice; Kim, Young",
                    "journal": "Endocrinology Today",
                    "publication_date": "2022-03-04",
                    "disease": "Type 2 Diabetes",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "Metformin",
                    "medical_outcome": "A1C reduction",
                    "result": "1.2%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly worse"
                },
                "similarity": {
                    "disease_correct": 0.733036458492279,
                    "medication_group_correct": 0.5247234106063843,
                    "therapy_or_medication_correct": 0.9999998807907104,
                    "medical_outcome_correct": 0.7979474067687988,
                    "result_correct": 1.0,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.5732789039611816,
                    "score": 5.628986179828644
                }
            },
            {
                "pred_row": {
                    "id": 10,
                    "pubmed_id": 20202,
                    "paper": "Diabetes Management Innovations",
                    "authors": "Lee, Alice; Kim, Young",
                    "journal": "Endocrinology Today",
                    "publication_date": "2022-03-04",
                    "disease": "Type 2 Diabetes",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "Insulin therapy",
                    "medical_outcome": "A1C reduction",
                    "result": "2.0%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly worse"
                },
                "similarity": {
                    "disease_correct": 0.733036458492279,
                    "medication_group_correct": 0.5247234106063843,
                    "therapy_or_medication_correct": 0.692405104637146,
                    "medical_outcome_correct": 0.7979474067687988,
                    "result_correct": 0.9495049118995667,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.5732789039611816,
                    "score": 5.270896315574646
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 20202,
            "papername": "Diabetes Management Innovations",
            "authors": "Lee, Alice; Kim, Young",
            "publication_date": "2022-03-04",
            "journal": "Endocrinology Today",
            "disease": "Diabetes",
            "medication_group": "Insulin group",
            "therapy_or_medication": "Insulin",
            "medical_outcome": "Reduction in A1C",
            "result": "2.0%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 10,
            "pubmed_id": 20202,
            "paper": "Diabetes Management Innovations",
            "authors": "Lee, Alice; Kim, Young",
            "journal": "Endocrinology Today",
            "publication_date": "2022-03-04",
            "disease": "Type 2 Diabetes",
            "medication_group": "No group specified",
            "therapy_or_medication": "Insulin therapy",
            "medical_outcome": "A1C reduction",
            "result": "2.0%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly worse"
        },
        "best_similarity": {
            "disease_correct": 0.733036458492279,
            "medication_group_correct": 0.6302679181098938,
            "therapy_or_medication_correct": 0.8375988602638245,
            "medical_outcome_correct": 0.7979474067687988,
            "result_correct": 0.9999998211860657,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 0.790851891040802,
            "score": 5.789702475070953
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 9,
                    "pubmed_id": 20202,
                    "paper": "Diabetes Management Innovations",
                    "authors": "Lee, Alice; Kim, Young",
                    "journal": "Endocrinology Today",
                    "publication_date": "2022-03-04",
                    "disease": "Type 2 Diabetes",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "Metformin",
                    "medical_outcome": "A1C reduction",
                    "result": "1.2%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly worse"
                },
                "similarity": {
                    "disease_correct": 0.733036458492279,
                    "medication_group_correct": 0.6302679181098938,
                    "therapy_or_medication_correct": 0.5928972959518433,
                    "medical_outcome_correct": 0.7979474067687988,
                    "result_correct": 0.9495049118995667,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.790851891040802,
                    "score": 5.494506001472473
                }
            },
            {
                "pred_row": {
                    "id": 10,
                    "pubmed_id": 20202,
                    "paper": "Diabetes Management Innovations",
                    "authors": "Lee, Alice; Kim, Young",
                    "journal": "Endocrinology Today",
                    "publication_date": "2022-03-04",
                    "disease": "Type 2 Diabetes",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "Insulin therapy",
                    "medical_outcome": "A1C reduction",
                    "result": "2.0%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly worse"
                },
                "similarity": {
                    "disease_correct": 0.733036458492279,
                    "medication_group_correct": 0.6302679181098938,
                    "therapy_or_medication_correct": 0.8375988602638245,
                    "medical_outcome_correct": 0.7979474067687988,
                    "result_correct": 0.9999998211860657,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.790851891040802,
                    "score": 5.789702475070953
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 30303,
            "papername": "COPD and New Therapeutic Approaches",
            "authors": "Patel, Raj; Singh, Maya",
            "publication_date": "2021-11-20",
            "journal": "Respiratory Medicine",
            "disease": "COPD",
            "medication_group": "Corticosteroid group",
            "therapy_or_medication": "Corticosteroids",
            "medical_outcome": "Improvement in FEV1",
            "result": 0.1,
            "outcome_category": "Physiological Measure",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 12,
            "pubmed_id": 30303,
            "paper": "COPD and New Therapeutic Approaches",
            "authors": "Patel, Raj; Singh, Maya",
            "journal": "Respiratory Medicine",
            "publication_date": "2021-11-20",
            "disease": "Chronic Obstructive Pulmonary Disease (COPD)",
            "medication_group": "No group specified",
            "therapy_or_medication": "Inhaled corticosteroids (ICS) and long-acting bronchodilators (LABA or LAMA)",
            "medical_outcome": "Percentage improvement in FEV1 from baseline",
            "result": "8%",
            "outcome_category": "Physiological Measure",
            "outcome_evaluation": "significantly worse"
        },
        "best_similarity": {
            "disease_correct": 0.30662208795547485,
            "medication_group_correct": 0.49546343088150024,
            "therapy_or_medication_correct": 0.7638890147209167,
            "medical_outcome_correct": 0.8447293639183044,
            "result_correct": 0.6805226802825928,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 0.790851891040802,
            "score": 4.882078588008881
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 11,
                    "pubmed_id": 30303,
                    "paper": "COPD and New Therapeutic Approaches",
                    "authors": "Patel, Raj; Singh, Maya",
                    "journal": "Respiratory Medicine",
                    "publication_date": "2021-11-20",
                    "disease": "Chronic Obstructive Pulmonary Disease (COPD)",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "Inhaled corticosteroids (ICS) and long-acting bronchodilators (LABA or LAMA)",
                    "medical_outcome": "Percentage improvement in FEV1 from baseline",
                    "result": "10%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.30662208795547485,
                    "medication_group_correct": 0.49546343088150024,
                    "therapy_or_medication_correct": 0.7638890147209167,
                    "medical_outcome_correct": 0.8447293639183044,
                    "result_correct": 0.6802288293838501,
                    "outcome_category_correct": 0.7687371969223022,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 4.859669744968414
                }
            },
            {
                "pred_row": {
                    "id": 12,
                    "pubmed_id": 30303,
                    "paper": "COPD and New Therapeutic Approaches",
                    "authors": "Patel, Raj; Singh, Maya",
                    "journal": "Respiratory Medicine",
                    "publication_date": "2021-11-20",
                    "disease": "Chronic Obstructive Pulmonary Disease (COPD)",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "Inhaled corticosteroids (ICS) and long-acting bronchodilators (LABA or LAMA)",
                    "medical_outcome": "Percentage improvement in FEV1 from baseline",
                    "result": "8%",
                    "outcome_category": "Physiological Measure",
                    "outcome_evaluation": "significantly worse"
                },
                "similarity": {
                    "disease_correct": 0.30662208795547485,
                    "medication_group_correct": 0.49546343088150024,
                    "therapy_or_medication_correct": 0.7638890147209167,
                    "medical_outcome_correct": 0.8447293639183044,
                    "result_correct": 0.6805226802825928,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.790851891040802,
                    "score": 4.882078588008881
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 30303,
            "papername": "COPD and New Therapeutic Approaches",
            "authors": "Patel, Raj; Singh, Maya",
            "publication_date": "2021-11-20",
            "journal": "Respiratory Medicine",
            "disease": "COPD",
            "medication_group": "Bronchodilator group",
            "therapy_or_medication": "Bronchodilators",
            "medical_outcome": "Improvement in FEV1",
            "result": 0.08,
            "outcome_category": "Physiological Measure",
            "outcome_evaluation": "no significant differences"
        },
        "pred_row": {
            "id": 12,
            "pubmed_id": 30303,
            "paper": "COPD and New Therapeutic Approaches",
            "authors": "Patel, Raj; Singh, Maya",
            "journal": "Respiratory Medicine",
            "publication_date": "2021-11-20",
            "disease": "Chronic Obstructive Pulmonary Disease (COPD)",
            "medication_group": "No group specified",
            "therapy_or_medication": "Inhaled corticosteroids (ICS) and long-acting bronchodilators (LABA or LAMA)",
            "medical_outcome": "Percentage improvement in FEV1 from baseline",
            "result": "8%",
            "outcome_category": "Physiological Measure",
            "outcome_evaluation": "significantly worse"
        },
        "best_similarity": {
            "disease_correct": 0.30662208795547485,
            "medication_group_correct": 0.45707398653030396,
            "therapy_or_medication_correct": 0.7345694303512573,
            "medical_outcome_correct": 0.8447293639183044,
            "result_correct": 0.6430200338363647,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 0.5732789039611816,
            "score": 4.5592939257621765
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 11,
                    "pubmed_id": 30303,
                    "paper": "COPD and New Therapeutic Approaches",
                    "authors": "Patel, Raj; Singh, Maya",
                    "journal": "Respiratory Medicine",
                    "publication_date": "2021-11-20",
                    "disease": "Chronic Obstructive Pulmonary Disease (COPD)",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "Inhaled corticosteroids (ICS) and long-acting bronchodilators (LABA or LAMA)",
                    "medical_outcome": "Percentage improvement in FEV1 from baseline",
                    "result": "10%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.30662208795547485,
                    "medication_group_correct": 0.45707398653030396,
                    "therapy_or_medication_correct": 0.7345694303512573,
                    "medical_outcome_correct": 0.8447293639183044,
                    "result_correct": 0.6414428949356079,
                    "outcome_category_correct": 0.7687371969223022,
                    "outcome_evaluation_correct": 0.632323145866394,
                    "score": 4.385498106479645
                }
            },
            {
                "pred_row": {
                    "id": 12,
                    "pubmed_id": 30303,
                    "paper": "COPD and New Therapeutic Approaches",
                    "authors": "Patel, Raj; Singh, Maya",
                    "journal": "Respiratory Medicine",
                    "publication_date": "2021-11-20",
                    "disease": "Chronic Obstructive Pulmonary Disease (COPD)",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "Inhaled corticosteroids (ICS) and long-acting bronchodilators (LABA or LAMA)",
                    "medical_outcome": "Percentage improvement in FEV1 from baseline",
                    "result": "8%",
                    "outcome_category": "Physiological Measure",
                    "outcome_evaluation": "significantly worse"
                },
                "similarity": {
                    "disease_correct": 0.30662208795547485,
                    "medication_group_correct": 0.45707398653030396,
                    "therapy_or_medication_correct": 0.7345694303512573,
                    "medical_outcome_correct": 0.8447293639183044,
                    "result_correct": 0.6430200338363647,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.5732789039611816,
                    "score": 4.5592939257621765
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 40404,
            "papername": "Heart Failure: A Modern Approach",
            "authors": "Chen, Liu; Wang, Ming",
            "publication_date": "2023-06-17",
            "journal": "Cardiology Journal",
            "disease": "Heart Failure",
            "medication_group": "ACE inhibitors group",
            "therapy_or_medication": "ACE Inhibitors",
            "medical_outcome": "Reduction in Mortality",
            "result": "5.5%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "no significant differences"
        },
        "pred_row": {
            "id": 13,
            "pubmed_id": 40404,
            "paper": "Heart Failure: A Modern Approach",
            "authors": "Chen, Liu; Wang, Ming",
            "journal": "Cardiology Journal",
            "publication_date": "2023-06-17",
            "disease": "Heart Failure",
            "medication_group": "No group specified",
            "therapy_or_medication": "ACE inhibitors",
            "medical_outcome": "Mortality reduction",
            "result": "5.5%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "no significant difference"
        },
        "best_similarity": {
            "disease_correct": 0.9999998211860657,
            "medication_group_correct": 0.5563846826553345,
            "therapy_or_medication_correct": 1.0,
            "medical_outcome_correct": 0.9141057729721069,
            "result_correct": 1.0000001192092896,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 0.8671942949295044,
            "score": 6.337684810161591
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 13,
                    "pubmed_id": 40404,
                    "paper": "Heart Failure: A Modern Approach",
                    "authors": "Chen, Liu; Wang, Ming",
                    "journal": "Cardiology Journal",
                    "publication_date": "2023-06-17",
                    "disease": "Heart Failure",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "ACE inhibitors",
                    "medical_outcome": "Mortality reduction",
                    "result": "5.5%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "no significant difference"
                },
                "similarity": {
                    "disease_correct": 0.9999998211860657,
                    "medication_group_correct": 0.5563846826553345,
                    "therapy_or_medication_correct": 1.0,
                    "medical_outcome_correct": 0.9141057729721069,
                    "result_correct": 1.0000001192092896,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.8671942949295044,
                    "score": 6.337684810161591
                }
            },
            {
                "pred_row": {
                    "id": 14,
                    "pubmed_id": 40404,
                    "paper": "Heart Failure: A Modern Approach",
                    "authors": "Chen, Liu; Wang, Ming",
                    "journal": "Cardiology Journal",
                    "publication_date": "2023-06-17",
                    "disease": "Heart Failure",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "Beta blockers",
                    "medical_outcome": "Mortality reduction",
                    "result": "6.1%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "no significant difference"
                },
                "similarity": {
                    "disease_correct": 0.9999998211860657,
                    "medication_group_correct": 0.5563846826553345,
                    "therapy_or_medication_correct": 0.6777094602584839,
                    "medical_outcome_correct": 0.9141057729721069,
                    "result_correct": 0.9452469944953918,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.8671942949295044,
                    "score": 5.960641145706177
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 40404,
            "papername": "Heart Failure: A Modern Approach",
            "authors": "Chen, Liu; Wang, Ming",
            "publication_date": "2023-06-17",
            "journal": "Cardiology Journal",
            "disease": "Heart Failure",
            "medication_group": "Beta blockers group",
            "therapy_or_medication": "Beta Blockers",
            "medical_outcome": "Reduction in Mortality",
            "result": "6.1%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "no significant differences"
        },
        "pred_row": {
            "id": 14,
            "pubmed_id": 40404,
            "paper": "Heart Failure: A Modern Approach",
            "authors": "Chen, Liu; Wang, Ming",
            "journal": "Cardiology Journal",
            "publication_date": "2023-06-17",
            "disease": "Heart Failure",
            "medication_group": "No group specified",
            "therapy_or_medication": "Beta blockers",
            "medical_outcome": "Mortality reduction",
            "result": "6.1%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "no significant difference"
        },
        "best_similarity": {
            "disease_correct": 0.9999998211860657,
            "medication_group_correct": 0.44781699776649475,
            "therapy_or_medication_correct": 0.9999999403953552,
            "medical_outcome_correct": 0.9141057729721069,
            "result_correct": 1.0000001192092896,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 0.8671942949295044,
            "score": 6.229117065668106
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 13,
                    "pubmed_id": 40404,
                    "paper": "Heart Failure: A Modern Approach",
                    "authors": "Chen, Liu; Wang, Ming",
                    "journal": "Cardiology Journal",
                    "publication_date": "2023-06-17",
                    "disease": "Heart Failure",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "ACE inhibitors",
                    "medical_outcome": "Mortality reduction",
                    "result": "5.5%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "no significant difference"
                },
                "similarity": {
                    "disease_correct": 0.9999998211860657,
                    "medication_group_correct": 0.44781699776649475,
                    "therapy_or_medication_correct": 0.6777094602584839,
                    "medical_outcome_correct": 0.9141057729721069,
                    "result_correct": 0.9452469944953918,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.8671942949295044,
                    "score": 5.852073460817337
                }
            },
            {
                "pred_row": {
                    "id": 14,
                    "pubmed_id": 40404,
                    "paper": "Heart Failure: A Modern Approach",
                    "authors": "Chen, Liu; Wang, Ming",
                    "journal": "Cardiology Journal",
                    "publication_date": "2023-06-17",
                    "disease": "Heart Failure",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "Beta blockers",
                    "medical_outcome": "Mortality reduction",
                    "result": "6.1%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "no significant difference"
                },
                "similarity": {
                    "disease_correct": 0.9999998211860657,
                    "medication_group_correct": 0.44781699776649475,
                    "therapy_or_medication_correct": 0.9999999403953552,
                    "medical_outcome_correct": 0.9141057729721069,
                    "result_correct": 1.0000001192092896,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.8671942949295044,
                    "score": 6.229117065668106
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 50505,
            "papername": "New Insights into Parkinson's Disease",
            "authors": "Garcia, Maria; Lopez, Carlos",
            "publication_date": "2024-07-21",
            "journal": "Neurological Sciences",
            "disease": "Parkinson's",
            "medication_group": "No group specified",
            "therapy_or_medication": "Levodopa",
            "medical_outcome": "Reduction in Symptoms",
            "result": 0.3,
            "outcome_category": "Symptom Intensity and Relief",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 15,
            "pubmed_id": 50505,
            "paper": "New Insights into Parkinson's Disease",
            "authors": "Garcia, Maria; Lopez, Carlos",
            "journal": "Neurological Sciences",
            "publication_date": "2024-07-21",
            "disease": "Parkinson's disease",
            "medication_group": "Patients diagnosed with Parkinson's disease and experiencing at least mild to moderate symptoms",
            "therapy_or_medication": "Levodopa",
            "medical_outcome": "percentage reduction in overall Parkinson's symptoms",
            "result": "30%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 0.7776836156845093,
            "medication_group_correct": 0.3773135542869568,
            "therapy_or_medication_correct": 1.0,
            "medical_outcome_correct": 0.7989555597305298,
            "result_correct": 0.7367587685585022,
            "outcome_category_correct": 0.6335793137550354,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 5.324290633201599
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 15,
                    "pubmed_id": 50505,
                    "paper": "New Insights into Parkinson's Disease",
                    "authors": "Garcia, Maria; Lopez, Carlos",
                    "journal": "Neurological Sciences",
                    "publication_date": "2024-07-21",
                    "disease": "Parkinson's disease",
                    "medication_group": "Patients diagnosed with Parkinson's disease and experiencing at least mild to moderate symptoms",
                    "therapy_or_medication": "Levodopa",
                    "medical_outcome": "percentage reduction in overall Parkinson's symptoms",
                    "result": "30%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.7776836156845093,
                    "medication_group_correct": 0.3773135542869568,
                    "therapy_or_medication_correct": 1.0,
                    "medical_outcome_correct": 0.7989555597305298,
                    "result_correct": 0.7367587685585022,
                    "outcome_category_correct": 0.6335793137550354,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.324290633201599
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 60606,
            "papername": "Breast Cancer: Treatment Horizons",
            "authors": "Martin, Andrew; Ng, Tiffany",
            "publication_date": "2023-10-30",
            "journal": "Oncology Reports",
            "disease": "Breast Cancer",
            "medication_group": "No group specified",
            "therapy_or_medication": "Tamoxifen",
            "medical_outcome": "Reduction in Recurrence",
            "result": "25.5%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 16,
            "pubmed_id": 60606,
            "paper": "Breast Cancer: Treatment Horizons",
            "authors": "Martin, Andrew; Ng, Tiffany",
            "journal": "Oncology Reports",
            "publication_date": "2023-10-30",
            "disease": "Breast cancer",
            "medication_group": "Women diagnosed with estrogen receptor-positive breast cancer",
            "therapy_or_medication": "Tamoxifen",
            "medical_outcome": "reduction in recurrence rates",
            "result": "25.5%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0000001192092896,
            "medication_group_correct": 0.3430217206478119,
            "therapy_or_medication_correct": 1.0,
            "medical_outcome_correct": 0.7898229360580444,
            "result_correct": 1.0000001192092896,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 6.132844835519791
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 16,
                    "pubmed_id": 60606,
                    "paper": "Breast Cancer: Treatment Horizons",
                    "authors": "Martin, Andrew; Ng, Tiffany",
                    "journal": "Oncology Reports",
                    "publication_date": "2023-10-30",
                    "disease": "Breast cancer",
                    "medication_group": "Women diagnosed with estrogen receptor-positive breast cancer",
                    "therapy_or_medication": "Tamoxifen",
                    "medical_outcome": "reduction in recurrence rates",
                    "result": "25.5%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.3430217206478119,
                    "therapy_or_medication_correct": 1.0,
                    "medical_outcome_correct": 0.7898229360580444,
                    "result_correct": 1.0000001192092896,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.132844835519791
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 70707,
            "papername": "Advances in Rheumatoid Arthritis Therapy",
            "authors": "O'Connor, Sean; Walsh, Fiona",
            "publication_date": "2024-03-17",
            "journal": "Rheumatology International",
            "disease": "Arthritis",
            "medication_group": "No group specified",
            "therapy_or_medication": "Methotrexate",
            "medical_outcome": "Reduction in Pain",
            "result": 0.4,
            "outcome_category": "Symptom Intensity and Relief",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 17,
            "pubmed_id": 70707,
            "paper": "Advances in Rheumatoid Arthritis Therapy",
            "authors": "O'Connor, Sean; Walsh, Fiona",
            "journal": "Rheumatology International",
            "publication_date": "2024-03-17",
            "disease": "Rheumatoid Arthritis",
            "medication_group": "Arthritis patients",
            "therapy_or_medication": "Methotrexate",
            "medical_outcome": "percentage reduction in pain levels",
            "result": "40%",
            "outcome_category": "Symptom Intensity and Relief",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 0.2728271484375,
            "medication_group_correct": 0.596625566482544,
            "therapy_or_medication_correct": 1.0,
            "medical_outcome_correct": 0.8682041168212891,
            "result_correct": 0.7082979679107666,
            "outcome_category_correct": 1.0,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 5.445954620838165
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 17,
                    "pubmed_id": 70707,
                    "paper": "Advances in Rheumatoid Arthritis Therapy",
                    "authors": "O'Connor, Sean; Walsh, Fiona",
                    "journal": "Rheumatology International",
                    "publication_date": "2024-03-17",
                    "disease": "Rheumatoid Arthritis",
                    "medication_group": "Arthritis patients",
                    "therapy_or_medication": "Methotrexate",
                    "medical_outcome": "percentage reduction in pain levels",
                    "result": "40%",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.2728271484375,
                    "medication_group_correct": 0.596625566482544,
                    "therapy_or_medication_correct": 1.0,
                    "medical_outcome_correct": 0.8682041168212891,
                    "result_correct": 0.7082979679107666,
                    "outcome_category_correct": 1.0,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.445954620838165
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 80808,
            "papername": "Alzheimer's Disease: Beyond the Basics",
            "authors": "Suzuki, Hiro; Tanaka, Yumi",
            "publication_date": "2022-10-10",
            "journal": "Journal of Geriatric Medicine",
            "disease": "Alzheimer's",
            "medication_group": "No group specified",
            "therapy_or_medication": "Donepezil",
            "medical_outcome": "Cognitive Improvement",
            "result": 0.15,
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 18,
            "pubmed_id": 80808,
            "paper": "Alzheimer's Disease: Beyond the Basics",
            "authors": "Suzuki, Hiro; Tanaka, Yumi",
            "journal": "Journal of Geriatric Medicine",
            "publication_date": "2022-10-10",
            "disease": "Alzheimer's disease",
            "medication_group": "Patients diagnosed with mild to moderate Alzheimer's disease",
            "therapy_or_medication": "Donepezil",
            "medical_outcome": "Cognitive function improvement",
            "result": "15%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 0.8405335545539856,
            "medication_group_correct": 0.39695245027542114,
            "therapy_or_medication_correct": 1.0000001192092896,
            "medical_outcome_correct": 0.9286990761756897,
            "result_correct": 0.7188842296600342,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 5.885069370269775
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 18,
                    "pubmed_id": 80808,
                    "paper": "Alzheimer's Disease: Beyond the Basics",
                    "authors": "Suzuki, Hiro; Tanaka, Yumi",
                    "journal": "Journal of Geriatric Medicine",
                    "publication_date": "2022-10-10",
                    "disease": "Alzheimer's disease",
                    "medication_group": "Patients diagnosed with mild to moderate Alzheimer's disease",
                    "therapy_or_medication": "Donepezil",
                    "medical_outcome": "Cognitive function improvement",
                    "result": "15%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.8405335545539856,
                    "medication_group_correct": 0.39695245027542114,
                    "therapy_or_medication_correct": 1.0000001192092896,
                    "medical_outcome_correct": 0.9286990761756897,
                    "result_correct": 0.7188842296600342,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.885069370269775
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 90909,
            "papername": "Stroke Rehabilitation Techniques",
            "authors": "Dubois, Rémi; Fontaine, Brigitte",
            "publication_date": "2023-05-26",
            "journal": "Stroke Research Today",
            "disease": "Stroke",
            "medication_group": "physiotherapy group",
            "therapy_or_medication": "Physiotherapy",
            "medical_outcome": "Recovery Improvement",
            "result": 0.2,
            "outcome_category": "Physiological Measure",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 19,
            "pubmed_id": 90909,
            "paper": "Stroke Rehabilitation Techniques",
            "authors": "Dubois, Rémi; Fontaine, Brigitte",
            "journal": "Stroke Research Today",
            "publication_date": "2023-05-26",
            "disease": "Stroke",
            "medication_group": "250 stroke survivors",
            "therapy_or_medication": "Physiotherapy",
            "medical_outcome": "Improvement in motor function",
            "result": "20% recovery improvement",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 0.9999999403953552,
            "medication_group_correct": 0.43780067563056946,
            "therapy_or_medication_correct": 1.000000238418579,
            "medical_outcome_correct": 0.6976847648620605,
            "result_correct": 0.5829256176948547,
            "outcome_category_correct": 0.7687371969223022,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 5.487148255109787
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 19,
                    "pubmed_id": 90909,
                    "paper": "Stroke Rehabilitation Techniques",
                    "authors": "Dubois, Rémi; Fontaine, Brigitte",
                    "journal": "Stroke Research Today",
                    "publication_date": "2023-05-26",
                    "disease": "Stroke",
                    "medication_group": "250 stroke survivors",
                    "therapy_or_medication": "Physiotherapy",
                    "medical_outcome": "Improvement in motor function",
                    "result": "20% recovery improvement",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.9999999403953552,
                    "medication_group_correct": 0.43780067563056946,
                    "therapy_or_medication_correct": 1.000000238418579,
                    "medical_outcome_correct": 0.6976847648620605,
                    "result_correct": 0.5829256176948547,
                    "outcome_category_correct": 0.7687371969223022,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.487148255109787
                }
            },
            {
                "pred_row": {
                    "id": 20,
                    "pubmed_id": 90909,
                    "paper": "Stroke Rehabilitation Techniques",
                    "authors": "Dubois, Rémi; Fontaine, Brigitte",
                    "journal": "Stroke Research Today",
                    "publication_date": "2023-05-26",
                    "disease": "Stroke",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "Enhanced physiotherapy",
                    "medical_outcome": "FIM and BI",
                    "result": "Significant improvement",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.9999999403953552,
                    "medication_group_correct": 0.39146900177001953,
                    "therapy_or_medication_correct": 0.9354562759399414,
                    "medical_outcome_correct": 0.5920241475105286,
                    "result_correct": 0.5515100955963135,
                    "outcome_category_correct": 0.7687371969223022,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.239196479320526
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 70101,
            "papername": "Advances in Pediatric Asthma Management",
            "authors": "Fisher, Anne; Roberts, Charles",
            "publication_date": "2024-01-10",
            "journal": "Pediatric Respiratory Journal",
            "disease": "Asthma",
            "medication_group": "Inhaler group",
            "therapy_or_medication": "Inhalers",
            "medical_outcome": "Symptom Reduction",
            "result": 0.3,
            "outcome_category": "Symptom Intensity and Relief",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 21,
            "pubmed_id": 70101,
            "paper": "Advances in Pediatric Asthma Management",
            "authors": "Fisher, Anne; Roberts, Charles",
            "journal": "Pediatric Respiratory Journal",
            "publication_date": "2024-01-10",
            "disease": "Asthma",
            "medication_group": "400 asthma patients, divided into four groups",
            "therapy_or_medication": "Inhalers",
            "medical_outcome": "Symptom reduction",
            "result": "30%",
            "outcome_category": "Symptom Intensity and Relief",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0,
            "medication_group_correct": 0.6037970781326294,
            "therapy_or_medication_correct": 1.0,
            "medical_outcome_correct": 0.9999998211860657,
            "result_correct": 0.7367587685585022,
            "outcome_category_correct": 1.0,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 6.340555489063263
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 21,
                    "pubmed_id": 70101,
                    "paper": "Advances in Pediatric Asthma Management",
                    "authors": "Fisher, Anne; Roberts, Charles",
                    "journal": "Pediatric Respiratory Journal",
                    "publication_date": "2024-01-10",
                    "disease": "Asthma",
                    "medication_group": "400 asthma patients, divided into four groups",
                    "therapy_or_medication": "Inhalers",
                    "medical_outcome": "Symptom reduction",
                    "result": "30%",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.6037970781326294,
                    "therapy_or_medication_correct": 1.0,
                    "medical_outcome_correct": 0.9999998211860657,
                    "result_correct": 0.7367587685585022,
                    "outcome_category_correct": 1.0,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.340555489063263
                }
            },
            {
                "pred_row": {
                    "id": 22,
                    "pubmed_id": 70101,
                    "paper": "Advances in Pediatric Asthma Management",
                    "authors": "Fisher, Anne; Roberts, Charles",
                    "journal": "Pediatric Respiratory Journal",
                    "publication_date": "2024-01-10",
                    "disease": "Asthma",
                    "medication_group": "400 asthma patients, divided into four groups",
                    "therapy_or_medication": "Corticosteroids",
                    "medical_outcome": "Frequency of asthma attacks",
                    "result": "25% reduction",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.6037970781326294,
                    "therapy_or_medication_correct": 0.6464141607284546,
                    "medical_outcome_correct": 0.71197509765625,
                    "result_correct": 0.6522531509399414,
                    "outcome_category_correct": 0.6335793137550354,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.2480186223983765
                }
            },
            {
                "pred_row": {
                    "id": 23,
                    "pubmed_id": 70101,
                    "paper": "Advances in Pediatric Asthma Management",
                    "authors": "Fisher, Anne; Roberts, Charles",
                    "journal": "Pediatric Respiratory Journal",
                    "publication_date": "2024-01-10",
                    "disease": "Asthma",
                    "medication_group": "400 asthma patients, divided into four groups",
                    "therapy_or_medication": "Bronchodilators",
                    "medical_outcome": "FEV1 improvement",
                    "result": "20%",
                    "outcome_category": "Physiological Measure",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.6037970781326294,
                    "therapy_or_medication_correct": 0.6772893667221069,
                    "medical_outcome_correct": 0.6406682133674622,
                    "result_correct": 0.728091835975647,
                    "outcome_category_correct": 0.5669877529144287,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.21683406829834
                }
            },
            {
                "pred_row": {
                    "id": 24,
                    "pubmed_id": 70101,
                    "paper": "Advances in Pediatric Asthma Management",
                    "authors": "Fisher, Anne; Roberts, Charles",
                    "journal": "Pediatric Respiratory Journal",
                    "publication_date": "2024-01-10",
                    "disease": "Asthma",
                    "medication_group": "400 asthma patients, divided into four groups",
                    "therapy_or_medication": "Montelukast",
                    "medical_outcome": "Nighttime symptoms reduction",
                    "result": "35%",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.6037970781326294,
                    "therapy_or_medication_correct": 0.33647972345352173,
                    "medical_outcome_correct": 0.7227962017059326,
                    "result_correct": 0.6916147470474243,
                    "outcome_category_correct": 1.0,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.354687571525574
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 70101,
            "papername": "Advances in Pediatric Asthma Management",
            "authors": "Fisher, Anne; Roberts, Charles",
            "publication_date": "2024-01-10",
            "journal": "Pediatric Respiratory Journal",
            "disease": "Asthma",
            "medication_group": "Corticosteroid group",
            "therapy_or_medication": "Corticosteroids",
            "medical_outcome": "Attack Frequency Reduction",
            "result": 0.25,
            "outcome_category": "Symptom Intensity and Relief",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 21,
            "pubmed_id": 70101,
            "paper": "Advances in Pediatric Asthma Management",
            "authors": "Fisher, Anne; Roberts, Charles",
            "journal": "Pediatric Respiratory Journal",
            "publication_date": "2024-01-10",
            "disease": "Asthma",
            "medication_group": "400 asthma patients, divided into four groups",
            "therapy_or_medication": "Inhalers",
            "medical_outcome": "Symptom reduction",
            "result": "30%",
            "outcome_category": "Symptom Intensity and Relief",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0,
            "medication_group_correct": 0.5144135355949402,
            "therapy_or_medication_correct": 0.6464141607284546,
            "medical_outcome_correct": 0.5959733724594116,
            "result_correct": 0.7246699929237366,
            "outcome_category_correct": 1.0,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 5.481470882892609
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 21,
                    "pubmed_id": 70101,
                    "paper": "Advances in Pediatric Asthma Management",
                    "authors": "Fisher, Anne; Roberts, Charles",
                    "journal": "Pediatric Respiratory Journal",
                    "publication_date": "2024-01-10",
                    "disease": "Asthma",
                    "medication_group": "400 asthma patients, divided into four groups",
                    "therapy_or_medication": "Inhalers",
                    "medical_outcome": "Symptom reduction",
                    "result": "30%",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.5144135355949402,
                    "therapy_or_medication_correct": 0.6464141607284546,
                    "medical_outcome_correct": 0.5959733724594116,
                    "result_correct": 0.7246699929237366,
                    "outcome_category_correct": 1.0,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.481470882892609
                }
            },
            {
                "pred_row": {
                    "id": 22,
                    "pubmed_id": 70101,
                    "paper": "Advances in Pediatric Asthma Management",
                    "authors": "Fisher, Anne; Roberts, Charles",
                    "journal": "Pediatric Respiratory Journal",
                    "publication_date": "2024-01-10",
                    "disease": "Asthma",
                    "medication_group": "400 asthma patients, divided into four groups",
                    "therapy_or_medication": "Corticosteroids",
                    "medical_outcome": "Frequency of asthma attacks",
                    "result": "25% reduction",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.5144135355949402,
                    "therapy_or_medication_correct": 1.0000001192092896,
                    "medical_outcome_correct": 0.5729936957359314,
                    "result_correct": 0.6621953248977661,
                    "outcome_category_correct": 0.6335793137550354,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.383181810379028
                }
            },
            {
                "pred_row": {
                    "id": 23,
                    "pubmed_id": 70101,
                    "paper": "Advances in Pediatric Asthma Management",
                    "authors": "Fisher, Anne; Roberts, Charles",
                    "journal": "Pediatric Respiratory Journal",
                    "publication_date": "2024-01-10",
                    "disease": "Asthma",
                    "medication_group": "400 asthma patients, divided into four groups",
                    "therapy_or_medication": "Bronchodilators",
                    "medical_outcome": "FEV1 improvement",
                    "result": "20%",
                    "outcome_category": "Physiological Measure",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.5144135355949402,
                    "therapy_or_medication_correct": 0.6788390874862671,
                    "medical_outcome_correct": 0.6125649809837341,
                    "result_correct": 0.7297960519790649,
                    "outcome_category_correct": 0.5669877529144287,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.102601230144501
                }
            },
            {
                "pred_row": {
                    "id": 24,
                    "pubmed_id": 70101,
                    "paper": "Advances in Pediatric Asthma Management",
                    "authors": "Fisher, Anne; Roberts, Charles",
                    "journal": "Pediatric Respiratory Journal",
                    "publication_date": "2024-01-10",
                    "disease": "Asthma",
                    "medication_group": "400 asthma patients, divided into four groups",
                    "therapy_or_medication": "Montelukast",
                    "medical_outcome": "Nighttime symptoms reduction",
                    "result": "35%",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.5144135355949402,
                    "therapy_or_medication_correct": 0.4172605872154236,
                    "medical_outcome_correct": 0.6898645162582397,
                    "result_correct": 0.6750593185424805,
                    "outcome_category_correct": 1.0,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.29659777879715
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 70101,
            "papername": "Advances in Pediatric Asthma Management",
            "authors": "Fisher, Anne; Roberts, Charles",
            "publication_date": "2024-01-10",
            "journal": "Pediatric Respiratory Journal",
            "disease": "Asthma",
            "medication_group": "Bronchodilator group",
            "therapy_or_medication": "Bronchodilators",
            "medical_outcome": "Improvement in FEV1",
            "result": 0.2,
            "outcome_category": "Physiological Measure",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 23,
            "pubmed_id": 70101,
            "paper": "Advances in Pediatric Asthma Management",
            "authors": "Fisher, Anne; Roberts, Charles",
            "journal": "Pediatric Respiratory Journal",
            "publication_date": "2024-01-10",
            "disease": "Asthma",
            "medication_group": "400 asthma patients, divided into four groups",
            "therapy_or_medication": "Bronchodilators",
            "medical_outcome": "FEV1 improvement",
            "result": "20%",
            "outcome_category": "Physiological Measure",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0,
            "medication_group_correct": 0.5302796363830566,
            "therapy_or_medication_correct": 1.0000001192092896,
            "medical_outcome_correct": 0.9151832461357117,
            "result_correct": 0.7083132863044739,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 6.153776228427887
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 21,
                    "pubmed_id": 70101,
                    "paper": "Advances in Pediatric Asthma Management",
                    "authors": "Fisher, Anne; Roberts, Charles",
                    "journal": "Pediatric Respiratory Journal",
                    "publication_date": "2024-01-10",
                    "disease": "Asthma",
                    "medication_group": "400 asthma patients, divided into four groups",
                    "therapy_or_medication": "Inhalers",
                    "medical_outcome": "Symptom reduction",
                    "result": "30%",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.5302796363830566,
                    "therapy_or_medication_correct": 0.6772893667221069,
                    "medical_outcome_correct": 0.6350323557853699,
                    "result_correct": 0.7168143391609192,
                    "outcome_category_correct": 0.5669877529144287,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.126403272151947
                }
            },
            {
                "pred_row": {
                    "id": 22,
                    "pubmed_id": 70101,
                    "paper": "Advances in Pediatric Asthma Management",
                    "authors": "Fisher, Anne; Roberts, Charles",
                    "journal": "Pediatric Respiratory Journal",
                    "publication_date": "2024-01-10",
                    "disease": "Asthma",
                    "medication_group": "400 asthma patients, divided into four groups",
                    "therapy_or_medication": "Corticosteroids",
                    "medical_outcome": "Frequency of asthma attacks",
                    "result": "25% reduction",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.5302796363830566,
                    "therapy_or_medication_correct": 0.6788390874862671,
                    "medical_outcome_correct": 0.6038203239440918,
                    "result_correct": 0.6427268981933594,
                    "outcome_category_correct": 0.7687371969223022,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.224402964115143
                }
            },
            {
                "pred_row": {
                    "id": 23,
                    "pubmed_id": 70101,
                    "paper": "Advances in Pediatric Asthma Management",
                    "authors": "Fisher, Anne; Roberts, Charles",
                    "journal": "Pediatric Respiratory Journal",
                    "publication_date": "2024-01-10",
                    "disease": "Asthma",
                    "medication_group": "400 asthma patients, divided into four groups",
                    "therapy_or_medication": "Bronchodilators",
                    "medical_outcome": "FEV1 improvement",
                    "result": "20%",
                    "outcome_category": "Physiological Measure",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.5302796363830566,
                    "therapy_or_medication_correct": 1.0000001192092896,
                    "medical_outcome_correct": 0.9151832461357117,
                    "result_correct": 0.7083132863044739,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.153776228427887
                }
            },
            {
                "pred_row": {
                    "id": 24,
                    "pubmed_id": 70101,
                    "paper": "Advances in Pediatric Asthma Management",
                    "authors": "Fisher, Anne; Roberts, Charles",
                    "journal": "Pediatric Respiratory Journal",
                    "publication_date": "2024-01-10",
                    "disease": "Asthma",
                    "medication_group": "400 asthma patients, divided into four groups",
                    "therapy_or_medication": "Montelukast",
                    "medical_outcome": "Nighttime symptoms reduction",
                    "result": "35%",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.5302796363830566,
                    "therapy_or_medication_correct": 0.40236538648605347,
                    "medical_outcome_correct": 0.5802854895591736,
                    "result_correct": 0.6693260669708252,
                    "outcome_category_correct": 0.5669877529144287,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 4.749244153499603
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 70101,
            "papername": "Advances in Pediatric Asthma Management",
            "authors": "Fisher, Anne; Roberts, Charles",
            "publication_date": "2024-01-10",
            "journal": "Pediatric Respiratory Journal",
            "disease": "Asthma",
            "medication_group": "Montelukast group",
            "therapy_or_medication": "Montelukast",
            "medical_outcome": "Nighttime Symptoms Reduction",
            "result": 0.35,
            "outcome_category": "Symptom Intensity and Relief",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 24,
            "pubmed_id": 70101,
            "paper": "Advances in Pediatric Asthma Management",
            "authors": "Fisher, Anne; Roberts, Charles",
            "journal": "Pediatric Respiratory Journal",
            "publication_date": "2024-01-10",
            "disease": "Asthma",
            "medication_group": "400 asthma patients, divided into four groups",
            "therapy_or_medication": "Montelukast",
            "medical_outcome": "Nighttime symptoms reduction",
            "result": "35%",
            "outcome_category": "Symptom Intensity and Relief",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0,
            "medication_group_correct": 0.5140041708946228,
            "therapy_or_medication_correct": 1.0000001192092896,
            "medical_outcome_correct": 1.0000001192092896,
            "result_correct": 0.7251928448677063,
            "outcome_category_correct": 1.0,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 6.239197075366974
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 21,
                    "pubmed_id": 70101,
                    "paper": "Advances in Pediatric Asthma Management",
                    "authors": "Fisher, Anne; Roberts, Charles",
                    "journal": "Pediatric Respiratory Journal",
                    "publication_date": "2024-01-10",
                    "disease": "Asthma",
                    "medication_group": "400 asthma patients, divided into four groups",
                    "therapy_or_medication": "Inhalers",
                    "medical_outcome": "Symptom reduction",
                    "result": "30%",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.5140041708946228,
                    "therapy_or_medication_correct": 0.33647972345352173,
                    "medical_outcome_correct": 0.7227962017059326,
                    "result_correct": 0.7438833713531494,
                    "outcome_category_correct": 1.0,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.317163288593292
                }
            },
            {
                "pred_row": {
                    "id": 22,
                    "pubmed_id": 70101,
                    "paper": "Advances in Pediatric Asthma Management",
                    "authors": "Fisher, Anne; Roberts, Charles",
                    "journal": "Pediatric Respiratory Journal",
                    "publication_date": "2024-01-10",
                    "disease": "Asthma",
                    "medication_group": "400 asthma patients, divided into four groups",
                    "therapy_or_medication": "Corticosteroids",
                    "medical_outcome": "Frequency of asthma attacks",
                    "result": "25% reduction",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.5140041708946228,
                    "therapy_or_medication_correct": 0.4172605872154236,
                    "medical_outcome_correct": 0.7604373097419739,
                    "result_correct": 0.6668701767921448,
                    "outcome_category_correct": 0.6335793137550354,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 4.992151379585266
                }
            },
            {
                "pred_row": {
                    "id": 23,
                    "pubmed_id": 70101,
                    "paper": "Advances in Pediatric Asthma Management",
                    "authors": "Fisher, Anne; Roberts, Charles",
                    "journal": "Pediatric Respiratory Journal",
                    "publication_date": "2024-01-10",
                    "disease": "Asthma",
                    "medication_group": "400 asthma patients, divided into four groups",
                    "therapy_or_medication": "Bronchodilators",
                    "medical_outcome": "FEV1 improvement",
                    "result": "20%",
                    "outcome_category": "Physiological Measure",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.5140041708946228,
                    "therapy_or_medication_correct": 0.40236538648605347,
                    "medical_outcome_correct": 0.6232593059539795,
                    "result_correct": 0.7273318767547607,
                    "outcome_category_correct": 0.5669877529144287,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 4.833948314189911
                }
            },
            {
                "pred_row": {
                    "id": 24,
                    "pubmed_id": 70101,
                    "paper": "Advances in Pediatric Asthma Management",
                    "authors": "Fisher, Anne; Roberts, Charles",
                    "journal": "Pediatric Respiratory Journal",
                    "publication_date": "2024-01-10",
                    "disease": "Asthma",
                    "medication_group": "400 asthma patients, divided into four groups",
                    "therapy_or_medication": "Montelukast",
                    "medical_outcome": "Nighttime symptoms reduction",
                    "result": "35%",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.5140041708946228,
                    "therapy_or_medication_correct": 1.0000001192092896,
                    "medical_outcome_correct": 1.0000001192092896,
                    "result_correct": 0.7251928448677063,
                    "outcome_category_correct": 1.0,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.239197075366974
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 70202,
            "papername": "Breakthroughs in Hepatitis C Treatment",
            "authors": "Nguyen, Julia; Lee, David",
            "publication_date": "2024-03-15",
            "journal": "Liver Disease & Therapy",
            "disease": "Hepatitis C",
            "medication_group": "Direct-acting antivirals group",
            "therapy_or_medication": "Direct-acting Antivirals",
            "medical_outcome": "Sustained Virologic Response",
            "result": 0.95,
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 25,
            "pubmed_id": 70202,
            "paper": "Breakthroughs in Hepatitis C Treatment",
            "authors": "Nguyen, Julia; Lee, David",
            "journal": "Liver Disease & Therapy",
            "publication_date": "2024-03-15",
            "disease": "Hepatitis C",
            "medication_group": "No group specified",
            "therapy_or_medication": "Direct-acting antivirals",
            "medical_outcome": "Sustained virologic response",
            "result": "95%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0,
            "medication_group_correct": 0.44401249289512634,
            "therapy_or_medication_correct": 0.9999999403953552,
            "medical_outcome_correct": 0.9999998807907104,
            "result_correct": 0.6930093765258789,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 6.137021631002426
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 25,
                    "pubmed_id": 70202,
                    "paper": "Breakthroughs in Hepatitis C Treatment",
                    "authors": "Nguyen, Julia; Lee, David",
                    "journal": "Liver Disease & Therapy",
                    "publication_date": "2024-03-15",
                    "disease": "Hepatitis C",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "Direct-acting antivirals",
                    "medical_outcome": "Sustained virologic response",
                    "result": "95%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.44401249289512634,
                    "therapy_or_medication_correct": 0.9999999403953552,
                    "medical_outcome_correct": 0.9999998807907104,
                    "result_correct": 0.6930093765258789,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.137021631002426
                }
            },
            {
                "pred_row": {
                    "id": 26,
                    "pubmed_id": 70202,
                    "paper": "Breakthroughs in Hepatitis C Treatment",
                    "authors": "Nguyen, Julia; Lee, David",
                    "journal": "Liver Disease & Therapy",
                    "publication_date": "2024-03-15",
                    "disease": "Hepatitis C",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "Ribavirin",
                    "medical_outcome": "Reduction in viral load",
                    "result": "90%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.44401249289512634,
                    "therapy_or_medication_correct": 0.6440858840942383,
                    "medical_outcome_correct": 0.7246887683868408,
                    "result_correct": 0.6818490028381348,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.494636088609695
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 70202,
            "papername": "Breakthroughs in Hepatitis C Treatment",
            "authors": "Nguyen, Julia; Lee, David",
            "publication_date": "2024-03-15",
            "journal": "Liver Disease & Therapy",
            "disease": "Hepatitis C",
            "medication_group": "Ribavirin group",
            "therapy_or_medication": "Ribavirin",
            "medical_outcome": "Reduction in Viral Load",
            "result": 0.9,
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 26,
            "pubmed_id": 70202,
            "paper": "Breakthroughs in Hepatitis C Treatment",
            "authors": "Nguyen, Julia; Lee, David",
            "journal": "Liver Disease & Therapy",
            "publication_date": "2024-03-15",
            "disease": "Hepatitis C",
            "medication_group": "No group specified",
            "therapy_or_medication": "Ribavirin",
            "medical_outcome": "Reduction in viral load",
            "result": "90%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0,
            "medication_group_correct": 0.5217463374137878,
            "therapy_or_medication_correct": 0.9999999403953552,
            "medical_outcome_correct": 1.0,
            "result_correct": 0.6751202940940857,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 6.196866512298584
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 25,
                    "pubmed_id": 70202,
                    "paper": "Breakthroughs in Hepatitis C Treatment",
                    "authors": "Nguyen, Julia; Lee, David",
                    "journal": "Liver Disease & Therapy",
                    "publication_date": "2024-03-15",
                    "disease": "Hepatitis C",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "Direct-acting antivirals",
                    "medical_outcome": "Sustained virologic response",
                    "result": "95%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.5217463374137878,
                    "therapy_or_medication_correct": 0.6440858840942383,
                    "medical_outcome_correct": 0.7246887683868408,
                    "result_correct": 0.6604457497596741,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.550966680049896
                }
            },
            {
                "pred_row": {
                    "id": 26,
                    "pubmed_id": 70202,
                    "paper": "Breakthroughs in Hepatitis C Treatment",
                    "authors": "Nguyen, Julia; Lee, David",
                    "journal": "Liver Disease & Therapy",
                    "publication_date": "2024-03-15",
                    "disease": "Hepatitis C",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "Ribavirin",
                    "medical_outcome": "Reduction in viral load",
                    "result": "90%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.5217463374137878,
                    "therapy_or_medication_correct": 0.9999999403953552,
                    "medical_outcome_correct": 1.0,
                    "result_correct": 0.6751202940940857,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.196866512298584
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 70303,
            "papername": "New Horizons in Multiple Sclerosis Therapy",
            "authors": "Watkins, Sarah; Morris, Greg",
            "publication_date": "2024-05-22",
            "journal": "Neurology Today",
            "disease": "Multiple Sclerosis",
            "medication_group": "Ocrelizumab group",
            "therapy_or_medication": "Ocrelizumab",
            "medical_outcome": "Reduction in Relapse Rate",
            "result": 0.4,
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 27,
            "pubmed_id": 70303,
            "paper": "New Horizons in Multiple Sclerosis Therapy",
            "authors": "Watkins, Sarah; Morris, Greg",
            "journal": "Neurology Today",
            "publication_date": "2024-05-22",
            "disease": "Multiple Sclerosis",
            "medication_group": "400 MS patients",
            "therapy_or_medication": "Ocrelizumab",
            "medical_outcome": "reduction in relapse rate",
            "result": "40%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0,
            "medication_group_correct": 0.4997812509536743,
            "therapy_or_medication_correct": 1.0000001192092896,
            "medical_outcome_correct": 1.0,
            "result_correct": 0.7082979679107666,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 6.208079278469086
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 27,
                    "pubmed_id": 70303,
                    "paper": "New Horizons in Multiple Sclerosis Therapy",
                    "authors": "Watkins, Sarah; Morris, Greg",
                    "journal": "Neurology Today",
                    "publication_date": "2024-05-22",
                    "disease": "Multiple Sclerosis",
                    "medication_group": "400 MS patients",
                    "therapy_or_medication": "Ocrelizumab",
                    "medical_outcome": "reduction in relapse rate",
                    "result": "40%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.4997812509536743,
                    "therapy_or_medication_correct": 1.0000001192092896,
                    "medical_outcome_correct": 1.0,
                    "result_correct": 0.7082979679107666,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.208079278469086
                }
            },
            {
                "pred_row": {
                    "id": 28,
                    "pubmed_id": 70303,
                    "paper": "New Horizons in Multiple Sclerosis Therapy",
                    "authors": "Watkins, Sarah; Morris, Greg",
                    "journal": "Neurology Today",
                    "publication_date": "2024-05-22",
                    "disease": "Multiple Sclerosis",
                    "medication_group": "400 MS patients",
                    "therapy_or_medication": "Fingolimod",
                    "medical_outcome": "delay in disability progression",
                    "result": "30%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.4997812509536743,
                    "therapy_or_medication_correct": 0.5405124425888062,
                    "medical_outcome_correct": 0.8010380268096924,
                    "result_correct": 0.7156444191932678,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.556976079940796
                }
            },
            {
                "pred_row": {
                    "id": 29,
                    "pubmed_id": 70303,
                    "paper": "New Horizons in Multiple Sclerosis Therapy",
                    "authors": "Watkins, Sarah; Morris, Greg",
                    "journal": "Neurology Today",
                    "publication_date": "2024-05-22",
                    "disease": "Multiple Sclerosis",
                    "medication_group": "400 MS patients",
                    "therapy_or_medication": "Natalizumab",
                    "medical_outcome": "improvement in EDSS score",
                    "result": "25%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.4997812509536743,
                    "therapy_or_medication_correct": 0.7941705584526062,
                    "medical_outcome_correct": 0.6822563409805298,
                    "result_correct": 0.7089830040931702,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.685191094875336
                }
            },
            {
                "pred_row": {
                    "id": 30,
                    "pubmed_id": 70303,
                    "paper": "New Horizons in Multiple Sclerosis Therapy",
                    "authors": "Watkins, Sarah; Morris, Greg",
                    "journal": "Neurology Today",
                    "publication_date": "2024-05-22",
                    "disease": "Multiple Sclerosis",
                    "medication_group": "400 MS patients",
                    "therapy_or_medication": "Interferons",
                    "medical_outcome": "reduction in new lesion formation",
                    "result": "35%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.4997812509536743,
                    "therapy_or_medication_correct": 0.5146353244781494,
                    "medical_outcome_correct": 0.7905988097190857,
                    "result_correct": 0.685712456703186,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.490727782249451
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 70303,
            "papername": "New Horizons in Multiple Sclerosis Therapy",
            "authors": "Watkins, Sarah; Morris, Greg",
            "publication_date": "2024-05-22",
            "journal": "Neurology Today",
            "disease": "Multiple Sclerosis",
            "medication_group": "Fingolimod group",
            "therapy_or_medication": "Fingolimod",
            "medical_outcome": "Disability Progression Delay",
            "result": 0.3,
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 28,
            "pubmed_id": 70303,
            "paper": "New Horizons in Multiple Sclerosis Therapy",
            "authors": "Watkins, Sarah; Morris, Greg",
            "journal": "Neurology Today",
            "publication_date": "2024-05-22",
            "disease": "Multiple Sclerosis",
            "medication_group": "400 MS patients",
            "therapy_or_medication": "Fingolimod",
            "medical_outcome": "delay in disability progression",
            "result": "30%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0,
            "medication_group_correct": 0.5532276034355164,
            "therapy_or_medication_correct": 1.0000001192092896,
            "medical_outcome_correct": 0.8932804465293884,
            "result_correct": 0.7367587685585022,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 6.183266878128052
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 27,
                    "pubmed_id": 70303,
                    "paper": "New Horizons in Multiple Sclerosis Therapy",
                    "authors": "Watkins, Sarah; Morris, Greg",
                    "journal": "Neurology Today",
                    "publication_date": "2024-05-22",
                    "disease": "Multiple Sclerosis",
                    "medication_group": "400 MS patients",
                    "therapy_or_medication": "Ocrelizumab",
                    "medical_outcome": "reduction in relapse rate",
                    "result": "40%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.5532276034355164,
                    "therapy_or_medication_correct": 0.5405124425888062,
                    "medical_outcome_correct": 0.6895976662635803,
                    "result_correct": 0.7156912684440613,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.499028921127319
                }
            },
            {
                "pred_row": {
                    "id": 28,
                    "pubmed_id": 70303,
                    "paper": "New Horizons in Multiple Sclerosis Therapy",
                    "authors": "Watkins, Sarah; Morris, Greg",
                    "journal": "Neurology Today",
                    "publication_date": "2024-05-22",
                    "disease": "Multiple Sclerosis",
                    "medication_group": "400 MS patients",
                    "therapy_or_medication": "Fingolimod",
                    "medical_outcome": "delay in disability progression",
                    "result": "30%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.5532276034355164,
                    "therapy_or_medication_correct": 1.0000001192092896,
                    "medical_outcome_correct": 0.8932804465293884,
                    "result_correct": 0.7367587685585022,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.183266878128052
                }
            },
            {
                "pred_row": {
                    "id": 29,
                    "pubmed_id": 70303,
                    "paper": "New Horizons in Multiple Sclerosis Therapy",
                    "authors": "Watkins, Sarah; Morris, Greg",
                    "journal": "Neurology Today",
                    "publication_date": "2024-05-22",
                    "disease": "Multiple Sclerosis",
                    "medication_group": "400 MS patients",
                    "therapy_or_medication": "Natalizumab",
                    "medical_outcome": "improvement in EDSS score",
                    "result": "25%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.5532276034355164,
                    "therapy_or_medication_correct": 0.5121117830276489,
                    "medical_outcome_correct": 0.623502254486084,
                    "result_correct": 0.7206388115882874,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.409480392932892
                }
            },
            {
                "pred_row": {
                    "id": 30,
                    "pubmed_id": 70303,
                    "paper": "New Horizons in Multiple Sclerosis Therapy",
                    "authors": "Watkins, Sarah; Morris, Greg",
                    "journal": "Neurology Today",
                    "publication_date": "2024-05-22",
                    "disease": "Multiple Sclerosis",
                    "medication_group": "400 MS patients",
                    "therapy_or_medication": "Interferons",
                    "medical_outcome": "reduction in new lesion formation",
                    "result": "35%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.5532276034355164,
                    "therapy_or_medication_correct": 0.46600717306137085,
                    "medical_outcome_correct": 0.6636688113212585,
                    "result_correct": 0.6916147470474243,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.374518275260925
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 70303,
            "papername": "New Horizons in Multiple Sclerosis Therapy",
            "authors": "Watkins, Sarah; Morris, Greg",
            "publication_date": "2024-05-22",
            "journal": "Neurology Today",
            "disease": "Multiple Sclerosis",
            "medication_group": "Natalizumab group",
            "therapy_or_medication": "Natalizumab",
            "medical_outcome": "Improvement in EDSS Score",
            "result": 0.25,
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 29,
            "pubmed_id": 70303,
            "paper": "New Horizons in Multiple Sclerosis Therapy",
            "authors": "Watkins, Sarah; Morris, Greg",
            "journal": "Neurology Today",
            "publication_date": "2024-05-22",
            "disease": "Multiple Sclerosis",
            "medication_group": "400 MS patients",
            "therapy_or_medication": "Natalizumab",
            "medical_outcome": "improvement in EDSS score",
            "result": "25%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0,
            "medication_group_correct": 0.5132340788841248,
            "therapy_or_medication_correct": 0.9999999403953552,
            "medical_outcome_correct": 1.0,
            "result_correct": 0.7425962090492249,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 6.25583016872406
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 27,
                    "pubmed_id": 70303,
                    "paper": "New Horizons in Multiple Sclerosis Therapy",
                    "authors": "Watkins, Sarah; Morris, Greg",
                    "journal": "Neurology Today",
                    "publication_date": "2024-05-22",
                    "disease": "Multiple Sclerosis",
                    "medication_group": "400 MS patients",
                    "therapy_or_medication": "Ocrelizumab",
                    "medical_outcome": "reduction in relapse rate",
                    "result": "40%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.5132340788841248,
                    "therapy_or_medication_correct": 0.7941705584526062,
                    "medical_outcome_correct": 0.6822563409805298,
                    "result_correct": 0.7111594080924988,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.700820326805115
                }
            },
            {
                "pred_row": {
                    "id": 28,
                    "pubmed_id": 70303,
                    "paper": "New Horizons in Multiple Sclerosis Therapy",
                    "authors": "Watkins, Sarah; Morris, Greg",
                    "journal": "Neurology Today",
                    "publication_date": "2024-05-22",
                    "disease": "Multiple Sclerosis",
                    "medication_group": "400 MS patients",
                    "therapy_or_medication": "Fingolimod",
                    "medical_outcome": "delay in disability progression",
                    "result": "30%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.5132340788841248,
                    "therapy_or_medication_correct": 0.5121117830276489,
                    "medical_outcome_correct": 0.680184006690979,
                    "result_correct": 0.7246699929237366,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.4301998019218445
                }
            },
            {
                "pred_row": {
                    "id": 29,
                    "pubmed_id": 70303,
                    "paper": "New Horizons in Multiple Sclerosis Therapy",
                    "authors": "Watkins, Sarah; Morris, Greg",
                    "journal": "Neurology Today",
                    "publication_date": "2024-05-22",
                    "disease": "Multiple Sclerosis",
                    "medication_group": "400 MS patients",
                    "therapy_or_medication": "Natalizumab",
                    "medical_outcome": "improvement in EDSS score",
                    "result": "25%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.5132340788841248,
                    "therapy_or_medication_correct": 0.9999999403953552,
                    "medical_outcome_correct": 1.0,
                    "result_correct": 0.7425962090492249,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.25583016872406
                }
            },
            {
                "pred_row": {
                    "id": 30,
                    "pubmed_id": 70303,
                    "paper": "New Horizons in Multiple Sclerosis Therapy",
                    "authors": "Watkins, Sarah; Morris, Greg",
                    "journal": "Neurology Today",
                    "publication_date": "2024-05-22",
                    "disease": "Multiple Sclerosis",
                    "medication_group": "400 MS patients",
                    "therapy_or_medication": "Interferons",
                    "medical_outcome": "reduction in new lesion formation",
                    "result": "35%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.5132340788841248,
                    "therapy_or_medication_correct": 0.4957568049430847,
                    "medical_outcome_correct": 0.6191977858543396,
                    "result_correct": 0.6750593185424805,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.303247928619385
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 70303,
            "papername": "New Horizons in Multiple Sclerosis Therapy",
            "authors": "Watkins, Sarah; Morris, Greg",
            "publication_date": "2024-05-22",
            "journal": "Neurology Today",
            "disease": "Multiple Sclerosis",
            "medication_group": "Interferons group",
            "therapy_or_medication": "Interferons",
            "medical_outcome": "Reduction in New Lesions",
            "result": 0.35,
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 30,
            "pubmed_id": 70303,
            "paper": "New Horizons in Multiple Sclerosis Therapy",
            "authors": "Watkins, Sarah; Morris, Greg",
            "journal": "Neurology Today",
            "publication_date": "2024-05-22",
            "disease": "Multiple Sclerosis",
            "medication_group": "400 MS patients",
            "therapy_or_medication": "Interferons",
            "medical_outcome": "reduction in new lesion formation",
            "result": "35%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0,
            "medication_group_correct": 0.5001487731933594,
            "therapy_or_medication_correct": 1.0,
            "medical_outcome_correct": 0.8683303594589233,
            "result_correct": 0.7251928448677063,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 6.093671917915344
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 27,
                    "pubmed_id": 70303,
                    "paper": "New Horizons in Multiple Sclerosis Therapy",
                    "authors": "Watkins, Sarah; Morris, Greg",
                    "journal": "Neurology Today",
                    "publication_date": "2024-05-22",
                    "disease": "Multiple Sclerosis",
                    "medication_group": "400 MS patients",
                    "therapy_or_medication": "Ocrelizumab",
                    "medical_outcome": "reduction in relapse rate",
                    "result": "40%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.5001487731933594,
                    "therapy_or_medication_correct": 0.5146353244781494,
                    "medical_outcome_correct": 0.7492890954017639,
                    "result_correct": 0.7294970750808716,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.4935702085494995
                }
            },
            {
                "pred_row": {
                    "id": 28,
                    "pubmed_id": 70303,
                    "paper": "New Horizons in Multiple Sclerosis Therapy",
                    "authors": "Watkins, Sarah; Morris, Greg",
                    "journal": "Neurology Today",
                    "publication_date": "2024-05-22",
                    "disease": "Multiple Sclerosis",
                    "medication_group": "400 MS patients",
                    "therapy_or_medication": "Fingolimod",
                    "medical_outcome": "delay in disability progression",
                    "result": "30%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.5001487731933594,
                    "therapy_or_medication_correct": 0.46600717306137085,
                    "medical_outcome_correct": 0.7876479625701904,
                    "result_correct": 0.7438833713531494,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.497687220573425
                }
            },
            {
                "pred_row": {
                    "id": 29,
                    "pubmed_id": 70303,
                    "paper": "New Horizons in Multiple Sclerosis Therapy",
                    "authors": "Watkins, Sarah; Morris, Greg",
                    "journal": "Neurology Today",
                    "publication_date": "2024-05-22",
                    "disease": "Multiple Sclerosis",
                    "medication_group": "400 MS patients",
                    "therapy_or_medication": "Natalizumab",
                    "medical_outcome": "improvement in EDSS score",
                    "result": "25%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.5001487731933594,
                    "therapy_or_medication_correct": 0.4957568049430847,
                    "medical_outcome_correct": 0.6700189709663391,
                    "result_correct": 0.7282050251960754,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.394129514694214
                }
            },
            {
                "pred_row": {
                    "id": 30,
                    "pubmed_id": 70303,
                    "paper": "New Horizons in Multiple Sclerosis Therapy",
                    "authors": "Watkins, Sarah; Morris, Greg",
                    "journal": "Neurology Today",
                    "publication_date": "2024-05-22",
                    "disease": "Multiple Sclerosis",
                    "medication_group": "400 MS patients",
                    "therapy_or_medication": "Interferons",
                    "medical_outcome": "reduction in new lesion formation",
                    "result": "35%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.5001487731933594,
                    "therapy_or_medication_correct": 1.0,
                    "medical_outcome_correct": 0.8683303594589233,
                    "result_correct": 0.7251928448677063,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.093671917915344
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 22222,
            "papername": "Chronic Heart Failure and New Interventions",
            "authors": "Jordan, Michael; Pippen, Scott",
            "publication_date": "2023-05-26",
            "journal": "Heart Care Journal",
            "disease": "Heart Failure",
            "medication_group": "Females group",
            "therapy_or_medication": "Digoxin",
            "medical_outcome": "Mortality Reduction",
            "result": "3.3%",
            "outcome_category": "Health Economics",
            "outcome_evaluation": "no significant differences"
        },
        "pred_row": {
            "id": 31,
            "pubmed_id": 22222,
            "paper": "Chronic Heart Failure and New Interventions",
            "authors": "Jordan, Michael; Pippen, Scott",
            "journal": "Heart Care Journal",
            "publication_date": "2023-05-26",
            "disease": "Heart failure",
            "medication_group": "Females",
            "therapy_or_medication": "Digoxin",
            "medical_outcome": "Mortality reduction",
            "result": "3.3%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 0.9999998211860657,
            "medication_group_correct": 0.8877124786376953,
            "therapy_or_medication_correct": 1.0000001192092896,
            "medical_outcome_correct": 1.0,
            "result_correct": 1.0,
            "outcome_category_correct": 0.719482958316803,
            "outcome_evaluation_correct": 0.632323145866394,
            "score": 6.239518523216248
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 31,
                    "pubmed_id": 22222,
                    "paper": "Chronic Heart Failure and New Interventions",
                    "authors": "Jordan, Michael; Pippen, Scott",
                    "journal": "Heart Care Journal",
                    "publication_date": "2023-05-26",
                    "disease": "Heart failure",
                    "medication_group": "Females",
                    "therapy_or_medication": "Digoxin",
                    "medical_outcome": "Mortality reduction",
                    "result": "3.3%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.9999998211860657,
                    "medication_group_correct": 0.8877124786376953,
                    "therapy_or_medication_correct": 1.0000001192092896,
                    "medical_outcome_correct": 1.0,
                    "result_correct": 1.0,
                    "outcome_category_correct": 0.719482958316803,
                    "outcome_evaluation_correct": 0.632323145866394,
                    "score": 6.239518523216248
                }
            },
            {
                "pred_row": {
                    "id": 32,
                    "pubmed_id": 22222,
                    "paper": "Chronic Heart Failure and New Interventions",
                    "authors": "Jordan, Michael; Pippen, Scott",
                    "journal": "Heart Care Journal",
                    "publication_date": "2023-05-26",
                    "disease": "Heart failure",
                    "medication_group": "'No group specified'",
                    "therapy_or_medication": "Diuretics",
                    "medical_outcome": "Hospitalization rates",
                    "result": "20% reduction",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.9999998211860657,
                    "medication_group_correct": 0.5887293219566345,
                    "therapy_or_medication_correct": 0.5662637948989868,
                    "medical_outcome_correct": 0.8121684193611145,
                    "result_correct": 0.639793336391449,
                    "outcome_category_correct": 0.719482958316803,
                    "outcome_evaluation_correct": 0.632323145866394,
                    "score": 4.9587607979774475
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 22222,
            "papername": "Chronic Heart Failure and New Interventions",
            "authors": "Jordan, Michael; Pippen, Scott",
            "publication_date": "2023-05-26",
            "journal": "Heart Care Journal",
            "disease": "Heart Failure",
            "medication_group": "Males group",
            "therapy_or_medication": "Diuretics",
            "medical_outcome": "Hospitalization Reduction",
            "result": 0.2,
            "outcome_category": "Health Economics",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 32,
            "pubmed_id": 22222,
            "paper": "Chronic Heart Failure and New Interventions",
            "authors": "Jordan, Michael; Pippen, Scott",
            "journal": "Heart Care Journal",
            "publication_date": "2023-05-26",
            "disease": "Heart failure",
            "medication_group": "'No group specified'",
            "therapy_or_medication": "Diuretics",
            "medical_outcome": "Hospitalization rates",
            "result": "20% reduction",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 0.9999998211860657,
            "medication_group_correct": 0.5885775685310364,
            "therapy_or_medication_correct": 0.9999998211860657,
            "medical_outcome_correct": 0.9388048052787781,
            "result_correct": 0.6535172462463379,
            "outcome_category_correct": 0.719482958316803,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 5.900382041931152
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 31,
                    "pubmed_id": 22222,
                    "paper": "Chronic Heart Failure and New Interventions",
                    "authors": "Jordan, Michael; Pippen, Scott",
                    "journal": "Heart Care Journal",
                    "publication_date": "2023-05-26",
                    "disease": "Heart failure",
                    "medication_group": "Females",
                    "therapy_or_medication": "Digoxin",
                    "medical_outcome": "Mortality reduction",
                    "result": "3.3%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.9999998211860657,
                    "medication_group_correct": 0.8612443804740906,
                    "therapy_or_medication_correct": 0.5662637948989868,
                    "medical_outcome_correct": 0.8330664038658142,
                    "result_correct": 0.6655842661857605,
                    "outcome_category_correct": 0.719482958316803,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.645641446113586
                }
            },
            {
                "pred_row": {
                    "id": 32,
                    "pubmed_id": 22222,
                    "paper": "Chronic Heart Failure and New Interventions",
                    "authors": "Jordan, Michael; Pippen, Scott",
                    "journal": "Heart Care Journal",
                    "publication_date": "2023-05-26",
                    "disease": "Heart failure",
                    "medication_group": "'No group specified'",
                    "therapy_or_medication": "Diuretics",
                    "medical_outcome": "Hospitalization rates",
                    "result": "20% reduction",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.9999998211860657,
                    "medication_group_correct": 0.5885775685310364,
                    "therapy_or_medication_correct": 0.9999998211860657,
                    "medical_outcome_correct": 0.9388048052787781,
                    "result_correct": 0.6535172462463379,
                    "outcome_category_correct": 0.719482958316803,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.900382041931152
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 33333,
            "papername": "Managing Ulcerative Colitis",
            "authors": "Fischer, Anna; Weber, Chris",
            "publication_date": "2024-06-10",
            "journal": "Gastroenterology Insights",
            "disease": "Ulcerative Colitis",
            "medication_group": "Mesalamine group",
            "therapy_or_medication": "Mesalamine",
            "medical_outcome": "Symptom Improvement",
            "result": 0.42,
            "outcome_category": "Symptom Intensity and Relief",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 33,
            "pubmed_id": 33333,
            "paper": "Managing Ulcerative Colitis",
            "authors": "Fischer, Anna; Weber, Chris",
            "journal": "Gastroenterology Insights",
            "publication_date": "2024-06-10",
            "disease": "Ulcerative colitis",
            "medication_group": "Patients with moderate to severe ulcerative colitis",
            "therapy_or_medication": "Mesalamine",
            "medical_outcome": "Improvement in overall symptoms",
            "result": "42%",
            "outcome_category": "Symptom Intensity and Relief",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0,
            "medication_group_correct": 0.4260086715221405,
            "therapy_or_medication_correct": 1.0000001192092896,
            "medical_outcome_correct": 0.8205087780952454,
            "result_correct": 0.7172206044197083,
            "outcome_category_correct": 1.0,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 5.963737994432449
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 33,
                    "pubmed_id": 33333,
                    "paper": "Managing Ulcerative Colitis",
                    "authors": "Fischer, Anna; Weber, Chris",
                    "journal": "Gastroenterology Insights",
                    "publication_date": "2024-06-10",
                    "disease": "Ulcerative colitis",
                    "medication_group": "Patients with moderate to severe ulcerative colitis",
                    "therapy_or_medication": "Mesalamine",
                    "medical_outcome": "Improvement in overall symptoms",
                    "result": "42%",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.4260086715221405,
                    "therapy_or_medication_correct": 1.0000001192092896,
                    "medical_outcome_correct": 0.8205087780952454,
                    "result_correct": 0.7172206044197083,
                    "outcome_category_correct": 1.0,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.963737994432449
                }
            },
            {
                "pred_row": {
                    "id": 34,
                    "pubmed_id": 33333,
                    "paper": "Managing Ulcerative Colitis",
                    "authors": "Fischer, Anna; Weber, Chris",
                    "journal": "Gastroenterology Insights",
                    "publication_date": "2024-06-10",
                    "disease": "Ulcerative colitis",
                    "medication_group": "Patients with moderate to severe ulcerative colitis",
                    "therapy_or_medication": "Steroids",
                    "medical_outcome": "Reduction in flare frequency",
                    "result": "30%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.4260086715221405,
                    "therapy_or_medication_correct": 0.6618916392326355,
                    "medical_outcome_correct": 0.6177048087120056,
                    "result_correct": 0.7075580954551697,
                    "outcome_category_correct": 0.6335793137550354,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.046742349863052
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 33333,
            "papername": "Managing Ulcerative Colitis",
            "authors": "Fischer, Anna; Weber, Chris",
            "publication_date": "2024-06-10",
            "journal": "Gastroenterology Insights",
            "disease": "Ulcerative Colitis",
            "medication_group": "Steroid group",
            "therapy_or_medication": "Steroids",
            "medical_outcome": "Flare Reduction",
            "result": 0.3,
            "outcome_category": "Symptom Intensity and Relief",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 34,
            "pubmed_id": 33333,
            "paper": "Managing Ulcerative Colitis",
            "authors": "Fischer, Anna; Weber, Chris",
            "journal": "Gastroenterology Insights",
            "publication_date": "2024-06-10",
            "disease": "Ulcerative colitis",
            "medication_group": "Patients with moderate to severe ulcerative colitis",
            "therapy_or_medication": "Steroids",
            "medical_outcome": "Reduction in flare frequency",
            "result": "30%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0,
            "medication_group_correct": 0.4807666838169098,
            "therapy_or_medication_correct": 1.0,
            "medical_outcome_correct": 0.7861864566802979,
            "result_correct": 0.7367587685585022,
            "outcome_category_correct": 0.6335793137550354,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 5.637291043996811
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 33,
                    "pubmed_id": 33333,
                    "paper": "Managing Ulcerative Colitis",
                    "authors": "Fischer, Anna; Weber, Chris",
                    "journal": "Gastroenterology Insights",
                    "publication_date": "2024-06-10",
                    "disease": "Ulcerative colitis",
                    "medication_group": "Patients with moderate to severe ulcerative colitis",
                    "therapy_or_medication": "Mesalamine",
                    "medical_outcome": "Improvement in overall symptoms",
                    "result": "42%",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.4807666838169098,
                    "therapy_or_medication_correct": 0.6618916392326355,
                    "medical_outcome_correct": 0.5438446402549744,
                    "result_correct": 0.7062807083129883,
                    "outcome_category_correct": 1.0,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.392783492803574
                }
            },
            {
                "pred_row": {
                    "id": 34,
                    "pubmed_id": 33333,
                    "paper": "Managing Ulcerative Colitis",
                    "authors": "Fischer, Anna; Weber, Chris",
                    "journal": "Gastroenterology Insights",
                    "publication_date": "2024-06-10",
                    "disease": "Ulcerative colitis",
                    "medication_group": "Patients with moderate to severe ulcerative colitis",
                    "therapy_or_medication": "Steroids",
                    "medical_outcome": "Reduction in flare frequency",
                    "result": "30%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.4807666838169098,
                    "therapy_or_medication_correct": 1.0,
                    "medical_outcome_correct": 0.7861864566802979,
                    "result_correct": 0.7367587685585022,
                    "outcome_category_correct": 0.6335793137550354,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.637291043996811
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 44444,
            "papername": "Melanoma Advances",
            "authors": "Snyder, Beth; Lowell, Robert",
            "publication_date": "2022-10-31",
            "journal": "Journal of Skin Cancer",
            "disease": "Melanoma",
            "medication_group": "Immunotherapy group",
            "therapy_or_medication": "Immunotherapy",
            "medical_outcome": "Survival Rate Increase",
            "result": 0.15,
            "outcome_category": "Quality of Life",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 35,
            "pubmed_id": 44444,
            "paper": "Melanoma Advances",
            "authors": "Snyder, Beth; Lowell, Robert",
            "journal": "Journal of Skin Cancer",
            "publication_date": "2022-10-31",
            "disease": "Melanoma",
            "medication_group": "200 melanoma patients (split evenly)",
            "therapy_or_medication": "Immunotherapy (checkpoint inhibitors)",
            "medical_outcome": "Increase in overall survival rate",
            "result": "15%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 0.9999998211860657,
            "medication_group_correct": 0.6595878601074219,
            "therapy_or_medication_correct": 0.8619112372398376,
            "medical_outcome_correct": 0.8960434198379517,
            "result_correct": 0.7188842296600342,
            "outcome_category_correct": 0.6459974050521851,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 5.782423794269562
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 35,
                    "pubmed_id": 44444,
                    "paper": "Melanoma Advances",
                    "authors": "Snyder, Beth; Lowell, Robert",
                    "journal": "Journal of Skin Cancer",
                    "publication_date": "2022-10-31",
                    "disease": "Melanoma",
                    "medication_group": "200 melanoma patients (split evenly)",
                    "therapy_or_medication": "Immunotherapy (checkpoint inhibitors)",
                    "medical_outcome": "Increase in overall survival rate",
                    "result": "15%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.9999998211860657,
                    "medication_group_correct": 0.6595878601074219,
                    "therapy_or_medication_correct": 0.8619112372398376,
                    "medical_outcome_correct": 0.8960434198379517,
                    "result_correct": 0.7188842296600342,
                    "outcome_category_correct": 0.6459974050521851,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.782423794269562
                }
            },
            {
                "pred_row": {
                    "id": 36,
                    "pubmed_id": 44444,
                    "paper": "Melanoma Advances",
                    "authors": "Snyder, Beth; Lowell, Robert",
                    "journal": "Journal of Skin Cancer",
                    "publication_date": "2022-10-31",
                    "disease": "Melanoma",
                    "medication_group": "200 melanoma patients (split evenly)",
                    "therapy_or_medication": "Targeted therapy (BRAF inhibitors)",
                    "medical_outcome": "Delay in disease progression",
                    "result": "10%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.9999998211860657,
                    "medication_group_correct": 0.6595878601074219,
                    "therapy_or_medication_correct": 0.5360532402992249,
                    "medical_outcome_correct": 0.8025055527687073,
                    "result_correct": 0.674666702747345,
                    "outcome_category_correct": 0.6459974050521851,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.318810403347015
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 44444,
            "papername": "Melanoma Advances",
            "authors": "Snyder, Beth; Lowell, Robert",
            "publication_date": "2022-10-31",
            "journal": "Journal of Skin Cancer",
            "disease": "Melanoma",
            "medication_group": "Targeted therapy group",
            "therapy_or_medication": "Targeted Therapy",
            "medical_outcome": "Progression Delay",
            "result": 0.1,
            "outcome_category": "Symptom Intensity and Relief ",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 36,
            "pubmed_id": 44444,
            "paper": "Melanoma Advances",
            "authors": "Snyder, Beth; Lowell, Robert",
            "journal": "Journal of Skin Cancer",
            "publication_date": "2022-10-31",
            "disease": "Melanoma",
            "medication_group": "200 melanoma patients (split evenly)",
            "therapy_or_medication": "Targeted therapy (BRAF inhibitors)",
            "medical_outcome": "Delay in disease progression",
            "result": "10%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 0.9999998211860657,
            "medication_group_correct": 0.6559251546859741,
            "therapy_or_medication_correct": 0.7090069651603699,
            "medical_outcome_correct": 0.6239318251609802,
            "result_correct": 0.6802288293838501,
            "outcome_category_correct": 0.6335793137550354,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 5.302671730518341
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 35,
                    "pubmed_id": 44444,
                    "paper": "Melanoma Advances",
                    "authors": "Snyder, Beth; Lowell, Robert",
                    "journal": "Journal of Skin Cancer",
                    "publication_date": "2022-10-31",
                    "disease": "Melanoma",
                    "medication_group": "200 melanoma patients (split evenly)",
                    "therapy_or_medication": "Immunotherapy (checkpoint inhibitors)",
                    "medical_outcome": "Increase in overall survival rate",
                    "result": "15%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.9999998211860657,
                    "medication_group_correct": 0.6559251546859741,
                    "therapy_or_medication_correct": 0.5481377840042114,
                    "medical_outcome_correct": 0.5321149230003357,
                    "result_correct": 0.6966152191162109,
                    "outcome_category_correct": 0.6335793137550354,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.066372036933899
                }
            },
            {
                "pred_row": {
                    "id": 36,
                    "pubmed_id": 44444,
                    "paper": "Melanoma Advances",
                    "authors": "Snyder, Beth; Lowell, Robert",
                    "journal": "Journal of Skin Cancer",
                    "publication_date": "2022-10-31",
                    "disease": "Melanoma",
                    "medication_group": "200 melanoma patients (split evenly)",
                    "therapy_or_medication": "Targeted therapy (BRAF inhibitors)",
                    "medical_outcome": "Delay in disease progression",
                    "result": "10%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.9999998211860657,
                    "medication_group_correct": 0.6559251546859741,
                    "therapy_or_medication_correct": 0.7090069651603699,
                    "medical_outcome_correct": 0.6239318251609802,
                    "result_correct": 0.6802288293838501,
                    "outcome_category_correct": 0.6335793137550354,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.302671730518341
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 66666,
            "papername": "Type 1 Diabetes Innovations",
            "authors": "O'Reilly, Fiona; Singh, Anand",
            "publication_date": "2021-01-30",
            "journal": "Diabetes Research Journal",
            "disease": "Diabetes Type 1",
            "medication_group": "Over 50 group",
            "therapy_or_medication": "Insulin Pump",
            "medical_outcome": "Glycemic Control",
            "result": "1.5%",
            "outcome_category": "Physiological Measure",
            "outcome_evaluation": "no significant differences"
        },
        "pred_row": {
            "id": 37,
            "pubmed_id": 66666,
            "paper": "Type 1 Diabetes Innovations",
            "authors": "O'Reilly, Fiona; Singh, Anand",
            "journal": "Diabetes Research Journal",
            "publication_date": "2021-01-30",
            "disease": "Type 1 diabetes",
            "medication_group": "Insulin pump users (over 50 years)",
            "therapy_or_medication": "Insulin pump",
            "medical_outcome": "Improvement in glycemic control",
            "result": "1.5%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 0.8678620457649231,
            "medication_group_correct": 0.6815053820610046,
            "therapy_or_medication_correct": 0.9999998807907104,
            "medical_outcome_correct": 0.9336080551147461,
            "result_correct": 0.9999998807907104,
            "outcome_category_correct": 0.7687371969223022,
            "outcome_evaluation_correct": 0.632323145866394,
            "score": 5.884035587310791
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 37,
                    "pubmed_id": 66666,
                    "paper": "Type 1 Diabetes Innovations",
                    "authors": "O'Reilly, Fiona; Singh, Anand",
                    "journal": "Diabetes Research Journal",
                    "publication_date": "2021-01-30",
                    "disease": "Type 1 diabetes",
                    "medication_group": "Insulin pump users (over 50 years)",
                    "therapy_or_medication": "Insulin pump",
                    "medical_outcome": "Improvement in glycemic control",
                    "result": "1.5%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.8678620457649231,
                    "medication_group_correct": 0.6815053820610046,
                    "therapy_or_medication_correct": 0.9999998807907104,
                    "medical_outcome_correct": 0.9336080551147461,
                    "result_correct": 0.9999998807907104,
                    "outcome_category_correct": 0.7687371969223022,
                    "outcome_evaluation_correct": 0.632323145866394,
                    "score": 5.884035587310791
                }
            },
            {
                "pred_row": {
                    "id": 38,
                    "pubmed_id": 66666,
                    "paper": "Type 1 Diabetes Innovations",
                    "authors": "O'Reilly, Fiona; Singh, Anand",
                    "journal": "Diabetes Research Journal",
                    "publication_date": "2021-01-30",
                    "disease": "Type 1 diabetes",
                    "medication_group": "CGM systems users (50 years and younger)",
                    "therapy_or_medication": "CGM systems",
                    "medical_outcome": "Increase in percentage of time spent within target glucose range",
                    "result": "50% increase",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.8678620457649231,
                    "medication_group_correct": 0.593774676322937,
                    "therapy_or_medication_correct": 0.5829296112060547,
                    "medical_outcome_correct": 0.5897493362426758,
                    "result_correct": 0.7417100667953491,
                    "outcome_category_correct": 0.7687371969223022,
                    "outcome_evaluation_correct": 0.632323145866394,
                    "score": 4.777086079120636
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 66666,
            "papername": "Type 1 Diabetes Innovations",
            "authors": "O'Reilly, Fiona; Singh, Anand",
            "publication_date": "2021-01-30",
            "journal": "Diabetes Research Journal",
            "disease": "Diabetes Type 1",
            "medication_group": "50 and younger group",
            "therapy_or_medication": "CGM",
            "medical_outcome": "Time in Range",
            "result": 0.5,
            "outcome_category": "Physiological Measure",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 38,
            "pubmed_id": 66666,
            "paper": "Type 1 Diabetes Innovations",
            "authors": "O'Reilly, Fiona; Singh, Anand",
            "journal": "Diabetes Research Journal",
            "publication_date": "2021-01-30",
            "disease": "Type 1 diabetes",
            "medication_group": "CGM systems users (50 years and younger)",
            "therapy_or_medication": "CGM systems",
            "medical_outcome": "Increase in percentage of time spent within target glucose range",
            "result": "50% increase",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 0.8678620457649231,
            "medication_group_correct": 0.689885139465332,
            "therapy_or_medication_correct": 0.7274203896522522,
            "medical_outcome_correct": 0.6291167140007019,
            "result_correct": 0.6605990529060364,
            "outcome_category_correct": 0.7687371969223022,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 5.3436203598976135
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 37,
                    "pubmed_id": 66666,
                    "paper": "Type 1 Diabetes Innovations",
                    "authors": "O'Reilly, Fiona; Singh, Anand",
                    "journal": "Diabetes Research Journal",
                    "publication_date": "2021-01-30",
                    "disease": "Type 1 diabetes",
                    "medication_group": "Insulin pump users (over 50 years)",
                    "therapy_or_medication": "Insulin pump",
                    "medical_outcome": "Improvement in glycemic control",
                    "result": "1.5%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.8678620457649231,
                    "medication_group_correct": 0.6271030306816101,
                    "therapy_or_medication_correct": 0.5520303249359131,
                    "medical_outcome_correct": 0.5163843631744385,
                    "result_correct": 0.7521851658821106,
                    "outcome_category_correct": 0.7687371969223022,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.084301948547363
                }
            },
            {
                "pred_row": {
                    "id": 38,
                    "pubmed_id": 66666,
                    "paper": "Type 1 Diabetes Innovations",
                    "authors": "O'Reilly, Fiona; Singh, Anand",
                    "journal": "Diabetes Research Journal",
                    "publication_date": "2021-01-30",
                    "disease": "Type 1 diabetes",
                    "medication_group": "CGM systems users (50 years and younger)",
                    "therapy_or_medication": "CGM systems",
                    "medical_outcome": "Increase in percentage of time spent within target glucose range",
                    "result": "50% increase",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.8678620457649231,
                    "medication_group_correct": 0.689885139465332,
                    "therapy_or_medication_correct": 0.7274203896522522,
                    "medical_outcome_correct": 0.6291167140007019,
                    "result_correct": 0.6605990529060364,
                    "outcome_category_correct": 0.7687371969223022,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.3436203598976135
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 77777,
            "papername": "Latest in Rheumatoid Arthritis",
            "authors": "Clark, Emma; Watson, James",
            "publication_date": "2024-05-20",
            "journal": "Journal of Autoimmune Diseases",
            "disease": "Rheumatoid Arthritis",
            "medication_group": "JAK inhibitors group",
            "therapy_or_medication": "JAK Inhibitors",
            "medical_outcome": "Pain Reduction",
            "result": 0.5,
            "outcome_category": "Symptom Intensity and Relief",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 39,
            "pubmed_id": 77777,
            "paper": "Latest in Rheumatoid Arthritis",
            "authors": "Clark, Emma; Watson, James",
            "journal": "Journal of Autoimmune Diseases",
            "publication_date": "2024-05-20",
            "disease": "Rheumatoid Arthritis",
            "medication_group": "300 RA patients",
            "therapy_or_medication": "JAK inhibitors",
            "medical_outcome": "Pain reduction",
            "result": "50% reduction",
            "outcome_category": "Symptom Intensity and Relief",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0000001192092896,
            "medication_group_correct": 0.642428457736969,
            "therapy_or_medication_correct": 1.0000001192092896,
            "medical_outcome_correct": 0.9999998211860657,
            "result_correct": 0.638393223285675,
            "outcome_category_correct": 1.0,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 6.2808215618133545
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 39,
                    "pubmed_id": 77777,
                    "paper": "Latest in Rheumatoid Arthritis",
                    "authors": "Clark, Emma; Watson, James",
                    "journal": "Journal of Autoimmune Diseases",
                    "publication_date": "2024-05-20",
                    "disease": "Rheumatoid Arthritis",
                    "medication_group": "300 RA patients",
                    "therapy_or_medication": "JAK inhibitors",
                    "medical_outcome": "Pain reduction",
                    "result": "50% reduction",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.642428457736969,
                    "therapy_or_medication_correct": 1.0000001192092896,
                    "medical_outcome_correct": 0.9999998211860657,
                    "result_correct": 0.638393223285675,
                    "outcome_category_correct": 1.0,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.2808215618133545
                }
            },
            {
                "pred_row": {
                    "id": 40,
                    "pubmed_id": 77777,
                    "paper": "Latest in Rheumatoid Arthritis",
                    "authors": "Clark, Emma; Watson, James",
                    "journal": "Journal of Autoimmune Diseases",
                    "publication_date": "2024-05-20",
                    "disease": "Rheumatoid Arthritis",
                    "medication_group": "300 RA patients",
                    "therapy_or_medication": "TNF inhibitors",
                    "medical_outcome": "Functional improvement (HAQ scores)",
                    "result": "35% improvement",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.642428457736969,
                    "therapy_or_medication_correct": 0.6069892048835754,
                    "medical_outcome_correct": 0.6096261739730835,
                    "result_correct": 0.6707226634025574,
                    "outcome_category_correct": 0.6335793137550354,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.163345754146576
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 77777,
            "papername": "Latest in Rheumatoid Arthritis",
            "authors": "Clark, Emma; Watson, James",
            "publication_date": "2024-05-20",
            "journal": "Journal of Autoimmune Diseases",
            "disease": "Rheumatoid Arthritis",
            "medication_group": "TNF inhibitors group",
            "therapy_or_medication": "TNF Inhibitors",
            "medical_outcome": "Functional Improvement",
            "result": 0.35,
            "outcome_category": "Quality of Life",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 40,
            "pubmed_id": 77777,
            "paper": "Latest in Rheumatoid Arthritis",
            "authors": "Clark, Emma; Watson, James",
            "journal": "Journal of Autoimmune Diseases",
            "publication_date": "2024-05-20",
            "disease": "Rheumatoid Arthritis",
            "medication_group": "300 RA patients",
            "therapy_or_medication": "TNF inhibitors",
            "medical_outcome": "Functional improvement (HAQ scores)",
            "result": "35% improvement",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0000001192092896,
            "medication_group_correct": 0.6044247150421143,
            "therapy_or_medication_correct": 1.0,
            "medical_outcome_correct": 0.6778437495231628,
            "result_correct": 0.6972634792327881,
            "outcome_category_correct": 0.6459974050521851,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 5.6255292892456055
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 39,
                    "pubmed_id": 77777,
                    "paper": "Latest in Rheumatoid Arthritis",
                    "authors": "Clark, Emma; Watson, James",
                    "journal": "Journal of Autoimmune Diseases",
                    "publication_date": "2024-05-20",
                    "disease": "Rheumatoid Arthritis",
                    "medication_group": "300 RA patients",
                    "therapy_or_medication": "JAK inhibitors",
                    "medical_outcome": "Pain reduction",
                    "result": "50% reduction",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.6044247150421143,
                    "therapy_or_medication_correct": 0.6069892048835754,
                    "medical_outcome_correct": 0.763698160648346,
                    "result_correct": 0.6687887907028198,
                    "outcome_category_correct": 0.5927481055259705,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.236648917198181
                }
            },
            {
                "pred_row": {
                    "id": 40,
                    "pubmed_id": 77777,
                    "paper": "Latest in Rheumatoid Arthritis",
                    "authors": "Clark, Emma; Watson, James",
                    "journal": "Journal of Autoimmune Diseases",
                    "publication_date": "2024-05-20",
                    "disease": "Rheumatoid Arthritis",
                    "medication_group": "300 RA patients",
                    "therapy_or_medication": "TNF inhibitors",
                    "medical_outcome": "Functional improvement (HAQ scores)",
                    "result": "35% improvement",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.6044247150421143,
                    "therapy_or_medication_correct": 1.0,
                    "medical_outcome_correct": 0.6778437495231628,
                    "result_correct": 0.6972634792327881,
                    "outcome_category_correct": 0.6459974050521851,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.6255292892456055
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 88888,
            "papername": "Advances in Stroke Treatment",
            "authors": "Yamamoto, Hiroshi; Tanaka, Sato",
            "publication_date": "2023-11-11",
            "journal": "Stroke Advanced Research",
            "disease": "Stroke",
            "medication_group": "Thrombectomy group",
            "therapy_or_medication": "Thrombectomy",
            "medical_outcome": "Recovery Rate",
            "result": 0.4,
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 41,
            "pubmed_id": 88888,
            "paper": "Advances in Stroke Treatment",
            "authors": "Yamamoto, Hiroshi; Tanaka, Sato",
            "journal": "Stroke Advanced Research",
            "publication_date": "2023-11-11",
            "disease": "Stroke",
            "medication_group": "No group specified",
            "therapy_or_medication": "Mechanical thrombectomy",
            "medical_outcome": "Recovery rate",
            "result": "40%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 0.9999999403953552,
            "medication_group_correct": 0.44148483872413635,
            "therapy_or_medication_correct": 0.9632241725921631,
            "medical_outcome_correct": 0.9999997019767761,
            "result_correct": 0.7082979679107666,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 6.113006561994553
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 41,
                    "pubmed_id": 88888,
                    "paper": "Advances in Stroke Treatment",
                    "authors": "Yamamoto, Hiroshi; Tanaka, Sato",
                    "journal": "Stroke Advanced Research",
                    "publication_date": "2023-11-11",
                    "disease": "Stroke",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "Mechanical thrombectomy",
                    "medical_outcome": "Recovery rate",
                    "result": "40%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.9999999403953552,
                    "medication_group_correct": 0.44148483872413635,
                    "therapy_or_medication_correct": 0.9632241725921631,
                    "medical_outcome_correct": 0.9999997019767761,
                    "result_correct": 0.7082979679107666,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.113006561994553
                }
            },
            {
                "pred_row": {
                    "id": 42,
                    "pubmed_id": 88888,
                    "paper": "Advances in Stroke Treatment",
                    "authors": "Yamamoto, Hiroshi; Tanaka, Sato",
                    "journal": "Stroke Advanced Research",
                    "publication_date": "2023-11-11",
                    "disease": "Stroke",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "Structured rehabilitation program",
                    "medical_outcome": "Functional recovery",
                    "result": "30% improvement",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.9999999403953552,
                    "medication_group_correct": 0.44148483872413635,
                    "therapy_or_medication_correct": 0.5300441384315491,
                    "medical_outcome_correct": 0.831037700176239,
                    "result_correct": 0.6437143087387085,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.446280866861343
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 88888,
            "papername": "Advances in Stroke Treatment",
            "authors": "Yamamoto, Hiroshi; Tanaka, Sato",
            "publication_date": "2023-11-11",
            "journal": "Stroke Advanced Research",
            "disease": "Stroke",
            "medication_group": "Rehabilitation group",
            "therapy_or_medication": "Rehabilitation",
            "medical_outcome": "Functional Recovery",
            "result": 0.3,
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 42,
            "pubmed_id": 88888,
            "paper": "Advances in Stroke Treatment",
            "authors": "Yamamoto, Hiroshi; Tanaka, Sato",
            "journal": "Stroke Advanced Research",
            "publication_date": "2023-11-11",
            "disease": "Stroke",
            "medication_group": "No group specified",
            "therapy_or_medication": "Structured rehabilitation program",
            "medical_outcome": "Functional recovery",
            "result": "30% improvement",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 0.9999999403953552,
            "medication_group_correct": 0.6443221569061279,
            "therapy_or_medication_correct": 0.7358821630477905,
            "medical_outcome_correct": 1.0,
            "result_correct": 0.6714159250259399,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 6.051620125770569
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 41,
                    "pubmed_id": 88888,
                    "paper": "Advances in Stroke Treatment",
                    "authors": "Yamamoto, Hiroshi; Tanaka, Sato",
                    "journal": "Stroke Advanced Research",
                    "publication_date": "2023-11-11",
                    "disease": "Stroke",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "Mechanical thrombectomy",
                    "medical_outcome": "Recovery rate",
                    "result": "40%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.9999999403953552,
                    "medication_group_correct": 0.6443221569061279,
                    "therapy_or_medication_correct": 0.4830944538116455,
                    "medical_outcome_correct": 0.831037700176239,
                    "result_correct": 0.7156912684440613,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.674145460128784
                }
            },
            {
                "pred_row": {
                    "id": 42,
                    "pubmed_id": 88888,
                    "paper": "Advances in Stroke Treatment",
                    "authors": "Yamamoto, Hiroshi; Tanaka, Sato",
                    "journal": "Stroke Advanced Research",
                    "publication_date": "2023-11-11",
                    "disease": "Stroke",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "Structured rehabilitation program",
                    "medical_outcome": "Functional recovery",
                    "result": "30% improvement",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.9999999403953552,
                    "medication_group_correct": 0.6443221569061279,
                    "therapy_or_medication_correct": 0.7358821630477905,
                    "medical_outcome_correct": 1.0,
                    "result_correct": 0.6714159250259399,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.051620125770569
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 99999,
            "papername": "Alzheimer’s Disease: Therapeutic Frontiers",
            "authors": "Lee, Caroline; Park, Young",
            "publication_date": "2024-04-24",
            "journal": "Neurology and Therapy",
            "disease": "Alzheimer's",
            "medication_group": "Cholinesterase inhibitors group",
            "therapy_or_medication": "Cholinesterase Inhibitors",
            "medical_outcome": "Cognitive Stabilization",
            "result": 0.12,
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 43,
            "pubmed_id": 99999,
            "paper": "Alzheimer’s Disease: Therapeutic Frontiers",
            "authors": "Lee, Caroline; Park, Young",
            "journal": "Neurology and Therapy",
            "publication_date": "2024-04-24",
            "disease": "Alzheimer's disease",
            "medication_group": "Patients with moderate Alzheimer's disease",
            "therapy_or_medication": "Cholinesterase inhibitors",
            "medical_outcome": "Cognitive stabilization",
            "result": "12% improvement",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 0.8405335545539856,
            "medication_group_correct": 0.5035809874534607,
            "therapy_or_medication_correct": 0.9999999403953552,
            "medical_outcome_correct": 1.0000001192092896,
            "result_correct": 0.6519161462783813,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 5.996030688285828
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 43,
                    "pubmed_id": 99999,
                    "paper": "Alzheimer’s Disease: Therapeutic Frontiers",
                    "authors": "Lee, Caroline; Park, Young",
                    "journal": "Neurology and Therapy",
                    "publication_date": "2024-04-24",
                    "disease": "Alzheimer's disease",
                    "medication_group": "Patients with moderate Alzheimer's disease",
                    "therapy_or_medication": "Cholinesterase inhibitors",
                    "medical_outcome": "Cognitive stabilization",
                    "result": "12% improvement",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.8405335545539856,
                    "medication_group_correct": 0.5035809874534607,
                    "therapy_or_medication_correct": 0.9999999403953552,
                    "medical_outcome_correct": 1.0000001192092896,
                    "result_correct": 0.6519161462783813,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.996030688285828
                }
            },
            {
                "pred_row": {
                    "id": 44,
                    "pubmed_id": 99999,
                    "paper": "Alzheimer’s Disease: Therapeutic Frontiers",
                    "authors": "Lee, Caroline; Park, Young",
                    "journal": "Neurology and Therapy",
                    "publication_date": "2024-04-24",
                    "disease": "Alzheimer's disease",
                    "medication_group": "Patients with moderate Alzheimer's disease",
                    "therapy_or_medication": "Memantine",
                    "medical_outcome": "Behavioral and psychological symptoms of dementia",
                    "result": "18% reduction",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.8405335545539856,
                    "medication_group_correct": 0.5035809874534607,
                    "therapy_or_medication_correct": 0.4889029562473297,
                    "medical_outcome_correct": 0.5809288024902344,
                    "result_correct": 0.6141687035560608,
                    "outcome_category_correct": 0.6335793137550354,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 4.661694139242172
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 99999,
            "papername": "Alzheimer’s Disease: Therapeutic Frontiers",
            "authors": "Lee, Caroline; Park, Young",
            "publication_date": "2024-04-24",
            "journal": "Neurology and Therapy",
            "disease": "Alzheimer's",
            "medication_group": "Memantine group",
            "therapy_or_medication": "Memantine",
            "medical_outcome": "Symptom Management",
            "result": 0.18,
            "outcome_category": "Symptom Intensity and Relief",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 44,
            "pubmed_id": 99999,
            "paper": "Alzheimer’s Disease: Therapeutic Frontiers",
            "authors": "Lee, Caroline; Park, Young",
            "journal": "Neurology and Therapy",
            "publication_date": "2024-04-24",
            "disease": "Alzheimer's disease",
            "medication_group": "Patients with moderate Alzheimer's disease",
            "therapy_or_medication": "Memantine",
            "medical_outcome": "Behavioral and psychological symptoms of dementia",
            "result": "18% reduction",
            "outcome_category": "Symptom Intensity and Relief",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 0.8405335545539856,
            "medication_group_correct": 0.3889957070350647,
            "therapy_or_medication_correct": 1.0000001192092896,
            "medical_outcome_correct": 0.7021571397781372,
            "result_correct": 0.6315698027610779,
            "outcome_category_correct": 1.0,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 5.563256144523621
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 43,
                    "pubmed_id": 99999,
                    "paper": "Alzheimer’s Disease: Therapeutic Frontiers",
                    "authors": "Lee, Caroline; Park, Young",
                    "journal": "Neurology and Therapy",
                    "publication_date": "2024-04-24",
                    "disease": "Alzheimer's disease",
                    "medication_group": "Patients with moderate Alzheimer's disease",
                    "therapy_or_medication": "Cholinesterase inhibitors",
                    "medical_outcome": "Cognitive stabilization",
                    "result": "12% improvement",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.8405335545539856,
                    "medication_group_correct": 0.3889957070350647,
                    "therapy_or_medication_correct": 0.4889029562473297,
                    "medical_outcome_correct": 0.5965433120727539,
                    "result_correct": 0.6390621662139893,
                    "outcome_category_correct": 0.6335793137550354,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 4.587616831064224
                }
            },
            {
                "pred_row": {
                    "id": 44,
                    "pubmed_id": 99999,
                    "paper": "Alzheimer’s Disease: Therapeutic Frontiers",
                    "authors": "Lee, Caroline; Park, Young",
                    "journal": "Neurology and Therapy",
                    "publication_date": "2024-04-24",
                    "disease": "Alzheimer's disease",
                    "medication_group": "Patients with moderate Alzheimer's disease",
                    "therapy_or_medication": "Memantine",
                    "medical_outcome": "Behavioral and psychological symptoms of dementia",
                    "result": "18% reduction",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.8405335545539856,
                    "medication_group_correct": 0.3889957070350647,
                    "therapy_or_medication_correct": 1.0000001192092896,
                    "medical_outcome_correct": 0.7021571397781372,
                    "result_correct": 0.6315698027610779,
                    "outcome_category_correct": 1.0,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.563256144523621
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 101010,
            "papername": "Innovative Asthma Treatments",
            "authors": "Thomson, Mark; Garry, Lucinda",
            "publication_date": "2023-03-03",
            "journal": "Respiratory Therapy Journal",
            "disease": "Asthma",
            "medication_group": "LABA group",
            "therapy_or_medication": "Long-acting Beta Agonists",
            "medical_outcome": "Attack Reduction",
            "result": 0.4,
            "outcome_category": "Symptom Intensity and Relief",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 46,
            "pubmed_id": 101010,
            "paper": "Innovative Asthma Treatments",
            "authors": "Thomson, Mark; Garry, Lucinda",
            "journal": "Respiratory Therapy Journal",
            "publication_date": "2023-03-03",
            "disease": "Asthma",
            "medication_group": "No group specified",
            "therapy_or_medication": "Corticosteroids",
            "medical_outcome": "symptom control",
            "result": "60% improvement",
            "outcome_category": "Symptom Intensity and Relief",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0,
            "medication_group_correct": 0.6414481401443481,
            "therapy_or_medication_correct": 0.617329478263855,
            "medical_outcome_correct": 0.6076397895812988,
            "result_correct": 0.6361842751502991,
            "outcome_category_correct": 1.0,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 5.502601504325867
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 45,
                    "pubmed_id": 101010,
                    "paper": "Innovative Asthma Treatments",
                    "authors": "Thomson, Mark; Garry, Lucinda",
                    "journal": "Respiratory Therapy Journal",
                    "publication_date": "2023-03-03",
                    "disease": "Asthma",
                    "medication_group": "400 asthma patients",
                    "therapy_or_medication": "Long-acting beta agonists (LABAs)",
                    "medical_outcome": "reduction in frequency of asthma attacks",
                    "result": "40%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.5936012864112854,
                    "therapy_or_medication_correct": 0.9199274778366089,
                    "medical_outcome_correct": 0.5174286365509033,
                    "result_correct": 0.7082979679107666,
                    "outcome_category_correct": 0.6335793137550354,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.372834503650665
                }
            },
            {
                "pred_row": {
                    "id": 46,
                    "pubmed_id": 101010,
                    "paper": "Innovative Asthma Treatments",
                    "authors": "Thomson, Mark; Garry, Lucinda",
                    "journal": "Respiratory Therapy Journal",
                    "publication_date": "2023-03-03",
                    "disease": "Asthma",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "Corticosteroids",
                    "medical_outcome": "symptom control",
                    "result": "60% improvement",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.6414481401443481,
                    "therapy_or_medication_correct": 0.617329478263855,
                    "medical_outcome_correct": 0.6076397895812988,
                    "result_correct": 0.6361842751502991,
                    "outcome_category_correct": 1.0,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.502601504325867
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 101010,
            "papername": "Innovative Asthma Treatments",
            "authors": "Thomson, Mark; Garry, Lucinda",
            "publication_date": "2023-03-03",
            "journal": "Respiratory Therapy Journal",
            "disease": "Asthma",
            "medication_group": "Corticosteroids group",
            "therapy_or_medication": "Corticosteroids",
            "medical_outcome": "Symptom Control",
            "result": 0.6,
            "outcome_category": "Symptom Intensity and Relief",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 46,
            "pubmed_id": 101010,
            "paper": "Innovative Asthma Treatments",
            "authors": "Thomson, Mark; Garry, Lucinda",
            "journal": "Respiratory Therapy Journal",
            "publication_date": "2023-03-03",
            "disease": "Asthma",
            "medication_group": "No group specified",
            "therapy_or_medication": "Corticosteroids",
            "medical_outcome": "symptom control",
            "result": "60% improvement",
            "outcome_category": "Symptom Intensity and Relief",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0,
            "medication_group_correct": 0.4693104922771454,
            "therapy_or_medication_correct": 1.0000001192092896,
            "medical_outcome_correct": 1.0000001192092896,
            "result_correct": 0.6322442889213562,
            "outcome_category_correct": 1.0,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 6.101554840803146
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 45,
                    "pubmed_id": 101010,
                    "paper": "Innovative Asthma Treatments",
                    "authors": "Thomson, Mark; Garry, Lucinda",
                    "journal": "Respiratory Therapy Journal",
                    "publication_date": "2023-03-03",
                    "disease": "Asthma",
                    "medication_group": "400 asthma patients",
                    "therapy_or_medication": "Long-acting beta agonists (LABAs)",
                    "medical_outcome": "reduction in frequency of asthma attacks",
                    "result": "40%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.5610231757164001,
                    "therapy_or_medication_correct": 0.5841146111488342,
                    "medical_outcome_correct": 0.6809842586517334,
                    "result_correct": 0.6936885714530945,
                    "outcome_category_correct": 0.6335793137550354,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.153389751911163
                }
            },
            {
                "pred_row": {
                    "id": 46,
                    "pubmed_id": 101010,
                    "paper": "Innovative Asthma Treatments",
                    "authors": "Thomson, Mark; Garry, Lucinda",
                    "journal": "Respiratory Therapy Journal",
                    "publication_date": "2023-03-03",
                    "disease": "Asthma",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "Corticosteroids",
                    "medical_outcome": "symptom control",
                    "result": "60% improvement",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.4693104922771454,
                    "therapy_or_medication_correct": 1.0000001192092896,
                    "medical_outcome_correct": 1.0000001192092896,
                    "result_correct": 0.6322442889213562,
                    "outcome_category_correct": 1.0,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.101554840803146
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 1111111,
            "papername": "Groundbreaking Skin Cancer Therapies",
            "authors": "Schwartz, Jacob; Patel, Amit",
            "publication_date": "2022-02-02",
            "journal": "Dermatology Online Journal",
            "disease": "Skin Cancer",
            "medication_group": "Randomised group",
            "therapy_or_medication": "PD-1 Inhibitors",
            "medical_outcome": "Tumor Reduction",
            "result": 0.3,
            "outcome_category": "Physiological Measure",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 47,
            "pubmed_id": 1111111,
            "paper": "Groundbreaking Skin Cancer Therapies",
            "authors": "Schwartz, Jacob; Patel, Amit",
            "journal": "Dermatology Online Journal",
            "publication_date": "2022-02-02",
            "disease": "Skin cancer",
            "medication_group": "No group specified",
            "therapy_or_medication": "PD-1 inhibitors",
            "medical_outcome": "tumor reduction",
            "result": "30%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0000001192092896,
            "medication_group_correct": 0.61281418800354,
            "therapy_or_medication_correct": 1.0,
            "medical_outcome_correct": 0.9999998807907104,
            "result_correct": 0.7367587685585022,
            "outcome_category_correct": 0.7687371969223022,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 6.11830997467041
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 47,
                    "pubmed_id": 1111111,
                    "paper": "Groundbreaking Skin Cancer Therapies",
                    "authors": "Schwartz, Jacob; Patel, Amit",
                    "journal": "Dermatology Online Journal",
                    "publication_date": "2022-02-02",
                    "disease": "Skin cancer",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "PD-1 inhibitors",
                    "medical_outcome": "tumor reduction",
                    "result": "30%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.61281418800354,
                    "therapy_or_medication_correct": 1.0,
                    "medical_outcome_correct": 0.9999998807907104,
                    "result_correct": 0.7367587685585022,
                    "outcome_category_correct": 0.7687371969223022,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.11830997467041
                }
            },
            {
                "pred_row": {
                    "id": 48,
                    "pubmed_id": 1111111,
                    "paper": "Groundbreaking Skin Cancer Therapies",
                    "authors": "Schwartz, Jacob; Patel, Amit",
                    "journal": "Dermatology Online Journal",
                    "publication_date": "2022-02-02",
                    "disease": "Skin cancer",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "CTLA-4 inhibitors",
                    "medical_outcome": "disease-free survival",
                    "result": "22% increase",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.61281418800354,
                    "therapy_or_medication_correct": 0.8747953176498413,
                    "medical_outcome_correct": 0.7579874992370605,
                    "result_correct": 0.675430953502655,
                    "outcome_category_correct": 0.7687371969223022,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.689765095710754
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 1111111,
            "papername": "Groundbreaking Skin Cancer Therapies",
            "authors": "Schwartz, Jacob; Patel, Amit",
            "publication_date": "2022-02-02",
            "journal": "Dermatology Online Journal",
            "disease": "Skin Cancer",
            "medication_group": "Randomised group",
            "therapy_or_medication": "CTLA-4 Inhibitors",
            "medical_outcome": "Disease-Free Survival",
            "result": 0.22,
            "outcome_category": "Quality of Life",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 48,
            "pubmed_id": 1111111,
            "paper": "Groundbreaking Skin Cancer Therapies",
            "authors": "Schwartz, Jacob; Patel, Amit",
            "journal": "Dermatology Online Journal",
            "publication_date": "2022-02-02",
            "disease": "Skin cancer",
            "medication_group": "No group specified",
            "therapy_or_medication": "CTLA-4 inhibitors",
            "medical_outcome": "disease-free survival",
            "result": "22% increase",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0000001192092896,
            "medication_group_correct": 0.61281418800354,
            "therapy_or_medication_correct": 1.0,
            "medical_outcome_correct": 1.0,
            "result_correct": 0.6583925485610962,
            "outcome_category_correct": 0.6459974050521851,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 5.9172040820121765
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 47,
                    "pubmed_id": 1111111,
                    "paper": "Groundbreaking Skin Cancer Therapies",
                    "authors": "Schwartz, Jacob; Patel, Amit",
                    "journal": "Dermatology Online Journal",
                    "publication_date": "2022-02-02",
                    "disease": "Skin cancer",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "PD-1 inhibitors",
                    "medical_outcome": "tumor reduction",
                    "result": "30%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.61281418800354,
                    "therapy_or_medication_correct": 0.8747953176498413,
                    "medical_outcome_correct": 0.7579874992370605,
                    "result_correct": 0.705880880355835,
                    "outcome_category_correct": 0.6459974050521851,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.597475230693817
                }
            },
            {
                "pred_row": {
                    "id": 48,
                    "pubmed_id": 1111111,
                    "paper": "Groundbreaking Skin Cancer Therapies",
                    "authors": "Schwartz, Jacob; Patel, Amit",
                    "journal": "Dermatology Online Journal",
                    "publication_date": "2022-02-02",
                    "disease": "Skin cancer",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "CTLA-4 inhibitors",
                    "medical_outcome": "disease-free survival",
                    "result": "22% increase",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.61281418800354,
                    "therapy_or_medication_correct": 1.0,
                    "medical_outcome_correct": 1.0,
                    "result_correct": 0.6583925485610962,
                    "outcome_category_correct": 0.6459974050521851,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.9172040820121765
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 1313131,
            "papername": "Progress in Hepatitis B Management",
            "authors": "O'Neal, Patrick; Johnson, Samuel",
            "publication_date": "2024-01-01",
            "journal": "Liver Disease Journal",
            "disease": "Hepatitis B",
            "medication_group": "Antiviral group",
            "therapy_or_medication": "Antivirals",
            "medical_outcome": "Viral Suppression",
            "result": 0.85,
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 49,
            "pubmed_id": 1313131,
            "paper": "Progress in Hepatitis B Management",
            "authors": "O'Neal, Patrick; Johnson, Samuel",
            "journal": "Liver Disease Journal",
            "publication_date": "2024-01-01",
            "disease": "Hepatitis B",
            "medication_group": "Antiviral group",
            "therapy_or_medication": "Latest antiviral medications",
            "medical_outcome": "Viral suppression",
            "result": "85%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0,
            "medication_group_correct": 0.9999998807907104,
            "therapy_or_medication_correct": 0.8371694684028625,
            "medical_outcome_correct": 1.0,
            "result_correct": 0.7119264006614685,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 6.549095690250397
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 49,
                    "pubmed_id": 1313131,
                    "paper": "Progress in Hepatitis B Management",
                    "authors": "O'Neal, Patrick; Johnson, Samuel",
                    "journal": "Liver Disease Journal",
                    "publication_date": "2024-01-01",
                    "disease": "Hepatitis B",
                    "medication_group": "Antiviral group",
                    "therapy_or_medication": "Latest antiviral medications",
                    "medical_outcome": "Viral suppression",
                    "result": "85%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.9999998807907104,
                    "therapy_or_medication_correct": 0.8371694684028625,
                    "medical_outcome_correct": 1.0,
                    "result_correct": 0.7119264006614685,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.549095690250397
                }
            },
            {
                "pred_row": {
                    "id": 50,
                    "pubmed_id": 1313131,
                    "paper": "Progress in Hepatitis B Management",
                    "authors": "O'Neal, Patrick; Johnson, Samuel",
                    "journal": "Liver Disease Journal",
                    "publication_date": "2024-01-01",
                    "disease": "Hepatitis B",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "Newly developed Hepatitis B vaccine",
                    "medical_outcome": "Infection prevention",
                    "result": "75% effectiveness rate",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.47253280878067017,
                    "therapy_or_medication_correct": 0.7608941793441772,
                    "medical_outcome_correct": 0.8549356460571289,
                    "result_correct": 0.620788037776947,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.709150612354279
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 1313131,
            "papername": "Progress in Hepatitis B Management",
            "authors": "O'Neal, Patrick; Johnson, Samuel",
            "publication_date": "2024-01-01",
            "journal": "Liver Disease Journal",
            "disease": "Hepatitis B",
            "medication_group": "Vaccine group",
            "therapy_or_medication": "Vaccine",
            "medical_outcome": "Infection Prevention",
            "result": 0.75,
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 50,
            "pubmed_id": 1313131,
            "paper": "Progress in Hepatitis B Management",
            "authors": "O'Neal, Patrick; Johnson, Samuel",
            "journal": "Liver Disease Journal",
            "publication_date": "2024-01-01",
            "disease": "Hepatitis B",
            "medication_group": "No group specified",
            "therapy_or_medication": "Newly developed Hepatitis B vaccine",
            "medical_outcome": "Infection prevention",
            "result": "75% effectiveness rate",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0,
            "medication_group_correct": 0.6398858428001404,
            "therapy_or_medication_correct": 0.4763537347316742,
            "medical_outcome_correct": 0.9999999403953552,
            "result_correct": 0.6375015377998352,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 5.75374099612236
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 49,
                    "pubmed_id": 1313131,
                    "paper": "Progress in Hepatitis B Management",
                    "authors": "O'Neal, Patrick; Johnson, Samuel",
                    "journal": "Liver Disease Journal",
                    "publication_date": "2024-01-01",
                    "disease": "Hepatitis B",
                    "medication_group": "Antiviral group",
                    "therapy_or_medication": "Latest antiviral medications",
                    "medical_outcome": "Viral suppression",
                    "result": "85%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.693155825138092,
                    "therapy_or_medication_correct": 0.4023998975753784,
                    "medical_outcome_correct": 0.8549356460571289,
                    "result_correct": 0.6837210059165955,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.63421231508255
                }
            },
            {
                "pred_row": {
                    "id": 50,
                    "pubmed_id": 1313131,
                    "paper": "Progress in Hepatitis B Management",
                    "authors": "O'Neal, Patrick; Johnson, Samuel",
                    "journal": "Liver Disease Journal",
                    "publication_date": "2024-01-01",
                    "disease": "Hepatitis B",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "Newly developed Hepatitis B vaccine",
                    "medical_outcome": "Infection prevention",
                    "result": "75% effectiveness rate",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.6398858428001404,
                    "therapy_or_medication_correct": 0.4763537347316742,
                    "medical_outcome_correct": 0.9999999403953552,
                    "result_correct": 0.6375015377998352,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.75374099612236
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 1414141,
            "papername": "New Frontiers in Lupus Treatment",
            "authors": "Green, Mary; Elton, Sarah",
            "publication_date": "2022-04-01",
            "journal": "Clinical Immunology Review",
            "disease": "Lupus",
            "medication_group": "No group specified",
            "therapy_or_medication": "Monoclonal Antibodies",
            "medical_outcome": "Symptom Reduction",
            "result": 0.45,
            "outcome_category": "Symptom Intensity and Relief",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 51,
            "pubmed_id": 1414141,
            "paper": "New Frontiers in Lupus Treatment",
            "authors": "Green, Mary; Elton, Sarah",
            "journal": "Clinical Immunology Review",
            "publication_date": "2022-04-01",
            "disease": "Lupus",
            "medication_group": "250 lupus patients",
            "therapy_or_medication": "Monoclonal antibodies regimen",
            "medical_outcome": "reduction of lupus symptoms",
            "result": "45%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 0.9999999403953552,
            "medication_group_correct": 0.4748006761074066,
            "therapy_or_medication_correct": 0.9160692691802979,
            "medical_outcome_correct": 0.788372278213501,
            "result_correct": 0.6775118708610535,
            "outcome_category_correct": 0.6335793137550354,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 5.490333169698715
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 51,
                    "pubmed_id": 1414141,
                    "paper": "New Frontiers in Lupus Treatment",
                    "authors": "Green, Mary; Elton, Sarah",
                    "journal": "Clinical Immunology Review",
                    "publication_date": "2022-04-01",
                    "disease": "Lupus",
                    "medication_group": "250 lupus patients",
                    "therapy_or_medication": "Monoclonal antibodies regimen",
                    "medical_outcome": "reduction of lupus symptoms",
                    "result": "45%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.9999999403953552,
                    "medication_group_correct": 0.4748006761074066,
                    "therapy_or_medication_correct": 0.9160692691802979,
                    "medical_outcome_correct": 0.788372278213501,
                    "result_correct": 0.6775118708610535,
                    "outcome_category_correct": 0.6335793137550354,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.490333169698715
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 1616161,
            "papername": "Hypertension: New Insights",
            "authors": "Andersen, Eric; Moy, Veronica",
            "publication_date": "2024-09-30",
            "journal": "Cardiovascular Research",
            "disease": "Hypertension",
            "medication_group": "No group specified",
            "therapy_or_medication": "Beta Blockers",
            "medical_outcome": "Blood Pressure Reduction",
            "result": "15 mmHg",
            "outcome_category": "Physiological Measure",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 52,
            "pubmed_id": 1616161,
            "paper": "Hypertension: New Insights",
            "authors": "Andersen, Eric; Moy, Veronica",
            "journal": "Cardiovascular Research",
            "publication_date": "2024-09-30",
            "disease": "Hypertension",
            "medication_group": "200 patients with diagnosed hypertension",
            "therapy_or_medication": "Beta blockers",
            "medical_outcome": "Reduction in systolic blood pressure",
            "result": "15 mmHg",
            "outcome_category": "Physiological Measure",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 0.9999998807907104,
            "medication_group_correct": 0.4507649540901184,
            "therapy_or_medication_correct": 0.9999999403953552,
            "medical_outcome_correct": 0.7939026951789856,
            "result_correct": 0.9999997019767761,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 6.244667112827301
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 52,
                    "pubmed_id": 1616161,
                    "paper": "Hypertension: New Insights",
                    "authors": "Andersen, Eric; Moy, Veronica",
                    "journal": "Cardiovascular Research",
                    "publication_date": "2024-09-30",
                    "disease": "Hypertension",
                    "medication_group": "200 patients with diagnosed hypertension",
                    "therapy_or_medication": "Beta blockers",
                    "medical_outcome": "Reduction in systolic blood pressure",
                    "result": "15 mmHg",
                    "outcome_category": "Physiological Measure",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.9999998807907104,
                    "medication_group_correct": 0.4507649540901184,
                    "therapy_or_medication_correct": 0.9999999403953552,
                    "medical_outcome_correct": 0.7939026951789856,
                    "result_correct": 0.9999997019767761,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.244667112827301
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 1717171,
            "papername": "Obesity and Metabolic Syndrome",
            "authors": "Kim, Sun; Lee, Moon",
            "publication_date": "2023-12-12",
            "journal": "Metabolic Science Journal",
            "disease": "Obesity",
            "medication_group": "No group specified",
            "therapy_or_medication": "Diet Change",
            "medical_outcome": "Weight Loss",
            "result": "200 kg",
            "outcome_category": "Physiological Measure",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 53,
            "pubmed_id": 1717171,
            "paper": "Obesity and Metabolic Syndrome",
            "authors": "Kim, Sun; Lee, Moon",
            "journal": "Metabolic Science Journal",
            "publication_date": "2023-12-12",
            "disease": "Obesity",
            "medication_group": "Participants with a BMI of 40 or higher",
            "therapy_or_medication": "Dietary intervention program",
            "medical_outcome": "Weight loss",
            "result": "200 kg",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 0.9999998807907104,
            "medication_group_correct": 0.4267478287220001,
            "therapy_or_medication_correct": 0.7606136202812195,
            "medical_outcome_correct": 1.0,
            "result_correct": 0.9999998807907104,
            "outcome_category_correct": 0.7687371969223022,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 5.956098228693008
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 53,
                    "pubmed_id": 1717171,
                    "paper": "Obesity and Metabolic Syndrome",
                    "authors": "Kim, Sun; Lee, Moon",
                    "journal": "Metabolic Science Journal",
                    "publication_date": "2023-12-12",
                    "disease": "Obesity",
                    "medication_group": "Participants with a BMI of 40 or higher",
                    "therapy_or_medication": "Dietary intervention program",
                    "medical_outcome": "Weight loss",
                    "result": "200 kg",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.9999998807907104,
                    "medication_group_correct": 0.4267478287220001,
                    "therapy_or_medication_correct": 0.7606136202812195,
                    "medical_outcome_correct": 1.0,
                    "result_correct": 0.9999998807907104,
                    "outcome_category_correct": 0.7687371969223022,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.956098228693008
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 1818181,
            "papername": "Pediatric Asthma Control",
            "authors": "Johnson, Keith; Patel, Harish",
            "publication_date": "2021-07-12",
            "journal": "Pediatric Pulmonology",
            "disease": "Asthma (Pediatric)",
            "medication_group": "Pediatric group",
            "therapy_or_medication": "Inhalers",
            "medical_outcome": "Asthma Control",
            "result": "150% dimishment",
            "outcome_category": "Symptom Intensity and Relief",
            "outcome_evaluation": "significantly worse"
        },
        "pred_row": {
            "id": 54,
            "pubmed_id": 1818181,
            "paper": "Pediatric Asthma Control",
            "authors": "Johnson, Keith; Patel, Harish",
            "journal": "Pediatric Pulmonology",
            "publication_date": "2021-07-12",
            "disease": "Pediatric asthma",
            "medication_group": "100 pediatric patients diagnosed with asthma, aged 5-15 years",
            "therapy_or_medication": "Inhalers",
            "medical_outcome": "Asthma control",
            "result": "150% dimishment",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly worse"
        },
        "best_similarity": {
            "disease_correct": 0.8358058333396912,
            "medication_group_correct": 0.5968539714813232,
            "therapy_or_medication_correct": 1.0,
            "medical_outcome_correct": 0.9999998807907104,
            "result_correct": 1.0,
            "outcome_category_correct": 0.6335793137550354,
            "outcome_evaluation_correct": 1.0,
            "score": 6.06623899936676
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 54,
                    "pubmed_id": 1818181,
                    "paper": "Pediatric Asthma Control",
                    "authors": "Johnson, Keith; Patel, Harish",
                    "journal": "Pediatric Pulmonology",
                    "publication_date": "2021-07-12",
                    "disease": "Pediatric asthma",
                    "medication_group": "100 pediatric patients diagnosed with asthma, aged 5-15 years",
                    "therapy_or_medication": "Inhalers",
                    "medical_outcome": "Asthma control",
                    "result": "150% dimishment",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly worse"
                },
                "similarity": {
                    "disease_correct": 0.8358058333396912,
                    "medication_group_correct": 0.5968539714813232,
                    "therapy_or_medication_correct": 1.0,
                    "medical_outcome_correct": 0.9999998807907104,
                    "result_correct": 1.0,
                    "outcome_category_correct": 0.6335793137550354,
                    "outcome_evaluation_correct": 1.0,
                    "score": 6.06623899936676
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 2020202,
            "papername": "Epilepsy in the New Era",
            "authors": "Santos, Maria; Rodriguez, Juan",
            "publication_date": "2022-08-31",
            "journal": "Neurological Review",
            "disease": "Epilepsy",
            "medication_group": "No group specified",
            "therapy_or_medication": "Anticonvulsants",
            "medical_outcome": "Seizure Increase",
            "result": "0.5 seizures/day",
            "outcome_category": "Symptom Intensity and Relief",
            "outcome_evaluation": "significantly worse"
        },
        "pred_row": {
            "id": 55,
            "pubmed_id": 2020202,
            "paper": "Epilepsy in the New Era",
            "authors": "Santos, Maria; Rodriguez, Juan",
            "journal": "Neurological Review",
            "publication_date": "2022-08-31",
            "disease": "Epilepsy",
            "medication_group": "150 patients diagnosed with epilepsy",
            "therapy_or_medication": "Anticonvulsant medications",
            "medical_outcome": "Reduction in seizure frequency",
            "result": "0.5 seizures per day",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly worse"
        },
        "best_similarity": {
            "disease_correct": 0.9999999403953552,
            "medication_group_correct": 0.4259793758392334,
            "therapy_or_medication_correct": 0.9442839026451111,
            "medical_outcome_correct": 0.8497375249862671,
            "result_correct": 0.9639207720756531,
            "outcome_category_correct": 0.6335793137550354,
            "outcome_evaluation_correct": 1.0,
            "score": 5.817500829696655
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 55,
                    "pubmed_id": 2020202,
                    "paper": "Epilepsy in the New Era",
                    "authors": "Santos, Maria; Rodriguez, Juan",
                    "journal": "Neurological Review",
                    "publication_date": "2022-08-31",
                    "disease": "Epilepsy",
                    "medication_group": "150 patients diagnosed with epilepsy",
                    "therapy_or_medication": "Anticonvulsant medications",
                    "medical_outcome": "Reduction in seizure frequency",
                    "result": "0.5 seizures per day",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly worse"
                },
                "similarity": {
                    "disease_correct": 0.9999999403953552,
                    "medication_group_correct": 0.4259793758392334,
                    "therapy_or_medication_correct": 0.9442839026451111,
                    "medical_outcome_correct": 0.8497375249862671,
                    "result_correct": 0.9639207720756531,
                    "outcome_category_correct": 0.6335793137550354,
                    "outcome_evaluation_correct": 1.0,
                    "score": 5.817500829696655
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 50101,
            "papername": "Comprehensive Analysis of Migraine Treatments",
            "authors": "Harris, Emily; Martin, Greg",
            "publication_date": "2023-03-15 00:00:00",
            "journal": "Headache Research Journal",
            "disease": "Migraine",
            "medication_group": "Erenumab group",
            "therapy_or_medication": "Erenumab",
            "medical_outcome": "Reduction in MMD",
            "result": "52.3%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 56,
            "pubmed_id": 50101,
            "paper": "Comprehensive Analysis of Migraine Treatments",
            "authors": "Harris, Emily; Martin, Greg",
            "journal": "Headache Research Journal",
            "publication_date": "2023-03-15",
            "disease": "Migraine",
            "medication_group": "Erenumab group",
            "therapy_or_medication": "Erenumab",
            "medical_outcome": "reduction in MMD",
            "result": "52.3%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0000001192092896,
            "medication_group_correct": 1.0,
            "therapy_or_medication_correct": 0.9999997615814209,
            "medical_outcome_correct": 0.9999998211860657,
            "result_correct": 1.0,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 6.999999642372131
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 56,
                    "pubmed_id": 50101,
                    "paper": "Comprehensive Analysis of Migraine Treatments",
                    "authors": "Harris, Emily; Martin, Greg",
                    "journal": "Headache Research Journal",
                    "publication_date": "2023-03-15",
                    "disease": "Migraine",
                    "medication_group": "Erenumab group",
                    "therapy_or_medication": "Erenumab",
                    "medical_outcome": "reduction in MMD",
                    "result": "52.3%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 1.0,
                    "therapy_or_medication_correct": 0.9999997615814209,
                    "medical_outcome_correct": 0.9999998211860657,
                    "result_correct": 1.0,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.999999642372131
                }
            },
            {
                "pred_row": {
                    "id": 57,
                    "pubmed_id": 50101,
                    "paper": "Comprehensive Analysis of Migraine Treatments",
                    "authors": "Harris, Emily; Martin, Greg",
                    "journal": "Headache Research Journal",
                    "publication_date": "2023-03-15",
                    "disease": "Migraine",
                    "medication_group": "CGRP inhibitor group (excluding Erenumab)",
                    "therapy_or_medication": "CGRP inhibitors (excluding Erenumab)",
                    "medical_outcome": "reduction in MMD",
                    "result": "49.9%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.84515380859375,
                    "therapy_or_medication_correct": 0.7984176874160767,
                    "medical_outcome_correct": 0.9999998211860657,
                    "result_correct": 0.9285141229629517,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.572085499763489
                }
            },
            {
                "pred_row": {
                    "id": 58,
                    "pubmed_id": 50101,
                    "paper": "Comprehensive Analysis of Migraine Treatments",
                    "authors": "Harris, Emily; Martin, Greg",
                    "journal": "Headache Research Journal",
                    "publication_date": "2023-03-15",
                    "disease": "Migraine",
                    "medication_group": "Topiramate group",
                    "therapy_or_medication": "Topiramate",
                    "medical_outcome": "reduction in MMD",
                    "result": "40.1%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly worse"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.614985466003418,
                    "therapy_or_medication_correct": 0.5977753400802612,
                    "medical_outcome_correct": 0.9999998211860657,
                    "result_correct": 0.8948625326156616,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.790851891040802,
                    "score": 5.898475289344788
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 50101,
            "papername": "Comprehensive Analysis of Migraine Treatments",
            "authors": "Harris, Emily; Martin, Greg",
            "publication_date": "2023-03-15 00:00:00",
            "journal": "Headache Research Journal",
            "disease": "Migraine",
            "medication_group": "CGRP inhibitor group",
            "therapy_or_medication": "CGRP inhibitor",
            "medical_outcome": "Discontinuation Rate",
            "result": "11.2%",
            "outcome_category": "Adverse Events and Side Effects",
            "outcome_evaluation": "significantly worse"
        },
        "pred_row": {
            "id": 57,
            "pubmed_id": 50101,
            "paper": "Comprehensive Analysis of Migraine Treatments",
            "authors": "Harris, Emily; Martin, Greg",
            "journal": "Headache Research Journal",
            "publication_date": "2023-03-15",
            "disease": "Migraine",
            "medication_group": "CGRP inhibitor group (excluding Erenumab)",
            "therapy_or_medication": "CGRP inhibitors (excluding Erenumab)",
            "medical_outcome": "reduction in MMD",
            "result": "49.9%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0000001192092896,
            "medication_group_correct": 0.8469067811965942,
            "therapy_or_medication_correct": 0.7896953225135803,
            "medical_outcome_correct": 0.6279245615005493,
            "result_correct": 0.9196234345436096,
            "outcome_category_correct": 0.6407684087753296,
            "outcome_evaluation_correct": 0.790851891040802,
            "score": 5.615770518779755
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 56,
                    "pubmed_id": 50101,
                    "paper": "Comprehensive Analysis of Migraine Treatments",
                    "authors": "Harris, Emily; Martin, Greg",
                    "journal": "Headache Research Journal",
                    "publication_date": "2023-03-15",
                    "disease": "Migraine",
                    "medication_group": "Erenumab group",
                    "therapy_or_medication": "Erenumab",
                    "medical_outcome": "reduction in MMD",
                    "result": "52.3%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.7763464450836182,
                    "therapy_or_medication_correct": 0.7185076475143433,
                    "medical_outcome_correct": 0.6279245615005493,
                    "result_correct": 0.9070628881454468,
                    "outcome_category_correct": 0.6407684087753296,
                    "outcome_evaluation_correct": 0.790851891040802,
                    "score": 5.461461961269379
                }
            },
            {
                "pred_row": {
                    "id": 57,
                    "pubmed_id": 50101,
                    "paper": "Comprehensive Analysis of Migraine Treatments",
                    "authors": "Harris, Emily; Martin, Greg",
                    "journal": "Headache Research Journal",
                    "publication_date": "2023-03-15",
                    "disease": "Migraine",
                    "medication_group": "CGRP inhibitor group (excluding Erenumab)",
                    "therapy_or_medication": "CGRP inhibitors (excluding Erenumab)",
                    "medical_outcome": "reduction in MMD",
                    "result": "49.9%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.8469067811965942,
                    "therapy_or_medication_correct": 0.7896953225135803,
                    "medical_outcome_correct": 0.6279245615005493,
                    "result_correct": 0.9196234345436096,
                    "outcome_category_correct": 0.6407684087753296,
                    "outcome_evaluation_correct": 0.790851891040802,
                    "score": 5.615770518779755
                }
            },
            {
                "pred_row": {
                    "id": 58,
                    "pubmed_id": 50101,
                    "paper": "Comprehensive Analysis of Migraine Treatments",
                    "authors": "Harris, Emily; Martin, Greg",
                    "journal": "Headache Research Journal",
                    "publication_date": "2023-03-15",
                    "disease": "Migraine",
                    "medication_group": "Topiramate group",
                    "therapy_or_medication": "Topiramate",
                    "medical_outcome": "reduction in MMD",
                    "result": "40.1%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly worse"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.5717882513999939,
                    "therapy_or_medication_correct": 0.5701068639755249,
                    "medical_outcome_correct": 0.6279245615005493,
                    "result_correct": 0.909949541091919,
                    "outcome_category_correct": 0.6407684087753296,
                    "outcome_evaluation_correct": 1.0,
                    "score": 5.320537745952606
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 50101,
            "papername": "Comprehensive Analysis of Migraine Treatments",
            "authors": "Harris, Emily; Martin, Greg",
            "publication_date": "2023-03-15 00:00:00",
            "journal": "Headache Research Journal",
            "disease": "Migraine",
            "medication_group": "Topiramate group",
            "therapy_or_medication": "Topiramate",
            "medical_outcome": "Reduction in MMD",
            "result": "40.1%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 58,
            "pubmed_id": 50101,
            "paper": "Comprehensive Analysis of Migraine Treatments",
            "authors": "Harris, Emily; Martin, Greg",
            "journal": "Headache Research Journal",
            "publication_date": "2023-03-15",
            "disease": "Migraine",
            "medication_group": "Topiramate group",
            "therapy_or_medication": "Topiramate",
            "medical_outcome": "reduction in MMD",
            "result": "40.1%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly worse"
        },
        "best_similarity": {
            "disease_correct": 1.0000001192092896,
            "medication_group_correct": 0.9999998807907104,
            "therapy_or_medication_correct": 1.0,
            "medical_outcome_correct": 0.9999998211860657,
            "result_correct": 1.0,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 0.790851891040802,
            "score": 6.790851831436157
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 56,
                    "pubmed_id": 50101,
                    "paper": "Comprehensive Analysis of Migraine Treatments",
                    "authors": "Harris, Emily; Martin, Greg",
                    "journal": "Headache Research Journal",
                    "publication_date": "2023-03-15",
                    "disease": "Migraine",
                    "medication_group": "Erenumab group",
                    "therapy_or_medication": "Erenumab",
                    "medical_outcome": "reduction in MMD",
                    "result": "52.3%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.614985466003418,
                    "therapy_or_medication_correct": 0.5977753400802612,
                    "medical_outcome_correct": 0.9999998211860657,
                    "result_correct": 0.8948625326156616,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.107623219490051
                }
            },
            {
                "pred_row": {
                    "id": 57,
                    "pubmed_id": 50101,
                    "paper": "Comprehensive Analysis of Migraine Treatments",
                    "authors": "Harris, Emily; Martin, Greg",
                    "journal": "Headache Research Journal",
                    "publication_date": "2023-03-15",
                    "disease": "Migraine",
                    "medication_group": "CGRP inhibitor group (excluding Erenumab)",
                    "therapy_or_medication": "CGRP inhibitors (excluding Erenumab)",
                    "medical_outcome": "reduction in MMD",
                    "result": "49.9%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.4895397126674652,
                    "therapy_or_medication_correct": 0.43259918689727783,
                    "medical_outcome_correct": 0.9999998211860657,
                    "result_correct": 0.920481264591217,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.8426200449466705
                }
            },
            {
                "pred_row": {
                    "id": 58,
                    "pubmed_id": 50101,
                    "paper": "Comprehensive Analysis of Migraine Treatments",
                    "authors": "Harris, Emily; Martin, Greg",
                    "journal": "Headache Research Journal",
                    "publication_date": "2023-03-15",
                    "disease": "Migraine",
                    "medication_group": "Topiramate group",
                    "therapy_or_medication": "Topiramate",
                    "medical_outcome": "reduction in MMD",
                    "result": "40.1%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly worse"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.9999998807907104,
                    "therapy_or_medication_correct": 1.0,
                    "medical_outcome_correct": 0.9999998211860657,
                    "result_correct": 1.0,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.790851891040802,
                    "score": 6.790851831436157
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 50101,
            "papername": "Comprehensive Analysis of Migraine Treatments",
            "authors": "Harris, Emily; Martin, Greg",
            "publication_date": "2023-03-15 00:00:00",
            "journal": "Headache Research Journal",
            "disease": "Migraine",
            "medication_group": "Erenumab group",
            "therapy_or_medication": "Erenumab",
            "medical_outcome": "Discontinuation Rate",
            "result": "5.0%",
            "outcome_category": "Adverse Events and Side Effects",
            "outcome_evaluation": "significantly worse"
        },
        "pred_row": {
            "id": 56,
            "pubmed_id": 50101,
            "paper": "Comprehensive Analysis of Migraine Treatments",
            "authors": "Harris, Emily; Martin, Greg",
            "journal": "Headache Research Journal",
            "publication_date": "2023-03-15",
            "disease": "Migraine",
            "medication_group": "Erenumab group",
            "therapy_or_medication": "Erenumab",
            "medical_outcome": "reduction in MMD",
            "result": "52.3%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0000001192092896,
            "medication_group_correct": 1.0,
            "therapy_or_medication_correct": 0.9999997615814209,
            "medical_outcome_correct": 0.6279245615005493,
            "result_correct": 0.8408493995666504,
            "outcome_category_correct": 0.6407684087753296,
            "outcome_evaluation_correct": 0.790851891040802,
            "score": 5.900394141674042
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 56,
                    "pubmed_id": 50101,
                    "paper": "Comprehensive Analysis of Migraine Treatments",
                    "authors": "Harris, Emily; Martin, Greg",
                    "journal": "Headache Research Journal",
                    "publication_date": "2023-03-15",
                    "disease": "Migraine",
                    "medication_group": "Erenumab group",
                    "therapy_or_medication": "Erenumab",
                    "medical_outcome": "reduction in MMD",
                    "result": "52.3%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 1.0,
                    "therapy_or_medication_correct": 0.9999997615814209,
                    "medical_outcome_correct": 0.6279245615005493,
                    "result_correct": 0.8408493995666504,
                    "outcome_category_correct": 0.6407684087753296,
                    "outcome_evaluation_correct": 0.790851891040802,
                    "score": 5.900394141674042
                }
            },
            {
                "pred_row": {
                    "id": 57,
                    "pubmed_id": 50101,
                    "paper": "Comprehensive Analysis of Migraine Treatments",
                    "authors": "Harris, Emily; Martin, Greg",
                    "journal": "Headache Research Journal",
                    "publication_date": "2023-03-15",
                    "disease": "Migraine",
                    "medication_group": "CGRP inhibitor group (excluding Erenumab)",
                    "therapy_or_medication": "CGRP inhibitors (excluding Erenumab)",
                    "medical_outcome": "reduction in MMD",
                    "result": "49.9%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.84515380859375,
                    "therapy_or_medication_correct": 0.7984176874160767,
                    "medical_outcome_correct": 0.6279245615005493,
                    "result_correct": 0.8626804351806641,
                    "outcome_category_correct": 0.6407684087753296,
                    "outcome_evaluation_correct": 0.790851891040802,
                    "score": 5.565796911716461
                }
            },
            {
                "pred_row": {
                    "id": 58,
                    "pubmed_id": 50101,
                    "paper": "Comprehensive Analysis of Migraine Treatments",
                    "authors": "Harris, Emily; Martin, Greg",
                    "journal": "Headache Research Journal",
                    "publication_date": "2023-03-15",
                    "disease": "Migraine",
                    "medication_group": "Topiramate group",
                    "therapy_or_medication": "Topiramate",
                    "medical_outcome": "reduction in MMD",
                    "result": "40.1%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly worse"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.614985466003418,
                    "therapy_or_medication_correct": 0.5977753400802612,
                    "medical_outcome_correct": 0.6279245615005493,
                    "result_correct": 0.8614190816879272,
                    "outcome_category_correct": 0.6407684087753296,
                    "outcome_evaluation_correct": 1.0,
                    "score": 5.342872977256775
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 50101,
            "papername": "Comprehensive Analysis of Migraine Treatments",
            "authors": "Harris, Emily; Martin, Greg",
            "publication_date": "2023-03-15 00:00:00",
            "journal": "Headache Research Journal",
            "disease": "Migraine",
            "medication_group": "CGRP inhibitor group",
            "therapy_or_medication": "CGRP inhibitor",
            "medical_outcome": "Reduction in MMD",
            "result": "49.9%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 57,
            "pubmed_id": 50101,
            "paper": "Comprehensive Analysis of Migraine Treatments",
            "authors": "Harris, Emily; Martin, Greg",
            "journal": "Headache Research Journal",
            "publication_date": "2023-03-15",
            "disease": "Migraine",
            "medication_group": "CGRP inhibitor group (excluding Erenumab)",
            "therapy_or_medication": "CGRP inhibitors (excluding Erenumab)",
            "medical_outcome": "reduction in MMD",
            "result": "49.9%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0000001192092896,
            "medication_group_correct": 0.8469067811965942,
            "therapy_or_medication_correct": 0.7896953225135803,
            "medical_outcome_correct": 0.9999998211860657,
            "result_correct": 1.0,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 6.636601984500885
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 56,
                    "pubmed_id": 50101,
                    "paper": "Comprehensive Analysis of Migraine Treatments",
                    "authors": "Harris, Emily; Martin, Greg",
                    "journal": "Headache Research Journal",
                    "publication_date": "2023-03-15",
                    "disease": "Migraine",
                    "medication_group": "Erenumab group",
                    "therapy_or_medication": "Erenumab",
                    "medical_outcome": "reduction in MMD",
                    "result": "52.3%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.7763464450836182,
                    "therapy_or_medication_correct": 0.7185076475143433,
                    "medical_outcome_correct": 0.9999998211860657,
                    "result_correct": 0.9285141229629517,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.4233680963516235
                }
            },
            {
                "pred_row": {
                    "id": 57,
                    "pubmed_id": 50101,
                    "paper": "Comprehensive Analysis of Migraine Treatments",
                    "authors": "Harris, Emily; Martin, Greg",
                    "journal": "Headache Research Journal",
                    "publication_date": "2023-03-15",
                    "disease": "Migraine",
                    "medication_group": "CGRP inhibitor group (excluding Erenumab)",
                    "therapy_or_medication": "CGRP inhibitors (excluding Erenumab)",
                    "medical_outcome": "reduction in MMD",
                    "result": "49.9%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.8469067811965942,
                    "therapy_or_medication_correct": 0.7896953225135803,
                    "medical_outcome_correct": 0.9999998211860657,
                    "result_correct": 1.0,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.636601984500885
                }
            },
            {
                "pred_row": {
                    "id": 58,
                    "pubmed_id": 50101,
                    "paper": "Comprehensive Analysis of Migraine Treatments",
                    "authors": "Harris, Emily; Martin, Greg",
                    "journal": "Headache Research Journal",
                    "publication_date": "2023-03-15",
                    "disease": "Migraine",
                    "medication_group": "Topiramate group",
                    "therapy_or_medication": "Topiramate",
                    "medical_outcome": "reduction in MMD",
                    "result": "40.1%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly worse"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.5717882513999939,
                    "therapy_or_medication_correct": 0.5701068639755249,
                    "medical_outcome_correct": 0.9999998211860657,
                    "result_correct": 0.920481264591217,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.790851891040802,
                    "score": 5.853228330612183
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 50101,
            "papername": "Comprehensive Analysis of Migraine Treatments",
            "authors": "Harris, Emily; Martin, Greg",
            "publication_date": "2023-03-15 00:00:00",
            "journal": "Headache Research Journal",
            "disease": "Migraine",
            "medication_group": "Topiramate group",
            "therapy_or_medication": "Topiramate",
            "medical_outcome": "Discontinuation Rate",
            "result": "12.3%",
            "outcome_category": "Adverse Events and Side Effects",
            "outcome_evaluation": "significantly worse"
        },
        "pred_row": {
            "id": 58,
            "pubmed_id": 50101,
            "paper": "Comprehensive Analysis of Migraine Treatments",
            "authors": "Harris, Emily; Martin, Greg",
            "journal": "Headache Research Journal",
            "publication_date": "2023-03-15",
            "disease": "Migraine",
            "medication_group": "Topiramate group",
            "therapy_or_medication": "Topiramate",
            "medical_outcome": "reduction in MMD",
            "result": "40.1%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly worse"
        },
        "best_similarity": {
            "disease_correct": 1.0000001192092896,
            "medication_group_correct": 0.9999998807907104,
            "therapy_or_medication_correct": 1.0,
            "medical_outcome_correct": 0.6279245615005493,
            "result_correct": 0.8971917629241943,
            "outcome_category_correct": 0.6407684087753296,
            "outcome_evaluation_correct": 1.0,
            "score": 6.165884733200073
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 56,
                    "pubmed_id": 50101,
                    "paper": "Comprehensive Analysis of Migraine Treatments",
                    "authors": "Harris, Emily; Martin, Greg",
                    "journal": "Headache Research Journal",
                    "publication_date": "2023-03-15",
                    "disease": "Migraine",
                    "medication_group": "Erenumab group",
                    "therapy_or_medication": "Erenumab",
                    "medical_outcome": "reduction in MMD",
                    "result": "52.3%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.614985466003418,
                    "therapy_or_medication_correct": 0.5977753400802612,
                    "medical_outcome_correct": 0.6279245615005493,
                    "result_correct": 0.9283639788627625,
                    "outcome_category_correct": 0.6407684087753296,
                    "outcome_evaluation_correct": 0.790851891040802,
                    "score": 5.200669765472412
                }
            },
            {
                "pred_row": {
                    "id": 57,
                    "pubmed_id": 50101,
                    "paper": "Comprehensive Analysis of Migraine Treatments",
                    "authors": "Harris, Emily; Martin, Greg",
                    "journal": "Headache Research Journal",
                    "publication_date": "2023-03-15",
                    "disease": "Migraine",
                    "medication_group": "CGRP inhibitor group (excluding Erenumab)",
                    "therapy_or_medication": "CGRP inhibitors (excluding Erenumab)",
                    "medical_outcome": "reduction in MMD",
                    "result": "49.9%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.4895397126674652,
                    "therapy_or_medication_correct": 0.43259918689727783,
                    "medical_outcome_correct": 0.6279245615005493,
                    "result_correct": 0.9160287380218506,
                    "outcome_category_correct": 0.6407684087753296,
                    "outcome_evaluation_correct": 0.790851891040802,
                    "score": 4.897712618112564
                }
            },
            {
                "pred_row": {
                    "id": 58,
                    "pubmed_id": 50101,
                    "paper": "Comprehensive Analysis of Migraine Treatments",
                    "authors": "Harris, Emily; Martin, Greg",
                    "journal": "Headache Research Journal",
                    "publication_date": "2023-03-15",
                    "disease": "Migraine",
                    "medication_group": "Topiramate group",
                    "therapy_or_medication": "Topiramate",
                    "medical_outcome": "reduction in MMD",
                    "result": "40.1%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly worse"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.9999998807907104,
                    "therapy_or_medication_correct": 1.0,
                    "medical_outcome_correct": 0.6279245615005493,
                    "result_correct": 0.8971917629241943,
                    "outcome_category_correct": 0.6407684087753296,
                    "outcome_evaluation_correct": 1.0,
                    "score": 6.165884733200073
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 50303,
            "papername": "New Treatments in Hepatology",
            "authors": "Patel, Sanjay; Kumar, Neel",
            "publication_date": "2023-07-10 00:00:00",
            "journal": "Liver Health",
            "disease": "Hepatitis C",
            "medication_group": "No group specified",
            "therapy_or_medication": "Antivirals",
            "medical_outcome": "Viral Clearance",
            "result": 0.95,
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 59,
            "pubmed_id": 50303,
            "paper": "New Treatments in Hepatology",
            "authors": "Patel, Sanjay; Kumar, Neel",
            "journal": "Liver Health",
            "publication_date": "2023-07-10",
            "disease": "Hepatitis C",
            "medication_group": "300 patients with confirmed chronic Hepatitis C infection",
            "therapy_or_medication": "direct-acting antiviral agents",
            "medical_outcome": "viral clearance",
            "result": "95%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0,
            "medication_group_correct": 0.44540852308273315,
            "therapy_or_medication_correct": 0.8718594312667847,
            "medical_outcome_correct": 1.000000238418579,
            "result_correct": 0.6930093765258789,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 6.010277509689331
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 59,
                    "pubmed_id": 50303,
                    "paper": "New Treatments in Hepatology",
                    "authors": "Patel, Sanjay; Kumar, Neel",
                    "journal": "Liver Health",
                    "publication_date": "2023-07-10",
                    "disease": "Hepatitis C",
                    "medication_group": "300 patients with confirmed chronic Hepatitis C infection",
                    "therapy_or_medication": "direct-acting antiviral agents",
                    "medical_outcome": "viral clearance",
                    "result": "95%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.44540852308273315,
                    "therapy_or_medication_correct": 0.8718594312667847,
                    "medical_outcome_correct": 1.000000238418579,
                    "result_correct": 0.6930093765258789,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.010277509689331
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 50404,
            "papername": "Breakthroughs in Cardiovascular Disease",
            "authors": "Chang, Sarah; Lee, Michael",
            "publication_date": "2023-09-15 00:00:00",
            "journal": "Cardiology Today",
            "disease": "Heart Disease",
            "medication_group": "Statins group",
            "therapy_or_medication": "Statins",
            "medical_outcome": "Reduction in Cholesterol",
            "result": "55 mg/dL",
            "outcome_category": "Physiological Measure",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 60,
            "pubmed_id": 50404,
            "paper": "Breakthroughs in Cardiovascular Disease",
            "authors": "Chang, Sarah; Lee, Michael",
            "journal": "Cardiology Today",
            "publication_date": "2023-09-15",
            "disease": "Heart disease",
            "medication_group": "Patients with heart disease (statins group)",
            "therapy_or_medication": "Statins",
            "medical_outcome": "reduction in cholesterol levels",
            "result": "55 mg/dL",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "signifcantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0000001192092896,
            "medication_group_correct": 0.627103328704834,
            "therapy_or_medication_correct": 1.0,
            "medical_outcome_correct": 0.9634334444999695,
            "result_correct": 0.9999999403953552,
            "outcome_category_correct": 0.7687371969223022,
            "outcome_evaluation_correct": 0.5726467967033386,
            "score": 5.931920826435089
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 60,
                    "pubmed_id": 50404,
                    "paper": "Breakthroughs in Cardiovascular Disease",
                    "authors": "Chang, Sarah; Lee, Michael",
                    "journal": "Cardiology Today",
                    "publication_date": "2023-09-15",
                    "disease": "Heart disease",
                    "medication_group": "Patients with heart disease (statins group)",
                    "therapy_or_medication": "Statins",
                    "medical_outcome": "reduction in cholesterol levels",
                    "result": "55 mg/dL",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "signifcantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.627103328704834,
                    "therapy_or_medication_correct": 1.0,
                    "medical_outcome_correct": 0.9634334444999695,
                    "result_correct": 0.9999999403953552,
                    "outcome_category_correct": 0.7687371969223022,
                    "outcome_evaluation_correct": 0.5726467967033386,
                    "score": 5.931920826435089
                }
            },
            {
                "pred_row": {
                    "id": 61,
                    "pubmed_id": 50404,
                    "paper": "Breakthroughs in Cardiovascular Disease",
                    "authors": "Chang, Sarah; Lee, Michael",
                    "journal": "Cardiology Today",
                    "publication_date": "2023-09-15",
                    "disease": "Heart disease",
                    "medication_group": "Patients with heart disease (beta blockers group)",
                    "therapy_or_medication": "Beta blockers",
                    "medical_outcome": "reduction in mortality",
                    "result": "7.7%",
                    "outcome_category": "Physiological Measure",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.5146459937095642,
                    "therapy_or_medication_correct": 0.605645477771759,
                    "medical_outcome_correct": 0.7288179993629456,
                    "result_correct": 0.5362045168876648,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.385314047336578
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 50404,
            "papername": "Breakthroughs in Cardiovascular Disease",
            "authors": "Chang, Sarah; Lee, Michael",
            "publication_date": "2023-09-15 00:00:00",
            "journal": "Cardiology Today",
            "disease": "Heart Disease",
            "medication_group": "Beta blockers group",
            "therapy_or_medication": "Beta Blockers",
            "medical_outcome": "Reduction in Mortality",
            "result": "7.7%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 61,
            "pubmed_id": 50404,
            "paper": "Breakthroughs in Cardiovascular Disease",
            "authors": "Chang, Sarah; Lee, Michael",
            "journal": "Cardiology Today",
            "publication_date": "2023-09-15",
            "disease": "Heart disease",
            "medication_group": "Patients with heart disease (beta blockers group)",
            "therapy_or_medication": "Beta blockers",
            "medical_outcome": "reduction in mortality",
            "result": "7.7%",
            "outcome_category": "Physiological Measure",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0000001192092896,
            "medication_group_correct": 0.788592517375946,
            "therapy_or_medication_correct": 0.9999999403953552,
            "medical_outcome_correct": 1.0000001192092896,
            "result_correct": 1.0,
            "outcome_category_correct": 0.7687371969223022,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 6.557329714298248
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 60,
                    "pubmed_id": 50404,
                    "paper": "Breakthroughs in Cardiovascular Disease",
                    "authors": "Chang, Sarah; Lee, Michael",
                    "journal": "Cardiology Today",
                    "publication_date": "2023-09-15",
                    "disease": "Heart disease",
                    "medication_group": "Patients with heart disease (statins group)",
                    "therapy_or_medication": "Statins",
                    "medical_outcome": "reduction in cholesterol levels",
                    "result": "55 mg/dL",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "signifcantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.677951991558075,
                    "therapy_or_medication_correct": 0.605645477771759,
                    "medical_outcome_correct": 0.7465704083442688,
                    "result_correct": 0.5362045168876648,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.5726467967033386,
                    "score": 5.139019429683685
                }
            },
            {
                "pred_row": {
                    "id": 61,
                    "pubmed_id": 50404,
                    "paper": "Breakthroughs in Cardiovascular Disease",
                    "authors": "Chang, Sarah; Lee, Michael",
                    "journal": "Cardiology Today",
                    "publication_date": "2023-09-15",
                    "disease": "Heart disease",
                    "medication_group": "Patients with heart disease (beta blockers group)",
                    "therapy_or_medication": "Beta blockers",
                    "medical_outcome": "reduction in mortality",
                    "result": "7.7%",
                    "outcome_category": "Physiological Measure",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.788592517375946,
                    "therapy_or_medication_correct": 0.9999999403953552,
                    "medical_outcome_correct": 1.0000001192092896,
                    "result_correct": 1.0,
                    "outcome_category_correct": 0.7687371969223022,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.557329714298248
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 55555,
            "papername": "Understanding Rheumatoid Arthritis",
            "authors": "García, Maria; López, Carlos",
            "publication_date": "2024-02-28 00:00:00",
            "journal": "Arthritis Journal",
            "disease": "Arthritis",
            "medication_group": "Methotrexate group",
            "therapy_or_medication": "Methotrexate",
            "medical_outcome": "Pain Reduction",
            "result": 0.48,
            "outcome_category": "Symptom Intensity and Relief",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 62,
            "pubmed_id": 55555,
            "paper": "Understanding Rheumatoid Arthritis",
            "authors": "García, Maria; López, Carlos",
            "journal": "Arthritis Journal",
            "publication_date": "2024-02-28",
            "disease": "Rheumatoid Arthritis",
            "medication_group": "450 patients with rheumatoid arthritis",
            "therapy_or_medication": "Methotrexate",
            "medical_outcome": "Pain reduction",
            "result": "48%",
            "outcome_category": "Symptom Intensity and Relief",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 0.2728271484375,
            "medication_group_correct": 0.5296453237533569,
            "therapy_or_medication_correct": 1.0,
            "medical_outcome_correct": 0.9999998211860657,
            "result_correct": 0.7023350596427917,
            "outcome_category_correct": 1.0,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 5.50480717420578
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 62,
                    "pubmed_id": 55555,
                    "paper": "Understanding Rheumatoid Arthritis",
                    "authors": "García, Maria; López, Carlos",
                    "journal": "Arthritis Journal",
                    "publication_date": "2024-02-28",
                    "disease": "Rheumatoid Arthritis",
                    "medication_group": "450 patients with rheumatoid arthritis",
                    "therapy_or_medication": "Methotrexate",
                    "medical_outcome": "Pain reduction",
                    "result": "48%",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.2728271484375,
                    "medication_group_correct": 0.5296453237533569,
                    "therapy_or_medication_correct": 1.0,
                    "medical_outcome_correct": 0.9999998211860657,
                    "result_correct": 0.7023350596427917,
                    "outcome_category_correct": 1.0,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.50480717420578
                }
            },
            {
                "pred_row": {
                    "id": 63,
                    "pubmed_id": 55555,
                    "paper": "Understanding Rheumatoid Arthritis",
                    "authors": "García, Maria; López, Carlos",
                    "journal": "Arthritis Journal",
                    "publication_date": "2024-02-28",
                    "disease": "Rheumatoid Arthritis",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "TNF inhibitors",
                    "medical_outcome": "Symptom improvement",
                    "result": "60%",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.2728271484375,
                    "medication_group_correct": 0.35916396975517273,
                    "therapy_or_medication_correct": 0.4940725564956665,
                    "medical_outcome_correct": 0.7281370162963867,
                    "result_correct": 0.683453381061554,
                    "outcome_category_correct": 1.0,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 4.537653893232346
                }
            },
            {
                "pred_row": {
                    "id": 64,
                    "pubmed_id": 55555,
                    "paper": "Understanding Rheumatoid Arthritis",
                    "authors": "García, Maria; López, Carlos",
                    "journal": "Arthritis Journal",
                    "publication_date": "2024-02-28",
                    "disease": "Rheumatoid Arthritis",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "Steroids",
                    "medical_outcome": "Inflammation reduction",
                    "result": "500% reduction",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.2728271484375,
                    "medication_group_correct": 0.35916396975517273,
                    "therapy_or_medication_correct": 0.5393612384796143,
                    "medical_outcome_correct": 0.8813111782073975,
                    "result_correct": 0.5986801981925964,
                    "outcome_category_correct": 0.6335793137550354,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 4.284922868013382
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 55555,
            "papername": "Understanding Rheumatoid Arthritis",
            "authors": "García, Maria; López, Carlos",
            "publication_date": "2024-02-28 00:00:00",
            "journal": "Arthritis Journal",
            "disease": "Arthritis",
            "medication_group": "TNF inhibitors group",
            "therapy_or_medication": "TNF Inhibitors",
            "medical_outcome": "Symptom Improvement",
            "result": 0.6,
            "outcome_category": "Symptom Intensity and Relief",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 63,
            "pubmed_id": 55555,
            "paper": "Understanding Rheumatoid Arthritis",
            "authors": "García, Maria; López, Carlos",
            "journal": "Arthritis Journal",
            "publication_date": "2024-02-28",
            "disease": "Rheumatoid Arthritis",
            "medication_group": "No group specified",
            "therapy_or_medication": "TNF inhibitors",
            "medical_outcome": "Symptom improvement",
            "result": "60%",
            "outcome_category": "Symptom Intensity and Relief",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 0.2728271484375,
            "medication_group_correct": 0.5198366045951843,
            "therapy_or_medication_correct": 1.0,
            "medical_outcome_correct": 0.9999999403953552,
            "result_correct": 0.6794672608375549,
            "outcome_category_correct": 1.0,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 5.47213077545166
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 62,
                    "pubmed_id": 55555,
                    "paper": "Understanding Rheumatoid Arthritis",
                    "authors": "García, Maria; López, Carlos",
                    "journal": "Arthritis Journal",
                    "publication_date": "2024-02-28",
                    "disease": "Rheumatoid Arthritis",
                    "medication_group": "450 patients with rheumatoid arthritis",
                    "therapy_or_medication": "Methotrexate",
                    "medical_outcome": "Pain reduction",
                    "result": "48%",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.2728271484375,
                    "medication_group_correct": 0.5163319110870361,
                    "therapy_or_medication_correct": 0.4940725564956665,
                    "medical_outcome_correct": 0.7281370162963867,
                    "result_correct": 0.6736577153205872,
                    "outcome_category_correct": 1.0,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 4.685026168823242
                }
            },
            {
                "pred_row": {
                    "id": 63,
                    "pubmed_id": 55555,
                    "paper": "Understanding Rheumatoid Arthritis",
                    "authors": "García, Maria; López, Carlos",
                    "journal": "Arthritis Journal",
                    "publication_date": "2024-02-28",
                    "disease": "Rheumatoid Arthritis",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "TNF inhibitors",
                    "medical_outcome": "Symptom improvement",
                    "result": "60%",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.2728271484375,
                    "medication_group_correct": 0.5198366045951843,
                    "therapy_or_medication_correct": 1.0,
                    "medical_outcome_correct": 0.9999999403953552,
                    "result_correct": 0.6794672608375549,
                    "outcome_category_correct": 1.0,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.47213077545166
                }
            },
            {
                "pred_row": {
                    "id": 64,
                    "pubmed_id": 55555,
                    "paper": "Understanding Rheumatoid Arthritis",
                    "authors": "García, Maria; López, Carlos",
                    "journal": "Arthritis Journal",
                    "publication_date": "2024-02-28",
                    "disease": "Rheumatoid Arthritis",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "Steroids",
                    "medical_outcome": "Inflammation reduction",
                    "result": "500% reduction",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.2728271484375,
                    "medication_group_correct": 0.5198366045951843,
                    "therapy_or_medication_correct": 0.7194217443466187,
                    "medical_outcome_correct": 0.735105037689209,
                    "result_correct": 0.5791664719581604,
                    "outcome_category_correct": 0.6335793137550354,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 4.459936141967773
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 55555,
            "papername": "Understanding Rheumatoid Arthritis",
            "authors": "García, Maria; López, Carlos",
            "publication_date": "2024-02-28 00:00:00",
            "journal": "Arthritis Journal",
            "disease": "Arthritis",
            "medication_group": "Steroids group",
            "therapy_or_medication": "Steroids",
            "medical_outcome": "Reduction in Inflammation",
            "result": 5,
            "outcome_category": "Symptom Intensity and Relief",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 63,
            "pubmed_id": 55555,
            "paper": "Understanding Rheumatoid Arthritis",
            "authors": "García, Maria; López, Carlos",
            "journal": "Arthritis Journal",
            "publication_date": "2024-02-28",
            "disease": "Rheumatoid Arthritis",
            "medication_group": "No group specified",
            "therapy_or_medication": "TNF inhibitors",
            "medical_outcome": "Symptom improvement",
            "result": "60%",
            "outcome_category": "Symptom Intensity and Relief",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 0.2728271484375,
            "medication_group_correct": 0.6050910949707031,
            "therapy_or_medication_correct": 0.7194217443466187,
            "medical_outcome_correct": 0.73844975233078,
            "result_correct": 0.6803587079048157,
            "outcome_category_correct": 1.0,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 5.016148269176483
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 62,
                    "pubmed_id": 55555,
                    "paper": "Understanding Rheumatoid Arthritis",
                    "authors": "García, Maria; López, Carlos",
                    "journal": "Arthritis Journal",
                    "publication_date": "2024-02-28",
                    "disease": "Rheumatoid Arthritis",
                    "medication_group": "450 patients with rheumatoid arthritis",
                    "therapy_or_medication": "Methotrexate",
                    "medical_outcome": "Pain reduction",
                    "result": "48%",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.2728271484375,
                    "medication_group_correct": 0.510166585445404,
                    "therapy_or_medication_correct": 0.5393612384796143,
                    "medical_outcome_correct": 0.7980588674545288,
                    "result_correct": 0.6620410084724426,
                    "outcome_category_correct": 1.0,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 4.782454669475555
                }
            },
            {
                "pred_row": {
                    "id": 63,
                    "pubmed_id": 55555,
                    "paper": "Understanding Rheumatoid Arthritis",
                    "authors": "García, Maria; López, Carlos",
                    "journal": "Arthritis Journal",
                    "publication_date": "2024-02-28",
                    "disease": "Rheumatoid Arthritis",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "TNF inhibitors",
                    "medical_outcome": "Symptom improvement",
                    "result": "60%",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.2728271484375,
                    "medication_group_correct": 0.6050910949707031,
                    "therapy_or_medication_correct": 0.7194217443466187,
                    "medical_outcome_correct": 0.73844975233078,
                    "result_correct": 0.6803587079048157,
                    "outcome_category_correct": 1.0,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.016148269176483
                }
            },
            {
                "pred_row": {
                    "id": 64,
                    "pubmed_id": 55555,
                    "paper": "Understanding Rheumatoid Arthritis",
                    "authors": "García, Maria; López, Carlos",
                    "journal": "Arthritis Journal",
                    "publication_date": "2024-02-28",
                    "disease": "Rheumatoid Arthritis",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "Steroids",
                    "medical_outcome": "Inflammation reduction",
                    "result": "500% reduction",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.2728271484375,
                    "medication_group_correct": 0.6050910949707031,
                    "therapy_or_medication_correct": 1.0,
                    "medical_outcome_correct": 0.8875976800918579,
                    "result_correct": 0.5913320779800415,
                    "outcome_category_correct": 0.6335793137550354,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 4.990427136421204
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 50606,
            "papername": "Innovative Approaches in Lung Cancer",
            "authors": "Kim, Ji-Sung; Park, Soo-Hyun",
            "publication_date": "2023-10-05 00:00:00",
            "journal": "Lung Cancer Journal",
            "disease": "Lung Cancer",
            "medication_group": "Chemotherapy group",
            "therapy_or_medication": "Chemotherapy",
            "medical_outcome": "Reduction in Tumor Size",
            "result": 0.33,
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 65,
            "pubmed_id": 50606,
            "paper": "Innovative Approaches in Lung Cancer",
            "authors": "Kim, Ji-Sung; Park, Soo-Hyun",
            "journal": "Lung Cancer Journal",
            "publication_date": "2023-10-05",
            "disease": "Lung cancer",
            "medication_group": "400 patients with advanced lung cancer",
            "therapy_or_medication": "Chemotherapy",
            "medical_outcome": "reduction in tumor size",
            "result": "33%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0000001192092896,
            "medication_group_correct": 0.6410653591156006,
            "therapy_or_medication_correct": 0.9999998211860657,
            "medical_outcome_correct": 1.0,
            "result_correct": 0.7303541302680969,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 6.371419370174408
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 65,
                    "pubmed_id": 50606,
                    "paper": "Innovative Approaches in Lung Cancer",
                    "authors": "Kim, Ji-Sung; Park, Soo-Hyun",
                    "journal": "Lung Cancer Journal",
                    "publication_date": "2023-10-05",
                    "disease": "Lung cancer",
                    "medication_group": "400 patients with advanced lung cancer",
                    "therapy_or_medication": "Chemotherapy",
                    "medical_outcome": "reduction in tumor size",
                    "result": "33%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.6410653591156006,
                    "therapy_or_medication_correct": 0.9999998211860657,
                    "medical_outcome_correct": 1.0,
                    "result_correct": 0.7303541302680969,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.371419370174408
                }
            },
            {
                "pred_row": {
                    "id": 66,
                    "pubmed_id": 50606,
                    "paper": "Innovative Approaches in Lung Cancer",
                    "authors": "Kim, Ji-Sung; Park, Soo-Hyun",
                    "journal": "Lung Cancer Journal",
                    "publication_date": "2023-10-05",
                    "disease": "Lung cancer",
                    "medication_group": "'No group specified'",
                    "therapy_or_medication": "Immunotherapy",
                    "medical_outcome": "improvement in survival rates",
                    "result": "65% improvement",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.595911979675293,
                    "therapy_or_medication_correct": 0.36712372303009033,
                    "medical_outcome_correct": 0.8290243148803711,
                    "result_correct": 0.6657456755638123,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.457805752754211
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 50606,
            "papername": "Innovative Approaches in Lung Cancer",
            "authors": "Kim, Ji-Sung; Park, Soo-Hyun",
            "publication_date": "2023-10-05 00:00:00",
            "journal": "Lung Cancer Journal",
            "disease": "Lung Cancer",
            "medication_group": "Immunotherapy group",
            "therapy_or_medication": "Immunotherapy",
            "medical_outcome": "Survival Rate",
            "result": 0.65,
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 66,
            "pubmed_id": 50606,
            "paper": "Innovative Approaches in Lung Cancer",
            "authors": "Kim, Ji-Sung; Park, Soo-Hyun",
            "journal": "Lung Cancer Journal",
            "publication_date": "2023-10-05",
            "disease": "Lung cancer",
            "medication_group": "'No group specified'",
            "therapy_or_medication": "Immunotherapy",
            "medical_outcome": "improvement in survival rates",
            "result": "65% improvement",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0000001192092896,
            "medication_group_correct": 0.38349342346191406,
            "therapy_or_medication_correct": 1.0000001192092896,
            "medical_outcome_correct": 0.8339686989784241,
            "result_correct": 0.6507941484451294,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 5.868256449699402
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 65,
                    "pubmed_id": 50606,
                    "paper": "Innovative Approaches in Lung Cancer",
                    "authors": "Kim, Ji-Sung; Park, Soo-Hyun",
                    "journal": "Lung Cancer Journal",
                    "publication_date": "2023-10-05",
                    "disease": "Lung cancer",
                    "medication_group": "400 patients with advanced lung cancer",
                    "therapy_or_medication": "Chemotherapy",
                    "medical_outcome": "reduction in tumor size",
                    "result": "33%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.6031763553619385,
                    "therapy_or_medication_correct": 0.36712372303009033,
                    "medical_outcome_correct": 0.6897076964378357,
                    "result_correct": 0.654384195804596,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.314392030239105
                }
            },
            {
                "pred_row": {
                    "id": 66,
                    "pubmed_id": 50606,
                    "paper": "Innovative Approaches in Lung Cancer",
                    "authors": "Kim, Ji-Sung; Park, Soo-Hyun",
                    "journal": "Lung Cancer Journal",
                    "publication_date": "2023-10-05",
                    "disease": "Lung cancer",
                    "medication_group": "'No group specified'",
                    "therapy_or_medication": "Immunotherapy",
                    "medical_outcome": "improvement in survival rates",
                    "result": "65% improvement",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.38349342346191406,
                    "therapy_or_medication_correct": 1.0000001192092896,
                    "medical_outcome_correct": 0.8339686989784241,
                    "result_correct": 0.6507941484451294,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.868256449699402
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 50808,
            "papername": "Recent Advances in Asthma Treatment",
            "authors": "Schmidt, Hans; Becker, Anja",
            "publication_date": "2023-12-22 00:00:00",
            "journal": "Respiratory Advances",
            "disease": "Asthma",
            "medication_group": "No group specified",
            "therapy_or_medication": "Inhalers",
            "medical_outcome": "Cost for medication reduction",
            "result": "4.580 € per year",
            "outcome_category": "Health Economics",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 67,
            "pubmed_id": 50808,
            "paper": "Recent Advances in Asthma Treatment",
            "authors": "Schmidt, Hans; Becker, Anja",
            "journal": "Respiratory Advances",
            "publication_date": "2023-12-22",
            "disease": "Asthma",
            "medication_group": "Patients with moderate to severe asthma",
            "therapy_or_medication": "Inhalers",
            "medical_outcome": "Reduction in cost for medications",
            "result": "4.580 € per year",
            "outcome_category": "Health Economics",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0,
            "medication_group_correct": 0.429466187953949,
            "therapy_or_medication_correct": 1.0,
            "medical_outcome_correct": 0.8543332815170288,
            "result_correct": 1.0,
            "outcome_category_correct": 0.9999999403953552,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 6.283799231052399
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 67,
                    "pubmed_id": 50808,
                    "paper": "Recent Advances in Asthma Treatment",
                    "authors": "Schmidt, Hans; Becker, Anja",
                    "journal": "Respiratory Advances",
                    "publication_date": "2023-12-22",
                    "disease": "Asthma",
                    "medication_group": "Patients with moderate to severe asthma",
                    "therapy_or_medication": "Inhalers",
                    "medical_outcome": "Reduction in cost for medications",
                    "result": "4.580 € per year",
                    "outcome_category": "Health Economics",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.429466187953949,
                    "therapy_or_medication_correct": 1.0,
                    "medical_outcome_correct": 0.8543332815170288,
                    "result_correct": 1.0,
                    "outcome_category_correct": 0.9999999403953552,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.283799231052399
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 50909,
            "papername": "Advancements in Alzheimer’s Therapy",
            "authors": "Dubois, Rémi; Fontaine, Brigitte",
            "publication_date": "2024-04-18 00:00:00",
            "journal": "Neurological Advances",
            "disease": "Alzheimer's",
            "medication_group": "No group specified",
            "therapy_or_medication": "Cholinesterase Inhibitors",
            "medical_outcome": "Cognitive Improvement",
            "result": 0.2,
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 68,
            "pubmed_id": 50909,
            "paper": "Advancements in Alzheimer’s Therapy",
            "authors": "Dubois, Rémi; Fontaine, Brigitte",
            "journal": "Neurological Advances",
            "publication_date": "2024-04-18",
            "disease": "Alzheimer's disease",
            "medication_group": "Patients with mild to moderate Alzheimer's disease (n=250)",
            "therapy_or_medication": "Cholinesterase inhibitors",
            "medical_outcome": "Improvement in cognitive function",
            "result": "20%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 0.8405335545539856,
            "medication_group_correct": 0.4258692264556885,
            "therapy_or_medication_correct": 0.9999999403953552,
            "medical_outcome_correct": 0.8510383367538452,
            "result_correct": 0.7083132863044739,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 5.825754284858704
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 68,
                    "pubmed_id": 50909,
                    "paper": "Advancements in Alzheimer’s Therapy",
                    "authors": "Dubois, Rémi; Fontaine, Brigitte",
                    "journal": "Neurological Advances",
                    "publication_date": "2024-04-18",
                    "disease": "Alzheimer's disease",
                    "medication_group": "Patients with mild to moderate Alzheimer's disease (n=250)",
                    "therapy_or_medication": "Cholinesterase inhibitors",
                    "medical_outcome": "Improvement in cognitive function",
                    "result": "20%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.8405335545539856,
                    "medication_group_correct": 0.4258692264556885,
                    "therapy_or_medication_correct": 0.9999999403953552,
                    "medical_outcome_correct": 0.8510383367538452,
                    "result_correct": 0.7083132863044739,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.825754284858704
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 51010,
            "papername": "Emerging Treatments in Osteoporosis",
            "authors": "Müller, Hans; Becker, Anja",
            "publication_date": "2023-05-30 00:00:00",
            "journal": "Bone Health Journal",
            "disease": "Osteoporosis",
            "medication_group": "No group specified",
            "therapy_or_medication": "Calcium",
            "medical_outcome": "Bone Density Increase",
            "result": "3.2%",
            "outcome_category": "Physiological Measure",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 69,
            "pubmed_id": 51010,
            "paper": "Emerging Treatments in Osteoporosis",
            "authors": "Müller, Hans; Becker, Anja",
            "journal": "Bone Health Journal",
            "publication_date": "2023-05-30",
            "disease": "Osteoporosis",
            "medication_group": "Patients with osteoporosis",
            "therapy_or_medication": "Calcium supplementation",
            "medical_outcome": "Increase in bone density",
            "result": "3.2%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0,
            "medication_group_correct": 0.32545211911201477,
            "therapy_or_medication_correct": 0.7277618050575256,
            "medical_outcome_correct": 0.90325927734375,
            "result_correct": 1.0,
            "outcome_category_correct": 0.7687371969223022,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 5.725210219621658
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 69,
                    "pubmed_id": 51010,
                    "paper": "Emerging Treatments in Osteoporosis",
                    "authors": "Müller, Hans; Becker, Anja",
                    "journal": "Bone Health Journal",
                    "publication_date": "2023-05-30",
                    "disease": "Osteoporosis",
                    "medication_group": "Patients with osteoporosis",
                    "therapy_or_medication": "Calcium supplementation",
                    "medical_outcome": "Increase in bone density",
                    "result": "3.2%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.32545211911201477,
                    "therapy_or_medication_correct": 0.7277618050575256,
                    "medical_outcome_correct": 0.90325927734375,
                    "result_correct": 1.0,
                    "outcome_category_correct": 0.7687371969223022,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.725210219621658
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 51111,
            "papername": "New Horizons in Kidney Disease Management",
            "authors": "Rossi, Matteo; Bianchi, Giulia",
            "publication_date": "2023-08-25 00:00:00",
            "journal": "Nephrology News",
            "disease": "Kidney Disease",
            "medication_group": "No group specified",
            "therapy_or_medication": "Dialysis",
            "medical_outcome": "average increase in GFR",
            "result": "250 mL/min",
            "outcome_category": "Physiological Measure",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 70,
            "pubmed_id": 51111,
            "paper": "New Horizons in Kidney Disease Management",
            "authors": "Rossi, Matteo; Bianchi, Giulia",
            "journal": "Nephrology News",
            "publication_date": "2023-08-25",
            "disease": "Kidney disease",
            "medication_group": "150 patients with end-stage renal disease undergoing dialysis",
            "therapy_or_medication": "Dialysis",
            "medical_outcome": "Increase in glomerular filtration rate (GFR)",
            "result": "250 mL/min",
            "outcome_category": "Physiological Measure",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0000001192092896,
            "medication_group_correct": 0.38839641213417053,
            "therapy_or_medication_correct": 1.0,
            "medical_outcome_correct": 0.6715201139450073,
            "result_correct": 0.9999999403953552,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 6.059916526079178
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 70,
                    "pubmed_id": 51111,
                    "paper": "New Horizons in Kidney Disease Management",
                    "authors": "Rossi, Matteo; Bianchi, Giulia",
                    "journal": "Nephrology News",
                    "publication_date": "2023-08-25",
                    "disease": "Kidney disease",
                    "medication_group": "150 patients with end-stage renal disease undergoing dialysis",
                    "therapy_or_medication": "Dialysis",
                    "medical_outcome": "Increase in glomerular filtration rate (GFR)",
                    "result": "250 mL/min",
                    "outcome_category": "Physiological Measure",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.38839641213417053,
                    "therapy_or_medication_correct": 1.0,
                    "medical_outcome_correct": 0.6715201139450073,
                    "result_correct": 0.9999999403953552,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.059916526079178
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 51212,
            "papername": "Breakthroughs in Multiple Sclerosis Therapy",
            "authors": "Adams, Richard; Jones, Emily",
            "publication_date": "2024-06-12 00:00:00",
            "journal": "MS Research Journal",
            "disease": "Multiple Sclerosis",
            "medication_group": "No group specified",
            "therapy_or_medication": "Interferons",
            "medical_outcome": "Reduction in Relapse",
            "result": "0 relapses/year",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 71,
            "pubmed_id": 51212,
            "paper": "Breakthroughs in Multiple Sclerosis Therapy",
            "authors": "Adams, Richard; Jones, Emily",
            "journal": "MS Research Journal",
            "publication_date": "2024-06-12",
            "disease": "Multiple sclerosis",
            "medication_group": "120 patients with relapsing-remitting MS",
            "therapy_or_medication": "Interferon therapy",
            "medical_outcome": "Relapse frequency",
            "result": "0 relapses per year",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0,
            "medication_group_correct": 0.40745508670806885,
            "therapy_or_medication_correct": 0.7800437211990356,
            "medical_outcome_correct": 0.9044569730758667,
            "result_correct": 0.8628667593002319,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 5.954822480678558
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 71,
                    "pubmed_id": 51212,
                    "paper": "Breakthroughs in Multiple Sclerosis Therapy",
                    "authors": "Adams, Richard; Jones, Emily",
                    "journal": "MS Research Journal",
                    "publication_date": "2024-06-12",
                    "disease": "Multiple sclerosis",
                    "medication_group": "120 patients with relapsing-remitting MS",
                    "therapy_or_medication": "Interferon therapy",
                    "medical_outcome": "Relapse frequency",
                    "result": "0 relapses per year",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.40745508670806885,
                    "therapy_or_medication_correct": 0.7800437211990356,
                    "medical_outcome_correct": 0.9044569730758667,
                    "result_correct": 0.8628667593002319,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.954822480678558
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 51313,
            "papername": "Thyroid Disorder Innovations",
            "authors": "Nguyen, Phuong; Tran, Bao",
            "publication_date": "2023-03-03 00:00:00",
            "journal": "Thyroid Health Journal",
            "disease": "Thyroid Disorder",
            "medication_group": "No group specified",
            "therapy_or_medication": "Thyroxine",
            "medical_outcome": "Normalization of Levels",
            "result": "0.005 µIU/mL",
            "outcome_category": "Physiological Measure",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 72,
            "pubmed_id": 51313,
            "paper": "Thyroid Disorder Innovations",
            "authors": "Nguyen, Phuong; Tran, Bao",
            "journal": "Thyroid Health Journal",
            "publication_date": "2023-03-03",
            "disease": "Thyroid disorders",
            "medication_group": "150 patients diagnosed with hypothyroidism",
            "therapy_or_medication": "Thyroxine",
            "medical_outcome": "TSH normalization",
            "result": "0.005 µIU/mL",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 0.940056324005127,
            "medication_group_correct": 0.4106298089027405,
            "therapy_or_medication_correct": 0.9999998807907104,
            "medical_outcome_correct": 0.7558109164237976,
            "result_correct": 1.0000001192092896,
            "outcome_category_correct": 0.7687371969223022,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 5.875234067440033
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 72,
                    "pubmed_id": 51313,
                    "paper": "Thyroid Disorder Innovations",
                    "authors": "Nguyen, Phuong; Tran, Bao",
                    "journal": "Thyroid Health Journal",
                    "publication_date": "2023-03-03",
                    "disease": "Thyroid disorders",
                    "medication_group": "150 patients diagnosed with hypothyroidism",
                    "therapy_or_medication": "Thyroxine",
                    "medical_outcome": "TSH normalization",
                    "result": "0.005 µIU/mL",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.940056324005127,
                    "medication_group_correct": 0.4106298089027405,
                    "therapy_or_medication_correct": 0.9999998807907104,
                    "medical_outcome_correct": 0.7558109164237976,
                    "result_correct": 1.0000001192092896,
                    "outcome_category_correct": 0.7687371969223022,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.875234067440033
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 60101,
            "papername": "Innovations in Psoriasis Therapy",
            "authors": "Anderson, Laura; Smith, Thomas",
            "publication_date": "2024-02-20 00:00:00",
            "journal": "Dermatology Weekly",
            "disease": "Psoriasis",
            "medication_group": "Randomised group",
            "therapy_or_medication": "Biologics",
            "medical_outcome": "Symptom Reduction",
            "result": "Lower baseline HBV DNA in MVR (<20 IU/mL), higher baseline CHI3L1 (LLV:83.3 ng/mL vs MVR: 54.5 ng/mL)",
            "outcome_category": "Symptom Intensity and Relief",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 73,
            "pubmed_id": 60101,
            "paper": "Innovations in Psoriasis Therapy",
            "authors": "Anderson, Laura; Smith, Thomas",
            "journal": "Dermatology Weekly",
            "publication_date": "2024-02-20",
            "disease": "Psoriasis",
            "medication_group": "Patients with moderate to severe psoriasis",
            "therapy_or_medication": "Biologics",
            "medical_outcome": "Symptom reduction",
            "result": "significant",
            "outcome_category": "Symptom Intensity and Relief",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0,
            "medication_group_correct": 0.4127381145954132,
            "therapy_or_medication_correct": 1.0000001192092896,
            "medical_outcome_correct": 0.9999998211860657,
            "result_correct": 0.19725006818771362,
            "outcome_category_correct": 1.0,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 5.609987944364548
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 73,
                    "pubmed_id": 60101,
                    "paper": "Innovations in Psoriasis Therapy",
                    "authors": "Anderson, Laura; Smith, Thomas",
                    "journal": "Dermatology Weekly",
                    "publication_date": "2024-02-20",
                    "disease": "Psoriasis",
                    "medication_group": "Patients with moderate to severe psoriasis",
                    "therapy_or_medication": "Biologics",
                    "medical_outcome": "Symptom reduction",
                    "result": "significant",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.4127381145954132,
                    "therapy_or_medication_correct": 1.0000001192092896,
                    "medical_outcome_correct": 0.9999998211860657,
                    "result_correct": 0.19725006818771362,
                    "outcome_category_correct": 1.0,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.609987944364548
                }
            },
            {
                "pred_row": {
                    "id": 74,
                    "pubmed_id": 60101,
                    "paper": "Innovations in Psoriasis Therapy",
                    "authors": "Anderson, Laura; Smith, Thomas",
                    "journal": "Dermatology Weekly",
                    "publication_date": "2024-02-20",
                    "disease": "Psoriasis",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "Methotrexate",
                    "medical_outcome": "Pain reduction",
                    "result": "-0.04 to -0.01",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.61281418800354,
                    "therapy_or_medication_correct": 0.42534175515174866,
                    "medical_outcome_correct": 0.7025116682052612,
                    "result_correct": 0.4963867962360382,
                    "outcome_category_correct": 1.0,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.237054228782654
                }
            },
            {
                "pred_row": {
                    "id": 75,
                    "pubmed_id": 60101,
                    "paper": "Innovations in Psoriasis Therapy",
                    "authors": "Anderson, Laura; Smith, Thomas",
                    "journal": "Dermatology Weekly",
                    "publication_date": "2024-02-20",
                    "disease": "Psoriasis",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "Corticosteroids",
                    "medical_outcome": "Inflammation reduction",
                    "result": "significant",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.61281418800354,
                    "therapy_or_medication_correct": 0.5581135749816895,
                    "medical_outcome_correct": 0.7394928932189941,
                    "result_correct": 0.19725006818771362,
                    "outcome_category_correct": 0.6335793137550354,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 4.741249859333038
                }
            },
            {
                "pred_row": {
                    "id": 76,
                    "pubmed_id": 60101,
                    "paper": "Innovations in Psoriasis Therapy",
                    "authors": "Anderson, Laura; Smith, Thomas",
                    "journal": "Dermatology Weekly",
                    "publication_date": "2024-02-20",
                    "disease": "Psoriasis",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "Phototherapy",
                    "medical_outcome": "Plaque clearance",
                    "result": "-93%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.61281418800354,
                    "therapy_or_medication_correct": 0.6703760623931885,
                    "medical_outcome_correct": 0.5008003115653992,
                    "result_correct": 0.3853817582130432,
                    "outcome_category_correct": 0.6335793137550354,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 4.802951455116272
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 60101,
            "papername": "Innovations in Psoriasis Therapy",
            "authors": "Anderson, Laura; Smith, Thomas",
            "publication_date": "2024-02-20 00:00:00",
            "journal": "Dermatology Weekly",
            "disease": "Psoriasis",
            "medication_group": "Randomised group",
            "therapy_or_medication": "Methotrexate",
            "medical_outcome": "Pain Reduction",
            "result": "-0.04 to -0.01",
            "outcome_category": "Symptom Intensity and Relief",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 74,
            "pubmed_id": 60101,
            "paper": "Innovations in Psoriasis Therapy",
            "authors": "Anderson, Laura; Smith, Thomas",
            "journal": "Dermatology Weekly",
            "publication_date": "2024-02-20",
            "disease": "Psoriasis",
            "medication_group": "No group specified",
            "therapy_or_medication": "Methotrexate",
            "medical_outcome": "Pain reduction",
            "result": "-0.04 to -0.01",
            "outcome_category": "Symptom Intensity and Relief",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0,
            "medication_group_correct": 0.61281418800354,
            "therapy_or_medication_correct": 1.0,
            "medical_outcome_correct": 0.9999998211860657,
            "result_correct": 1.0,
            "outcome_category_correct": 1.0,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 6.612813830375671
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 73,
                    "pubmed_id": 60101,
                    "paper": "Innovations in Psoriasis Therapy",
                    "authors": "Anderson, Laura; Smith, Thomas",
                    "journal": "Dermatology Weekly",
                    "publication_date": "2024-02-20",
                    "disease": "Psoriasis",
                    "medication_group": "Patients with moderate to severe psoriasis",
                    "therapy_or_medication": "Biologics",
                    "medical_outcome": "Symptom reduction",
                    "result": "significant",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.4127381145954132,
                    "therapy_or_medication_correct": 0.42534175515174866,
                    "medical_outcome_correct": 0.7025116682052612,
                    "result_correct": 0.31021639704704285,
                    "outcome_category_correct": 1.0,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 4.850807756185532
                }
            },
            {
                "pred_row": {
                    "id": 74,
                    "pubmed_id": 60101,
                    "paper": "Innovations in Psoriasis Therapy",
                    "authors": "Anderson, Laura; Smith, Thomas",
                    "journal": "Dermatology Weekly",
                    "publication_date": "2024-02-20",
                    "disease": "Psoriasis",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "Methotrexate",
                    "medical_outcome": "Pain reduction",
                    "result": "-0.04 to -0.01",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.61281418800354,
                    "therapy_or_medication_correct": 1.0,
                    "medical_outcome_correct": 0.9999998211860657,
                    "result_correct": 1.0,
                    "outcome_category_correct": 1.0,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.612813830375671
                }
            },
            {
                "pred_row": {
                    "id": 75,
                    "pubmed_id": 60101,
                    "paper": "Innovations in Psoriasis Therapy",
                    "authors": "Anderson, Laura; Smith, Thomas",
                    "journal": "Dermatology Weekly",
                    "publication_date": "2024-02-20",
                    "disease": "Psoriasis",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "Corticosteroids",
                    "medical_outcome": "Inflammation reduction",
                    "result": "significant",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.61281418800354,
                    "therapy_or_medication_correct": 0.628389298915863,
                    "medical_outcome_correct": 0.8813111782073975,
                    "result_correct": 0.31021639704704285,
                    "outcome_category_correct": 0.6335793137550354,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.0663101971149445
                }
            },
            {
                "pred_row": {
                    "id": 76,
                    "pubmed_id": 60101,
                    "paper": "Innovations in Psoriasis Therapy",
                    "authors": "Anderson, Laura; Smith, Thomas",
                    "journal": "Dermatology Weekly",
                    "publication_date": "2024-02-20",
                    "disease": "Psoriasis",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "Phototherapy",
                    "medical_outcome": "Plaque clearance",
                    "result": "-93%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.61281418800354,
                    "therapy_or_medication_correct": 0.38150498270988464,
                    "medical_outcome_correct": 0.672207236289978,
                    "result_correct": 0.599113941192627,
                    "outcome_category_correct": 0.6335793137550354,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 4.899219483137131
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 60101,
            "papername": "Innovations in Psoriasis Therapy",
            "authors": "Anderson, Laura; Smith, Thomas",
            "publication_date": "2024-02-20 00:00:00",
            "journal": "Dermatology Weekly",
            "disease": "Psoriasis",
            "medication_group": "Randomised group",
            "therapy_or_medication": "Corticosteroids",
            "medical_outcome": "Inflammation Reduction",
            "result": "Significantly lower",
            "outcome_category": "Symptom Intensity and Relief",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 75,
            "pubmed_id": 60101,
            "paper": "Innovations in Psoriasis Therapy",
            "authors": "Anderson, Laura; Smith, Thomas",
            "journal": "Dermatology Weekly",
            "publication_date": "2024-02-20",
            "disease": "Psoriasis",
            "medication_group": "No group specified",
            "therapy_or_medication": "Corticosteroids",
            "medical_outcome": "Inflammation reduction",
            "result": "significant",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0,
            "medication_group_correct": 0.61281418800354,
            "therapy_or_medication_correct": 1.0000001192092896,
            "medical_outcome_correct": 1.0000001192092896,
            "result_correct": 0.8305616974830627,
            "outcome_category_correct": 0.6335793137550354,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 6.076955258846283
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 73,
                    "pubmed_id": 60101,
                    "paper": "Innovations in Psoriasis Therapy",
                    "authors": "Anderson, Laura; Smith, Thomas",
                    "journal": "Dermatology Weekly",
                    "publication_date": "2024-02-20",
                    "disease": "Psoriasis",
                    "medication_group": "Patients with moderate to severe psoriasis",
                    "therapy_or_medication": "Biologics",
                    "medical_outcome": "Symptom reduction",
                    "result": "significant",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.4127381145954132,
                    "therapy_or_medication_correct": 0.5581135749816895,
                    "medical_outcome_correct": 0.7394928932189941,
                    "result_correct": 0.8305616974830627,
                    "outcome_category_correct": 1.0,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.540906101465225
                }
            },
            {
                "pred_row": {
                    "id": 74,
                    "pubmed_id": 60101,
                    "paper": "Innovations in Psoriasis Therapy",
                    "authors": "Anderson, Laura; Smith, Thomas",
                    "journal": "Dermatology Weekly",
                    "publication_date": "2024-02-20",
                    "disease": "Psoriasis",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "Methotrexate",
                    "medical_outcome": "Pain reduction",
                    "result": "-0.04 to -0.01",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.61281418800354,
                    "therapy_or_medication_correct": 0.628389298915863,
                    "medical_outcome_correct": 0.8813111782073975,
                    "result_correct": 0.3920139968395233,
                    "outcome_category_correct": 1.0,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.5145284831523895
                }
            },
            {
                "pred_row": {
                    "id": 75,
                    "pubmed_id": 60101,
                    "paper": "Innovations in Psoriasis Therapy",
                    "authors": "Anderson, Laura; Smith, Thomas",
                    "journal": "Dermatology Weekly",
                    "publication_date": "2024-02-20",
                    "disease": "Psoriasis",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "Corticosteroids",
                    "medical_outcome": "Inflammation reduction",
                    "result": "significant",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.61281418800354,
                    "therapy_or_medication_correct": 1.0000001192092896,
                    "medical_outcome_correct": 1.0000001192092896,
                    "result_correct": 0.8305616974830627,
                    "outcome_category_correct": 0.6335793137550354,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.076955258846283
                }
            },
            {
                "pred_row": {
                    "id": 76,
                    "pubmed_id": 60101,
                    "paper": "Innovations in Psoriasis Therapy",
                    "authors": "Anderson, Laura; Smith, Thomas",
                    "journal": "Dermatology Weekly",
                    "publication_date": "2024-02-20",
                    "disease": "Psoriasis",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "Phototherapy",
                    "medical_outcome": "Plaque clearance",
                    "result": "-93%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.61281418800354,
                    "therapy_or_medication_correct": 0.4526945948600769,
                    "medical_outcome_correct": 0.6875516176223755,
                    "result_correct": 0.5392508506774902,
                    "outcome_category_correct": 0.6335793137550354,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 4.925890386104584
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 60101,
            "papername": "Innovations in Psoriasis Therapy",
            "authors": "Anderson, Laura; Smith, Thomas",
            "publication_date": "2024-02-20 00:00:00",
            "journal": "Dermatology Weekly",
            "disease": "Psoriasis",
            "medication_group": "Randomised group",
            "therapy_or_medication": "Phototherapy",
            "medical_outcome": "Plaque Clearance",
            "result": "-93% (median)",
            "outcome_category": "Symptom Intensity and Relief",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 76,
            "pubmed_id": 60101,
            "paper": "Innovations in Psoriasis Therapy",
            "authors": "Anderson, Laura; Smith, Thomas",
            "journal": "Dermatology Weekly",
            "publication_date": "2024-02-20",
            "disease": "Psoriasis",
            "medication_group": "No group specified",
            "therapy_or_medication": "Phototherapy",
            "medical_outcome": "Plaque clearance",
            "result": "-93%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0,
            "medication_group_correct": 0.61281418800354,
            "therapy_or_medication_correct": 0.9999998807907104,
            "medical_outcome_correct": 1.0000001192092896,
            "result_correct": 0.8427291512489319,
            "outcome_category_correct": 0.6335793137550354,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 6.089122474193573
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 73,
                    "pubmed_id": 60101,
                    "paper": "Innovations in Psoriasis Therapy",
                    "authors": "Anderson, Laura; Smith, Thomas",
                    "journal": "Dermatology Weekly",
                    "publication_date": "2024-02-20",
                    "disease": "Psoriasis",
                    "medication_group": "Patients with moderate to severe psoriasis",
                    "therapy_or_medication": "Biologics",
                    "medical_outcome": "Symptom reduction",
                    "result": "significant",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.4127381145954132,
                    "therapy_or_medication_correct": 0.6703760623931885,
                    "medical_outcome_correct": 0.5008003115653992,
                    "result_correct": 0.40852460265159607,
                    "outcome_category_correct": 1.0,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 4.992438912391663
                }
            },
            {
                "pred_row": {
                    "id": 74,
                    "pubmed_id": 60101,
                    "paper": "Innovations in Psoriasis Therapy",
                    "authors": "Anderson, Laura; Smith, Thomas",
                    "journal": "Dermatology Weekly",
                    "publication_date": "2024-02-20",
                    "disease": "Psoriasis",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "Methotrexate",
                    "medical_outcome": "Pain reduction",
                    "result": "-0.04 to -0.01",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.61281418800354,
                    "therapy_or_medication_correct": 0.38150498270988464,
                    "medical_outcome_correct": 0.672207236289978,
                    "result_correct": 0.6260674595832825,
                    "outcome_category_correct": 1.0,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.292593687772751
                }
            },
            {
                "pred_row": {
                    "id": 75,
                    "pubmed_id": 60101,
                    "paper": "Innovations in Psoriasis Therapy",
                    "authors": "Anderson, Laura; Smith, Thomas",
                    "journal": "Dermatology Weekly",
                    "publication_date": "2024-02-20",
                    "disease": "Psoriasis",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "Corticosteroids",
                    "medical_outcome": "Inflammation reduction",
                    "result": "significant",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.61281418800354,
                    "therapy_or_medication_correct": 0.4526945948600769,
                    "medical_outcome_correct": 0.6875516176223755,
                    "result_correct": 0.40852460265159607,
                    "outcome_category_correct": 0.6335793137550354,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 4.79516413807869
                }
            },
            {
                "pred_row": {
                    "id": 76,
                    "pubmed_id": 60101,
                    "paper": "Innovations in Psoriasis Therapy",
                    "authors": "Anderson, Laura; Smith, Thomas",
                    "journal": "Dermatology Weekly",
                    "publication_date": "2024-02-20",
                    "disease": "Psoriasis",
                    "medication_group": "No group specified",
                    "therapy_or_medication": "Phototherapy",
                    "medical_outcome": "Plaque clearance",
                    "result": "-93%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.61281418800354,
                    "therapy_or_medication_correct": 0.9999998807907104,
                    "medical_outcome_correct": 1.0000001192092896,
                    "result_correct": 0.8427291512489319,
                    "outcome_category_correct": 0.6335793137550354,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.089122474193573
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 60202,
            "papername": "Breakthroughs in Type 1 Diabetes Management",
            "authors": "Barnes, Michael; Johnson, Patricia",
            "publication_date": "2023-05-15 00:00:00",
            "journal": "Diabetes and Endocrinology",
            "disease": "Diabetes Type 1",
            "medication_group": "Randomised group",
            "therapy_or_medication": "Insulin Pumps",
            "medical_outcome": "Glycemic Control Improvement",
            "result": 0.6,
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 77,
            "pubmed_id": 60202,
            "paper": "Breakthroughs in Type 1 Diabetes Management",
            "authors": "Barnes, Michael; Johnson, Patricia",
            "journal": "Diabetes and Endocrinology",
            "publication_date": "2023-05-15",
            "disease": "Type 1 Diabetes",
            "medication_group": "400 patients with Type 1 diabetes",
            "therapy_or_medication": "Insulin Pumps",
            "medical_outcome": "Glycemic Control",
            "result": "60%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 0.8678620457649231,
            "medication_group_correct": 0.44412195682525635,
            "therapy_or_medication_correct": 0.9999998211860657,
            "medical_outcome_correct": 0.9473491907119751,
            "result_correct": 0.6794672608375549,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 5.93880021572113
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 77,
                    "pubmed_id": 60202,
                    "paper": "Breakthroughs in Type 1 Diabetes Management",
                    "authors": "Barnes, Michael; Johnson, Patricia",
                    "journal": "Diabetes and Endocrinology",
                    "publication_date": "2023-05-15",
                    "disease": "Type 1 Diabetes",
                    "medication_group": "400 patients with Type 1 diabetes",
                    "therapy_or_medication": "Insulin Pumps",
                    "medical_outcome": "Glycemic Control",
                    "result": "60%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.8678620457649231,
                    "medication_group_correct": 0.44412195682525635,
                    "therapy_or_medication_correct": 0.9999998211860657,
                    "medical_outcome_correct": 0.9473491907119751,
                    "result_correct": 0.6794672608375549,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.93880021572113
                }
            },
            {
                "pred_row": {
                    "id": 78,
                    "pubmed_id": 60202,
                    "paper": "Breakthroughs in Type 1 Diabetes Management",
                    "authors": "Barnes, Michael; Johnson, Patricia",
                    "journal": "Diabetes and Endocrinology",
                    "publication_date": "2023-05-15",
                    "disease": "Type 1 Diabetes",
                    "medication_group": "400 patients with Type 1 diabetes",
                    "therapy_or_medication": "CGM Systems",
                    "medical_outcome": "Time spent within glucose target range",
                    "result": "70%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.8678620457649231,
                    "medication_group_correct": 0.44412195682525635,
                    "therapy_or_medication_correct": 0.5902634859085083,
                    "medical_outcome_correct": 0.5572905540466309,
                    "result_correct": 0.6877670884132385,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.147305071353912
                }
            },
            {
                "pred_row": {
                    "id": 79,
                    "pubmed_id": 60202,
                    "paper": "Breakthroughs in Type 1 Diabetes Management",
                    "authors": "Barnes, Michael; Johnson, Patricia",
                    "journal": "Diabetes and Endocrinology",
                    "publication_date": "2023-05-15",
                    "disease": "Type 1 Diabetes",
                    "medication_group": "400 patients with Type 1 diabetes",
                    "therapy_or_medication": "Closed Loop Systems",
                    "medical_outcome": "HbA1c levels",
                    "result": "1.8%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.8678620457649231,
                    "medication_group_correct": 0.44412195682525635,
                    "therapy_or_medication_correct": 0.6426836252212524,
                    "medical_outcome_correct": 0.6297187805175781,
                    "result_correct": 0.7161498069763184,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.300536155700684
                }
            },
            {
                "pred_row": {
                    "id": 80,
                    "pubmed_id": 60202,
                    "paper": "Breakthroughs in Type 1 Diabetes Management",
                    "authors": "Barnes, Michael; Johnson, Patricia",
                    "journal": "Diabetes and Endocrinology",
                    "publication_date": "2023-05-15",
                    "disease": "Type 1 Diabetes",
                    "medication_group": "400 patients with Type 1 diabetes",
                    "therapy_or_medication": "Artificial Pancreas Systems",
                    "medical_outcome": "Quality of Life",
                    "result": "80%",
                    "outcome_category": "Quality of Life",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.8678620457649231,
                    "medication_group_correct": 0.44412195682525635,
                    "therapy_or_medication_correct": 0.5853531956672668,
                    "medical_outcome_correct": 0.5295875668525696,
                    "result_correct": 0.6949798464775085,
                    "outcome_category_correct": 0.6459974050521851,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 4.767901837825775
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 60202,
            "papername": "Breakthroughs in Type 1 Diabetes Management",
            "authors": "Barnes, Michael; Johnson, Patricia",
            "publication_date": "2023-05-15 00:00:00",
            "journal": "Diabetes and Endocrinology",
            "disease": "Diabetes Type 1",
            "medication_group": "Randomised group",
            "therapy_or_medication": "CGM Systems",
            "medical_outcome": "Time in Range Improvement",
            "result": 0.7,
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 78,
            "pubmed_id": 60202,
            "paper": "Breakthroughs in Type 1 Diabetes Management",
            "authors": "Barnes, Michael; Johnson, Patricia",
            "journal": "Diabetes and Endocrinology",
            "publication_date": "2023-05-15",
            "disease": "Type 1 Diabetes",
            "medication_group": "400 patients with Type 1 diabetes",
            "therapy_or_medication": "CGM Systems",
            "medical_outcome": "Time spent within glucose target range",
            "result": "70%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 0.8678620457649231,
            "medication_group_correct": 0.44412195682525635,
            "therapy_or_medication_correct": 1.000000238418579,
            "medical_outcome_correct": 0.6926836371421814,
            "result_correct": 0.6964659690856934,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 5.7011337876319885
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 77,
                    "pubmed_id": 60202,
                    "paper": "Breakthroughs in Type 1 Diabetes Management",
                    "authors": "Barnes, Michael; Johnson, Patricia",
                    "journal": "Diabetes and Endocrinology",
                    "publication_date": "2023-05-15",
                    "disease": "Type 1 Diabetes",
                    "medication_group": "400 patients with Type 1 diabetes",
                    "therapy_or_medication": "Insulin Pumps",
                    "medical_outcome": "Glycemic Control",
                    "result": "60%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.8678620457649231,
                    "medication_group_correct": 0.44412195682525635,
                    "therapy_or_medication_correct": 0.5902634859085083,
                    "medical_outcome_correct": 0.5281432271003723,
                    "result_correct": 0.6709449291229248,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.10133558511734
                }
            },
            {
                "pred_row": {
                    "id": 78,
                    "pubmed_id": 60202,
                    "paper": "Breakthroughs in Type 1 Diabetes Management",
                    "authors": "Barnes, Michael; Johnson, Patricia",
                    "journal": "Diabetes and Endocrinology",
                    "publication_date": "2023-05-15",
                    "disease": "Type 1 Diabetes",
                    "medication_group": "400 patients with Type 1 diabetes",
                    "therapy_or_medication": "CGM Systems",
                    "medical_outcome": "Time spent within glucose target range",
                    "result": "70%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.8678620457649231,
                    "medication_group_correct": 0.44412195682525635,
                    "therapy_or_medication_correct": 1.000000238418579,
                    "medical_outcome_correct": 0.6926836371421814,
                    "result_correct": 0.6964659690856934,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.7011337876319885
                }
            },
            {
                "pred_row": {
                    "id": 79,
                    "pubmed_id": 60202,
                    "paper": "Breakthroughs in Type 1 Diabetes Management",
                    "authors": "Barnes, Michael; Johnson, Patricia",
                    "journal": "Diabetes and Endocrinology",
                    "publication_date": "2023-05-15",
                    "disease": "Type 1 Diabetes",
                    "medication_group": "400 patients with Type 1 diabetes",
                    "therapy_or_medication": "Closed Loop Systems",
                    "medical_outcome": "HbA1c levels",
                    "result": "1.8%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.8678620457649231,
                    "medication_group_correct": 0.44412195682525635,
                    "therapy_or_medication_correct": 0.636481523513794,
                    "medical_outcome_correct": 0.46054476499557495,
                    "result_correct": 0.7278639674186707,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.136874198913574
                }
            },
            {
                "pred_row": {
                    "id": 80,
                    "pubmed_id": 60202,
                    "paper": "Breakthroughs in Type 1 Diabetes Management",
                    "authors": "Barnes, Michael; Johnson, Patricia",
                    "journal": "Diabetes and Endocrinology",
                    "publication_date": "2023-05-15",
                    "disease": "Type 1 Diabetes",
                    "medication_group": "400 patients with Type 1 diabetes",
                    "therapy_or_medication": "Artificial Pancreas Systems",
                    "medical_outcome": "Quality of Life",
                    "result": "80%",
                    "outcome_category": "Quality of Life",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.8678620457649231,
                    "medication_group_correct": 0.44412195682525635,
                    "therapy_or_medication_correct": 0.6375235915184021,
                    "medical_outcome_correct": 0.6337592601776123,
                    "result_correct": 0.7061639428138733,
                    "outcome_category_correct": 0.6459974050521851,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 4.935428023338318
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 60202,
            "papername": "Breakthroughs in Type 1 Diabetes Management",
            "authors": "Barnes, Michael; Johnson, Patricia",
            "publication_date": "2023-05-15 00:00:00",
            "journal": "Diabetes and Endocrinology",
            "disease": "Diabetes Type 1",
            "medication_group": "Randomised group",
            "therapy_or_medication": "Closed Loop Systems",
            "medical_outcome": "HbA1c Reduction",
            "result": "1.8%",
            "outcome_category": "Physiological Measure",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 79,
            "pubmed_id": 60202,
            "paper": "Breakthroughs in Type 1 Diabetes Management",
            "authors": "Barnes, Michael; Johnson, Patricia",
            "journal": "Diabetes and Endocrinology",
            "publication_date": "2023-05-15",
            "disease": "Type 1 Diabetes",
            "medication_group": "400 patients with Type 1 diabetes",
            "therapy_or_medication": "Closed Loop Systems",
            "medical_outcome": "HbA1c levels",
            "result": "1.8%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 0.8678620457649231,
            "medication_group_correct": 0.44412195682525635,
            "therapy_or_medication_correct": 0.9999998807907104,
            "medical_outcome_correct": 0.9037778377532959,
            "result_correct": 0.9999998807907104,
            "outcome_category_correct": 0.7687371969223022,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 5.984498620033264
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 77,
                    "pubmed_id": 60202,
                    "paper": "Breakthroughs in Type 1 Diabetes Management",
                    "authors": "Barnes, Michael; Johnson, Patricia",
                    "journal": "Diabetes and Endocrinology",
                    "publication_date": "2023-05-15",
                    "disease": "Type 1 Diabetes",
                    "medication_group": "400 patients with Type 1 diabetes",
                    "therapy_or_medication": "Insulin Pumps",
                    "medical_outcome": "Glycemic Control",
                    "result": "60%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.8678620457649231,
                    "medication_group_correct": 0.44412195682525635,
                    "therapy_or_medication_correct": 0.6426836252212524,
                    "medical_outcome_correct": 0.6939718723297119,
                    "result_correct": 0.7308523654937744,
                    "outcome_category_correct": 0.7687371969223022,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.148228883743286
                }
            },
            {
                "pred_row": {
                    "id": 78,
                    "pubmed_id": 60202,
                    "paper": "Breakthroughs in Type 1 Diabetes Management",
                    "authors": "Barnes, Michael; Johnson, Patricia",
                    "journal": "Diabetes and Endocrinology",
                    "publication_date": "2023-05-15",
                    "disease": "Type 1 Diabetes",
                    "medication_group": "400 patients with Type 1 diabetes",
                    "therapy_or_medication": "CGM Systems",
                    "medical_outcome": "Time spent within glucose target range",
                    "result": "70%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.8678620457649231,
                    "medication_group_correct": 0.44412195682525635,
                    "therapy_or_medication_correct": 0.636481523513794,
                    "medical_outcome_correct": 0.5569930076599121,
                    "result_correct": 0.7537820935249329,
                    "outcome_category_correct": 0.7687371969223022,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.027977645397186
                }
            },
            {
                "pred_row": {
                    "id": 79,
                    "pubmed_id": 60202,
                    "paper": "Breakthroughs in Type 1 Diabetes Management",
                    "authors": "Barnes, Michael; Johnson, Patricia",
                    "journal": "Diabetes and Endocrinology",
                    "publication_date": "2023-05-15",
                    "disease": "Type 1 Diabetes",
                    "medication_group": "400 patients with Type 1 diabetes",
                    "therapy_or_medication": "Closed Loop Systems",
                    "medical_outcome": "HbA1c levels",
                    "result": "1.8%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.8678620457649231,
                    "medication_group_correct": 0.44412195682525635,
                    "therapy_or_medication_correct": 0.9999998807907104,
                    "medical_outcome_correct": 0.9037778377532959,
                    "result_correct": 0.9999998807907104,
                    "outcome_category_correct": 0.7687371969223022,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.984498620033264
                }
            },
            {
                "pred_row": {
                    "id": 80,
                    "pubmed_id": 60202,
                    "paper": "Breakthroughs in Type 1 Diabetes Management",
                    "authors": "Barnes, Michael; Johnson, Patricia",
                    "journal": "Diabetes and Endocrinology",
                    "publication_date": "2023-05-15",
                    "disease": "Type 1 Diabetes",
                    "medication_group": "400 patients with Type 1 diabetes",
                    "therapy_or_medication": "Artificial Pancreas Systems",
                    "medical_outcome": "Quality of Life",
                    "result": "80%",
                    "outcome_category": "Quality of Life",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.8678620457649231,
                    "medication_group_correct": 0.44412195682525635,
                    "therapy_or_medication_correct": 0.5709971189498901,
                    "medical_outcome_correct": 0.4932892620563507,
                    "result_correct": 0.7639167308807373,
                    "outcome_category_correct": 0.5712728500366211,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 4.711459785699844
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 60202,
            "papername": "Breakthroughs in Type 1 Diabetes Management",
            "authors": "Barnes, Michael; Johnson, Patricia",
            "publication_date": "2023-05-15 00:00:00",
            "journal": "Diabetes and Endocrinology",
            "disease": "Diabetes Type 1",
            "medication_group": "Randomised group",
            "therapy_or_medication": "Artificial Pancreas",
            "medical_outcome": "Quality of Life Improvement",
            "result": 0.8,
            "outcome_category": "Quality of Life",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 80,
            "pubmed_id": 60202,
            "paper": "Breakthroughs in Type 1 Diabetes Management",
            "authors": "Barnes, Michael; Johnson, Patricia",
            "journal": "Diabetes and Endocrinology",
            "publication_date": "2023-05-15",
            "disease": "Type 1 Diabetes",
            "medication_group": "400 patients with Type 1 diabetes",
            "therapy_or_medication": "Artificial Pancreas Systems",
            "medical_outcome": "Quality of Life",
            "result": "80%",
            "outcome_category": "Quality of Life",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 0.8678620457649231,
            "medication_group_correct": 0.44412195682525635,
            "therapy_or_medication_correct": 0.9311737418174744,
            "medical_outcome_correct": 0.9226361513137817,
            "result_correct": 0.7238072156906128,
            "outcome_category_correct": 0.9999998807907104,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 5.8896008133888245
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 77,
                    "pubmed_id": 60202,
                    "paper": "Breakthroughs in Type 1 Diabetes Management",
                    "authors": "Barnes, Michael; Johnson, Patricia",
                    "journal": "Diabetes and Endocrinology",
                    "publication_date": "2023-05-15",
                    "disease": "Type 1 Diabetes",
                    "medication_group": "400 patients with Type 1 diabetes",
                    "therapy_or_medication": "Insulin Pumps",
                    "medical_outcome": "Glycemic Control",
                    "result": "60%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.8678620457649231,
                    "medication_group_correct": 0.44412195682525635,
                    "therapy_or_medication_correct": 0.5680032968521118,
                    "medical_outcome_correct": 0.5790568590164185,
                    "result_correct": 0.6726723313331604,
                    "outcome_category_correct": 0.6459974050521851,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 4.777713716030121
                }
            },
            {
                "pred_row": {
                    "id": 78,
                    "pubmed_id": 60202,
                    "paper": "Breakthroughs in Type 1 Diabetes Management",
                    "authors": "Barnes, Michael; Johnson, Patricia",
                    "journal": "Diabetes and Endocrinology",
                    "publication_date": "2023-05-15",
                    "disease": "Type 1 Diabetes",
                    "medication_group": "400 patients with Type 1 diabetes",
                    "therapy_or_medication": "CGM Systems",
                    "medical_outcome": "Time spent within glucose target range",
                    "result": "70%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.8678620457649231,
                    "medication_group_correct": 0.44412195682525635,
                    "therapy_or_medication_correct": 0.5481283068656921,
                    "medical_outcome_correct": 0.6227989196777344,
                    "result_correct": 0.7000402212142944,
                    "outcome_category_correct": 0.6459974050521851,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 4.828948676586151
                }
            },
            {
                "pred_row": {
                    "id": 79,
                    "pubmed_id": 60202,
                    "paper": "Breakthroughs in Type 1 Diabetes Management",
                    "authors": "Barnes, Michael; Johnson, Patricia",
                    "journal": "Diabetes and Endocrinology",
                    "publication_date": "2023-05-15",
                    "disease": "Type 1 Diabetes",
                    "medication_group": "400 patients with Type 1 diabetes",
                    "therapy_or_medication": "Closed Loop Systems",
                    "medical_outcome": "HbA1c levels",
                    "result": "1.8%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.8678620457649231,
                    "medication_group_correct": 0.44412195682525635,
                    "therapy_or_medication_correct": 0.49424123764038086,
                    "medical_outcome_correct": 0.5393663644790649,
                    "result_correct": 0.7561169862747192,
                    "outcome_category_correct": 0.6459974050521851,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 4.747705817222595
                }
            },
            {
                "pred_row": {
                    "id": 80,
                    "pubmed_id": 60202,
                    "paper": "Breakthroughs in Type 1 Diabetes Management",
                    "authors": "Barnes, Michael; Johnson, Patricia",
                    "journal": "Diabetes and Endocrinology",
                    "publication_date": "2023-05-15",
                    "disease": "Type 1 Diabetes",
                    "medication_group": "400 patients with Type 1 diabetes",
                    "therapy_or_medication": "Artificial Pancreas Systems",
                    "medical_outcome": "Quality of Life",
                    "result": "80%",
                    "outcome_category": "Quality of Life",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.8678620457649231,
                    "medication_group_correct": 0.44412195682525635,
                    "therapy_or_medication_correct": 0.9311737418174744,
                    "medical_outcome_correct": 0.9226361513137817,
                    "result_correct": 0.7238072156906128,
                    "outcome_category_correct": 0.9999998807907104,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.8896008133888245
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 60303,
            "papername": "New Frontiers in Lung Cancer Therapy",
            "authors": "Wilson, Emily; Green, John",
            "publication_date": "2024-06-30 00:00:00",
            "journal": "Oncology Advances",
            "disease": "Lung Cancer",
            "medication_group": "Randomised group",
            "therapy_or_medication": "Chemotherapy",
            "medical_outcome": "Tumor Shrinkage",
            "result": 0.35,
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 81,
            "pubmed_id": 60303,
            "paper": "New Frontiers in Lung Cancer Therapy",
            "authors": "Wilson, Emily; Green, John",
            "journal": "Oncology Advances",
            "publication_date": "2024-06-30",
            "disease": "Lung cancer",
            "medication_group": "Chemotherapy group",
            "therapy_or_medication": "Chemotherapy",
            "medical_outcome": "Tumor shrinkage",
            "result": "35%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0000001192092896,
            "medication_group_correct": 0.6589515209197998,
            "therapy_or_medication_correct": 0.9999998211860657,
            "medical_outcome_correct": 1.0,
            "result_correct": 0.7251928448677063,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 6.3841442465782166
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 81,
                    "pubmed_id": 60303,
                    "paper": "New Frontiers in Lung Cancer Therapy",
                    "authors": "Wilson, Emily; Green, John",
                    "journal": "Oncology Advances",
                    "publication_date": "2024-06-30",
                    "disease": "Lung cancer",
                    "medication_group": "Chemotherapy group",
                    "therapy_or_medication": "Chemotherapy",
                    "medical_outcome": "Tumor shrinkage",
                    "result": "35%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.6589515209197998,
                    "therapy_or_medication_correct": 0.9999998211860657,
                    "medical_outcome_correct": 1.0,
                    "result_correct": 0.7251928448677063,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.3841442465782166
                }
            },
            {
                "pred_row": {
                    "id": 82,
                    "pubmed_id": 60303,
                    "paper": "New Frontiers in Lung Cancer Therapy",
                    "authors": "Wilson, Emily; Green, John",
                    "journal": "Oncology Advances",
                    "publication_date": "2024-06-30",
                    "disease": "Lung cancer",
                    "medication_group": "Radiation therapy group",
                    "therapy_or_medication": "Radiation therapy",
                    "medical_outcome": "Symptom alleviation",
                    "result": "40%",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.6284224390983582,
                    "therapy_or_medication_correct": 0.7224972248077393,
                    "medical_outcome_correct": 0.6954047679901123,
                    "result_correct": 0.7294970750808716,
                    "outcome_category_correct": 0.6335793137550354,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.409400761127472
                }
            },
            {
                "pred_row": {
                    "id": 83,
                    "pubmed_id": 60303,
                    "paper": "New Frontiers in Lung Cancer Therapy",
                    "authors": "Wilson, Emily; Green, John",
                    "journal": "Oncology Advances",
                    "publication_date": "2024-06-30",
                    "disease": "Lung cancer",
                    "medication_group": "Immunotherapy group",
                    "therapy_or_medication": "Immunotherapy",
                    "medical_outcome": "Survival rate increase",
                    "result": "25%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.42784562706947327,
                    "therapy_or_medication_correct": 0.36712372303009033,
                    "medical_outcome_correct": 0.7472934126853943,
                    "result_correct": 0.7282050251960754,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.270467847585678
                }
            },
            {
                "pred_row": {
                    "id": 84,
                    "pubmed_id": 60303,
                    "paper": "New Frontiers in Lung Cancer Therapy",
                    "authors": "Wilson, Emily; Green, John",
                    "journal": "Oncology Advances",
                    "publication_date": "2024-06-30",
                    "disease": "Lung cancer",
                    "medication_group": "Targeted therapy group",
                    "therapy_or_medication": "Targeted therapy",
                    "medical_outcome": "Progression-free survival",
                    "result": "50%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.6184169054031372,
                    "therapy_or_medication_correct": 0.8039138317108154,
                    "medical_outcome_correct": 0.7074892520904541,
                    "result_correct": 0.709126889705658,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.8389469385147095
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 60303,
            "papername": "New Frontiers in Lung Cancer Therapy",
            "authors": "Wilson, Emily; Green, John",
            "publication_date": "2024-06-30 00:00:00",
            "journal": "Oncology Advances",
            "disease": "Lung Cancer",
            "medication_group": "Randomised group",
            "therapy_or_medication": "Radiation Therapy",
            "medical_outcome": "Symptom Alleviation",
            "result": 0.4,
            "outcome_category": "Symptom Intensity and Relief",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 82,
            "pubmed_id": 60303,
            "paper": "New Frontiers in Lung Cancer Therapy",
            "authors": "Wilson, Emily; Green, John",
            "journal": "Oncology Advances",
            "publication_date": "2024-06-30",
            "disease": "Lung cancer",
            "medication_group": "Radiation therapy group",
            "therapy_or_medication": "Radiation therapy",
            "medical_outcome": "Symptom alleviation",
            "result": "40%",
            "outcome_category": "Symptom Intensity and Relief",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0000001192092896,
            "medication_group_correct": 0.6284224390983582,
            "therapy_or_medication_correct": 1.0000001192092896,
            "medical_outcome_correct": 0.9999999403953552,
            "result_correct": 0.7082979679107666,
            "outcome_category_correct": 1.0,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 6.336720407009125
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 81,
                    "pubmed_id": 60303,
                    "paper": "New Frontiers in Lung Cancer Therapy",
                    "authors": "Wilson, Emily; Green, John",
                    "journal": "Oncology Advances",
                    "publication_date": "2024-06-30",
                    "disease": "Lung cancer",
                    "medication_group": "Chemotherapy group",
                    "therapy_or_medication": "Chemotherapy",
                    "medical_outcome": "Tumor shrinkage",
                    "result": "35%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.6589515209197998,
                    "therapy_or_medication_correct": 0.7224972248077393,
                    "medical_outcome_correct": 0.6954047679901123,
                    "result_correct": 0.685712456703186,
                    "outcome_category_correct": 0.6335793137550354,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.396145224571228
                }
            },
            {
                "pred_row": {
                    "id": 82,
                    "pubmed_id": 60303,
                    "paper": "New Frontiers in Lung Cancer Therapy",
                    "authors": "Wilson, Emily; Green, John",
                    "journal": "Oncology Advances",
                    "publication_date": "2024-06-30",
                    "disease": "Lung cancer",
                    "medication_group": "Radiation therapy group",
                    "therapy_or_medication": "Radiation therapy",
                    "medical_outcome": "Symptom alleviation",
                    "result": "40%",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.6284224390983582,
                    "therapy_or_medication_correct": 1.0000001192092896,
                    "medical_outcome_correct": 0.9999999403953552,
                    "result_correct": 0.7082979679107666,
                    "outcome_category_correct": 1.0,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.336720407009125
                }
            },
            {
                "pred_row": {
                    "id": 83,
                    "pubmed_id": 60303,
                    "paper": "New Frontiers in Lung Cancer Therapy",
                    "authors": "Wilson, Emily; Green, John",
                    "journal": "Oncology Advances",
                    "publication_date": "2024-06-30",
                    "disease": "Lung cancer",
                    "medication_group": "Immunotherapy group",
                    "therapy_or_medication": "Immunotherapy",
                    "medical_outcome": "Survival rate increase",
                    "result": "25%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.42784562706947327,
                    "therapy_or_medication_correct": 0.6098944544792175,
                    "medical_outcome_correct": 0.6308978199958801,
                    "result_correct": 0.7089830040931702,
                    "outcome_category_correct": 0.6335793137550354,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.011200159788132
                }
            },
            {
                "pred_row": {
                    "id": 84,
                    "pubmed_id": 60303,
                    "paper": "New Frontiers in Lung Cancer Therapy",
                    "authors": "Wilson, Emily; Green, John",
                    "journal": "Oncology Advances",
                    "publication_date": "2024-06-30",
                    "disease": "Lung cancer",
                    "medication_group": "Targeted therapy group",
                    "therapy_or_medication": "Targeted therapy",
                    "medical_outcome": "Progression-free survival",
                    "result": "50%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.6184169054031372,
                    "therapy_or_medication_correct": 0.7592743635177612,
                    "medical_outcome_correct": 0.7381574511528015,
                    "result_correct": 0.6868492960929871,
                    "outcome_category_correct": 0.6335793137550354,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.436277270317078
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 60303,
            "papername": "New Frontiers in Lung Cancer Therapy",
            "authors": "Wilson, Emily; Green, John",
            "publication_date": "2024-06-30 00:00:00",
            "journal": "Oncology Advances",
            "disease": "Lung Cancer",
            "medication_group": "Randomised group",
            "therapy_or_medication": "Immunotherapy",
            "medical_outcome": "Survival Rate Increase",
            "result": 0.25,
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 83,
            "pubmed_id": 60303,
            "paper": "New Frontiers in Lung Cancer Therapy",
            "authors": "Wilson, Emily; Green, John",
            "journal": "Oncology Advances",
            "publication_date": "2024-06-30",
            "disease": "Lung cancer",
            "medication_group": "Immunotherapy group",
            "therapy_or_medication": "Immunotherapy",
            "medical_outcome": "Survival rate increase",
            "result": "25%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0000001192092896,
            "medication_group_correct": 0.42784562706947327,
            "therapy_or_medication_correct": 1.0000001192092896,
            "medical_outcome_correct": 0.9999999403953552,
            "result_correct": 0.7425962090492249,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 6.170441955327988
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 81,
                    "pubmed_id": 60303,
                    "paper": "New Frontiers in Lung Cancer Therapy",
                    "authors": "Wilson, Emily; Green, John",
                    "journal": "Oncology Advances",
                    "publication_date": "2024-06-30",
                    "disease": "Lung cancer",
                    "medication_group": "Chemotherapy group",
                    "therapy_or_medication": "Chemotherapy",
                    "medical_outcome": "Tumor shrinkage",
                    "result": "35%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.6589515209197998,
                    "therapy_or_medication_correct": 0.36712372303009033,
                    "medical_outcome_correct": 0.7472934126853943,
                    "result_correct": 0.6750593185424805,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.44842803478241
                }
            },
            {
                "pred_row": {
                    "id": 82,
                    "pubmed_id": 60303,
                    "paper": "New Frontiers in Lung Cancer Therapy",
                    "authors": "Wilson, Emily; Green, John",
                    "journal": "Oncology Advances",
                    "publication_date": "2024-06-30",
                    "disease": "Lung cancer",
                    "medication_group": "Radiation therapy group",
                    "therapy_or_medication": "Radiation therapy",
                    "medical_outcome": "Symptom alleviation",
                    "result": "40%",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.6284224390983582,
                    "therapy_or_medication_correct": 0.6098944544792175,
                    "medical_outcome_correct": 0.6308978199958801,
                    "result_correct": 0.7111594080924988,
                    "outcome_category_correct": 0.6335793137550354,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.213953375816345
                }
            },
            {
                "pred_row": {
                    "id": 83,
                    "pubmed_id": 60303,
                    "paper": "New Frontiers in Lung Cancer Therapy",
                    "authors": "Wilson, Emily; Green, John",
                    "journal": "Oncology Advances",
                    "publication_date": "2024-06-30",
                    "disease": "Lung cancer",
                    "medication_group": "Immunotherapy group",
                    "therapy_or_medication": "Immunotherapy",
                    "medical_outcome": "Survival rate increase",
                    "result": "25%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.42784562706947327,
                    "therapy_or_medication_correct": 1.0000001192092896,
                    "medical_outcome_correct": 0.9999999403953552,
                    "result_correct": 0.7425962090492249,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.170441955327988
                }
            },
            {
                "pred_row": {
                    "id": 84,
                    "pubmed_id": 60303,
                    "paper": "New Frontiers in Lung Cancer Therapy",
                    "authors": "Wilson, Emily; Green, John",
                    "journal": "Oncology Advances",
                    "publication_date": "2024-06-30",
                    "disease": "Lung cancer",
                    "medication_group": "Targeted therapy group",
                    "therapy_or_medication": "Targeted therapy",
                    "medical_outcome": "Progression-free survival",
                    "result": "50%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.6184169054031372,
                    "therapy_or_medication_correct": 0.47351253032684326,
                    "medical_outcome_correct": 0.7138062715530396,
                    "result_correct": 0.7090725898742676,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.514808356761932
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 60303,
            "papername": "New Frontiers in Lung Cancer Therapy",
            "authors": "Wilson, Emily; Green, John",
            "publication_date": "2024-06-30 00:00:00",
            "journal": "Oncology Advances",
            "disease": "Lung Cancer",
            "medication_group": "Randomised group",
            "therapy_or_medication": "Targeted Therapy",
            "medical_outcome": "Progression-Free Survival",
            "result": 0.5,
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 84,
            "pubmed_id": 60303,
            "paper": "New Frontiers in Lung Cancer Therapy",
            "authors": "Wilson, Emily; Green, John",
            "journal": "Oncology Advances",
            "publication_date": "2024-06-30",
            "disease": "Lung cancer",
            "medication_group": "Targeted therapy group",
            "therapy_or_medication": "Targeted therapy",
            "medical_outcome": "Progression-free survival",
            "result": "50%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0000001192092896,
            "medication_group_correct": 0.6184169054031372,
            "therapy_or_medication_correct": 1.0000001192092896,
            "medical_outcome_correct": 0.9999998807907104,
            "result_correct": 0.7118043899536133,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 6.330221354961395
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 81,
                    "pubmed_id": 60303,
                    "paper": "New Frontiers in Lung Cancer Therapy",
                    "authors": "Wilson, Emily; Green, John",
                    "journal": "Oncology Advances",
                    "publication_date": "2024-06-30",
                    "disease": "Lung cancer",
                    "medication_group": "Chemotherapy group",
                    "therapy_or_medication": "Chemotherapy",
                    "medical_outcome": "Tumor shrinkage",
                    "result": "35%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.6589515209197998,
                    "therapy_or_medication_correct": 0.8039138317108154,
                    "medical_outcome_correct": 0.7074892520904541,
                    "result_correct": 0.6824735999107361,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.85282826423645
                }
            },
            {
                "pred_row": {
                    "id": 82,
                    "pubmed_id": 60303,
                    "paper": "New Frontiers in Lung Cancer Therapy",
                    "authors": "Wilson, Emily; Green, John",
                    "journal": "Oncology Advances",
                    "publication_date": "2024-06-30",
                    "disease": "Lung cancer",
                    "medication_group": "Radiation therapy group",
                    "therapy_or_medication": "Radiation therapy",
                    "medical_outcome": "Symptom alleviation",
                    "result": "40%",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.6284224390983582,
                    "therapy_or_medication_correct": 0.7592743635177612,
                    "medical_outcome_correct": 0.7381574511528015,
                    "result_correct": 0.7105332016944885,
                    "outcome_category_correct": 0.6335793137550354,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.4699667096138
                }
            },
            {
                "pred_row": {
                    "id": 83,
                    "pubmed_id": 60303,
                    "paper": "New Frontiers in Lung Cancer Therapy",
                    "authors": "Wilson, Emily; Green, John",
                    "journal": "Oncology Advances",
                    "publication_date": "2024-06-30",
                    "disease": "Lung cancer",
                    "medication_group": "Immunotherapy group",
                    "therapy_or_medication": "Immunotherapy",
                    "medical_outcome": "Survival rate increase",
                    "result": "25%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.42784562706947327,
                    "therapy_or_medication_correct": 0.47351253032684326,
                    "medical_outcome_correct": 0.7138062715530396,
                    "result_correct": 0.7260441780090332,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.341208666563034
                }
            },
            {
                "pred_row": {
                    "id": 84,
                    "pubmed_id": 60303,
                    "paper": "New Frontiers in Lung Cancer Therapy",
                    "authors": "Wilson, Emily; Green, John",
                    "journal": "Oncology Advances",
                    "publication_date": "2024-06-30",
                    "disease": "Lung cancer",
                    "medication_group": "Targeted therapy group",
                    "therapy_or_medication": "Targeted therapy",
                    "medical_outcome": "Progression-free survival",
                    "result": "50%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.6184169054031372,
                    "therapy_or_medication_correct": 1.0000001192092896,
                    "medical_outcome_correct": 0.9999998807907104,
                    "result_correct": 0.7118043899536133,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.330221354961395
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 60404,
            "papername": "Advances in Chronic Kidney Disease",
            "authors": "Patel, Raj; Singh, Maya",
            "publication_date": "2023-09-01 00:00:00",
            "journal": "Nephrology Today",
            "disease": "Kidney Disease",
            "medication_group": "Randomised group",
            "therapy_or_medication": "Hemodialysis",
            "medical_outcome": "Toxin Clearance",
            "result": "100 mL/min",
            "outcome_category": "Physiological Measure",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 85,
            "pubmed_id": 60404,
            "paper": "Advances in Chronic Kidney Disease",
            "authors": "Patel, Raj; Singh, Maya",
            "journal": "Nephrology Today",
            "publication_date": "2023-09-01",
            "disease": "Kidney disease",
            "medication_group": "Patients with advanced kidney disease",
            "therapy_or_medication": "Hemodialysis",
            "medical_outcome": "Toxin clearance rate",
            "result": "100 mL/min",
            "outcome_category": "Physiological Measure",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0000001192092896,
            "medication_group_correct": 0.4913322925567627,
            "therapy_or_medication_correct": 1.0,
            "medical_outcome_correct": 0.8622201681137085,
            "result_correct": 1.0,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 6.353552520275116
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 85,
                    "pubmed_id": 60404,
                    "paper": "Advances in Chronic Kidney Disease",
                    "authors": "Patel, Raj; Singh, Maya",
                    "journal": "Nephrology Today",
                    "publication_date": "2023-09-01",
                    "disease": "Kidney disease",
                    "medication_group": "Patients with advanced kidney disease",
                    "therapy_or_medication": "Hemodialysis",
                    "medical_outcome": "Toxin clearance rate",
                    "result": "100 mL/min",
                    "outcome_category": "Physiological Measure",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.4913322925567627,
                    "therapy_or_medication_correct": 1.0,
                    "medical_outcome_correct": 0.8622201681137085,
                    "result_correct": 1.0,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.353552520275116
                }
            },
            {
                "pred_row": {
                    "id": 86,
                    "pubmed_id": 60404,
                    "paper": "Advances in Chronic Kidney Disease",
                    "authors": "Patel, Raj; Singh, Maya",
                    "journal": "Nephrology Today",
                    "publication_date": "2023-09-01",
                    "disease": "Kidney disease",
                    "medication_group": "Patients with advanced kidney disease",
                    "therapy_or_medication": "Peritoneal dialysis",
                    "medical_outcome": "Fluid removal efficiency",
                    "result": "120 mL/hour",
                    "outcome_category": "Physiological Measure",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.4913322925567627,
                    "therapy_or_medication_correct": 0.8511552810668945,
                    "medical_outcome_correct": 0.7637802958488464,
                    "result_correct": 0.9211323857307434,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.027400314807892
                }
            },
            {
                "pred_row": {
                    "id": 87,
                    "pubmed_id": 60404,
                    "paper": "Advances in Chronic Kidney Disease",
                    "authors": "Patel, Raj; Singh, Maya",
                    "journal": "Nephrology Today",
                    "publication_date": "2023-09-01",
                    "disease": "Kidney disease",
                    "medication_group": "Patients with advanced kidney disease",
                    "therapy_or_medication": "Kidney transplant",
                    "medical_outcome": "Graft survival rate",
                    "result": "92%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.4913322925567627,
                    "therapy_or_medication_correct": 0.6730354428291321,
                    "medical_outcome_correct": 0.5299989581108093,
                    "result_correct": 0.504564642906189,
                    "outcome_category_correct": 0.7687371969223022,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 4.9676684737205505
                }
            },
            {
                "pred_row": {
                    "id": 88,
                    "pubmed_id": 60404,
                    "paper": "Advances in Chronic Kidney Disease",
                    "authors": "Patel, Raj; Singh, Maya",
                    "journal": "Nephrology Today",
                    "publication_date": "2023-09-01",
                    "disease": "Kidney disease",
                    "medication_group": "Patients with advanced kidney disease",
                    "therapy_or_medication": "SGLT2 inhibitors",
                    "medical_outcome": "eGFR improvement",
                    "result": "15%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.4913322925567627,
                    "therapy_or_medication_correct": 0.49371138215065,
                    "medical_outcome_correct": 0.546865701675415,
                    "result_correct": 0.5823217034339905,
                    "outcome_category_correct": 0.7687371969223022,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 4.882968217134476
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 60404,
            "papername": "Advances in Chronic Kidney Disease",
            "authors": "Patel, Raj; Singh, Maya",
            "publication_date": "2023-09-01 00:00:00",
            "journal": "Nephrology Today",
            "disease": "Kidney Disease",
            "medication_group": "Randomised group",
            "therapy_or_medication": "Peritoneal Dialysis",
            "medical_outcome": "Fluid Removal Efficiency",
            "result": "120 mL/hour",
            "outcome_category": "Physiological Measure",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 86,
            "pubmed_id": 60404,
            "paper": "Advances in Chronic Kidney Disease",
            "authors": "Patel, Raj; Singh, Maya",
            "journal": "Nephrology Today",
            "publication_date": "2023-09-01",
            "disease": "Kidney disease",
            "medication_group": "Patients with advanced kidney disease",
            "therapy_or_medication": "Peritoneal dialysis",
            "medical_outcome": "Fluid removal efficiency",
            "result": "120 mL/hour",
            "outcome_category": "Physiological Measure",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0000001192092896,
            "medication_group_correct": 0.4913322925567627,
            "therapy_or_medication_correct": 1.0000001192092896,
            "medical_outcome_correct": 1.0000001192092896,
            "result_correct": 1.0000001192092896,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 6.491332709789276
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 85,
                    "pubmed_id": 60404,
                    "paper": "Advances in Chronic Kidney Disease",
                    "authors": "Patel, Raj; Singh, Maya",
                    "journal": "Nephrology Today",
                    "publication_date": "2023-09-01",
                    "disease": "Kidney disease",
                    "medication_group": "Patients with advanced kidney disease",
                    "therapy_or_medication": "Hemodialysis",
                    "medical_outcome": "Toxin clearance rate",
                    "result": "100 mL/min",
                    "outcome_category": "Physiological Measure",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.4913322925567627,
                    "therapy_or_medication_correct": 0.8511552810668945,
                    "medical_outcome_correct": 0.7424116730690002,
                    "result_correct": 0.9211323857307434,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.006031692028046
                }
            },
            {
                "pred_row": {
                    "id": 86,
                    "pubmed_id": 60404,
                    "paper": "Advances in Chronic Kidney Disease",
                    "authors": "Patel, Raj; Singh, Maya",
                    "journal": "Nephrology Today",
                    "publication_date": "2023-09-01",
                    "disease": "Kidney disease",
                    "medication_group": "Patients with advanced kidney disease",
                    "therapy_or_medication": "Peritoneal dialysis",
                    "medical_outcome": "Fluid removal efficiency",
                    "result": "120 mL/hour",
                    "outcome_category": "Physiological Measure",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.4913322925567627,
                    "therapy_or_medication_correct": 1.0000001192092896,
                    "medical_outcome_correct": 1.0000001192092896,
                    "result_correct": 1.0000001192092896,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.491332709789276
                }
            },
            {
                "pred_row": {
                    "id": 87,
                    "pubmed_id": 60404,
                    "paper": "Advances in Chronic Kidney Disease",
                    "authors": "Patel, Raj; Singh, Maya",
                    "journal": "Nephrology Today",
                    "publication_date": "2023-09-01",
                    "disease": "Kidney disease",
                    "medication_group": "Patients with advanced kidney disease",
                    "therapy_or_medication": "Kidney transplant",
                    "medical_outcome": "Graft survival rate",
                    "result": "92%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.4913322925567627,
                    "therapy_or_medication_correct": 0.6383730173110962,
                    "medical_outcome_correct": 0.5901553630828857,
                    "result_correct": 0.48464488983154297,
                    "outcome_category_correct": 0.7687371969223022,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 4.973242700099945
                }
            },
            {
                "pred_row": {
                    "id": 88,
                    "pubmed_id": 60404,
                    "paper": "Advances in Chronic Kidney Disease",
                    "authors": "Patel, Raj; Singh, Maya",
                    "journal": "Nephrology Today",
                    "publication_date": "2023-09-01",
                    "disease": "Kidney disease",
                    "medication_group": "Patients with advanced kidney disease",
                    "therapy_or_medication": "SGLT2 inhibitors",
                    "medical_outcome": "eGFR improvement",
                    "result": "15%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.4913322925567627,
                    "therapy_or_medication_correct": 0.447206050157547,
                    "medical_outcome_correct": 0.5182317495346069,
                    "result_correct": 0.578477144241333,
                    "outcome_category_correct": 0.7687371969223022,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 4.803984373807907
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 60404,
            "papername": "Advances in Chronic Kidney Disease",
            "authors": "Patel, Raj; Singh, Maya",
            "publication_date": "2023-09-01 00:00:00",
            "journal": "Nephrology Today",
            "disease": "Kidney Disease",
            "medication_group": "Randomised group",
            "therapy_or_medication": "Kidney Transplant",
            "medical_outcome": "Graft Survival Rate",
            "result": 0.92,
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 87,
            "pubmed_id": 60404,
            "paper": "Advances in Chronic Kidney Disease",
            "authors": "Patel, Raj; Singh, Maya",
            "journal": "Nephrology Today",
            "publication_date": "2023-09-01",
            "disease": "Kidney disease",
            "medication_group": "Patients with advanced kidney disease",
            "therapy_or_medication": "Kidney transplant",
            "medical_outcome": "Graft survival rate",
            "result": "92%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0000001192092896,
            "medication_group_correct": 0.4913322925567627,
            "therapy_or_medication_correct": 1.0,
            "medical_outcome_correct": 1.0,
            "result_correct": 0.7193149924278259,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 6.210647344589233
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 85,
                    "pubmed_id": 60404,
                    "paper": "Advances in Chronic Kidney Disease",
                    "authors": "Patel, Raj; Singh, Maya",
                    "journal": "Nephrology Today",
                    "publication_date": "2023-09-01",
                    "disease": "Kidney disease",
                    "medication_group": "Patients with advanced kidney disease",
                    "therapy_or_medication": "Hemodialysis",
                    "medical_outcome": "Toxin clearance rate",
                    "result": "100 mL/min",
                    "outcome_category": "Physiological Measure",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.4913322925567627,
                    "therapy_or_medication_correct": 0.6730354428291321,
                    "medical_outcome_correct": 0.7024557590484619,
                    "result_correct": 0.5252727270126343,
                    "outcome_category_correct": 0.7687371969223022,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.160833358764648
                }
            },
            {
                "pred_row": {
                    "id": 86,
                    "pubmed_id": 60404,
                    "paper": "Advances in Chronic Kidney Disease",
                    "authors": "Patel, Raj; Singh, Maya",
                    "journal": "Nephrology Today",
                    "publication_date": "2023-09-01",
                    "disease": "Kidney disease",
                    "medication_group": "Patients with advanced kidney disease",
                    "therapy_or_medication": "Peritoneal dialysis",
                    "medical_outcome": "Fluid removal efficiency",
                    "result": "120 mL/hour",
                    "outcome_category": "Physiological Measure",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.4913322925567627,
                    "therapy_or_medication_correct": 0.6383730173110962,
                    "medical_outcome_correct": 0.5901553630828857,
                    "result_correct": 0.5282080769538879,
                    "outcome_category_correct": 0.7687371969223022,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.01680588722229
                }
            },
            {
                "pred_row": {
                    "id": 87,
                    "pubmed_id": 60404,
                    "paper": "Advances in Chronic Kidney Disease",
                    "authors": "Patel, Raj; Singh, Maya",
                    "journal": "Nephrology Today",
                    "publication_date": "2023-09-01",
                    "disease": "Kidney disease",
                    "medication_group": "Patients with advanced kidney disease",
                    "therapy_or_medication": "Kidney transplant",
                    "medical_outcome": "Graft survival rate",
                    "result": "92%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.4913322925567627,
                    "therapy_or_medication_correct": 1.0,
                    "medical_outcome_correct": 1.0,
                    "result_correct": 0.7193149924278259,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.210647344589233
                }
            },
            {
                "pred_row": {
                    "id": 88,
                    "pubmed_id": 60404,
                    "paper": "Advances in Chronic Kidney Disease",
                    "authors": "Patel, Raj; Singh, Maya",
                    "journal": "Nephrology Today",
                    "publication_date": "2023-09-01",
                    "disease": "Kidney disease",
                    "medication_group": "Patients with advanced kidney disease",
                    "therapy_or_medication": "SGLT2 inhibitors",
                    "medical_outcome": "eGFR improvement",
                    "result": "15%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.4913322925567627,
                    "therapy_or_medication_correct": 0.5241872668266296,
                    "medical_outcome_correct": 0.7378678321838379,
                    "result_correct": 0.7081766128540039,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.461564064025879
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 60404,
            "papername": "Advances in Chronic Kidney Disease",
            "authors": "Patel, Raj; Singh, Maya",
            "publication_date": "2023-09-01 00:00:00",
            "journal": "Nephrology Today",
            "disease": "Kidney Disease",
            "medication_group": "Randomised group",
            "therapy_or_medication": "SGLT2 Inhibitors",
            "medical_outcome": "eGFR Improvement",
            "result": 0.15,
            "outcome_category": "Physiological Measure",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 88,
            "pubmed_id": 60404,
            "paper": "Advances in Chronic Kidney Disease",
            "authors": "Patel, Raj; Singh, Maya",
            "journal": "Nephrology Today",
            "publication_date": "2023-09-01",
            "disease": "Kidney disease",
            "medication_group": "Patients with advanced kidney disease",
            "therapy_or_medication": "SGLT2 inhibitors",
            "medical_outcome": "eGFR improvement",
            "result": "15%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0000001192092896,
            "medication_group_correct": 0.4913322925567627,
            "therapy_or_medication_correct": 0.9999999403953552,
            "medical_outcome_correct": 0.9999998807907104,
            "result_correct": 0.7188842296600342,
            "outcome_category_correct": 0.7687371969223022,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 5.97895348072052
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 85,
                    "pubmed_id": 60404,
                    "paper": "Advances in Chronic Kidney Disease",
                    "authors": "Patel, Raj; Singh, Maya",
                    "journal": "Nephrology Today",
                    "publication_date": "2023-09-01",
                    "disease": "Kidney disease",
                    "medication_group": "Patients with advanced kidney disease",
                    "therapy_or_medication": "Hemodialysis",
                    "medical_outcome": "Toxin clearance rate",
                    "result": "100 mL/min",
                    "outcome_category": "Physiological Measure",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.4913322925567627,
                    "therapy_or_medication_correct": 0.49371138215065,
                    "medical_outcome_correct": 0.6531773805618286,
                    "result_correct": 0.5326876044273376,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.170908719301224
                }
            },
            {
                "pred_row": {
                    "id": 86,
                    "pubmed_id": 60404,
                    "paper": "Advances in Chronic Kidney Disease",
                    "authors": "Patel, Raj; Singh, Maya",
                    "journal": "Nephrology Today",
                    "publication_date": "2023-09-01",
                    "disease": "Kidney disease",
                    "medication_group": "Patients with advanced kidney disease",
                    "therapy_or_medication": "Peritoneal dialysis",
                    "medical_outcome": "Fluid removal efficiency",
                    "result": "120 mL/hour",
                    "outcome_category": "Physiological Measure",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.4913322925567627,
                    "therapy_or_medication_correct": 0.447206050157547,
                    "medical_outcome_correct": 0.5182317495346069,
                    "result_correct": 0.5506134033203125,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.007383555173874
                }
            },
            {
                "pred_row": {
                    "id": 87,
                    "pubmed_id": 60404,
                    "paper": "Advances in Chronic Kidney Disease",
                    "authors": "Patel, Raj; Singh, Maya",
                    "journal": "Nephrology Today",
                    "publication_date": "2023-09-01",
                    "disease": "Kidney disease",
                    "medication_group": "Patients with advanced kidney disease",
                    "therapy_or_medication": "Kidney transplant",
                    "medical_outcome": "Graft survival rate",
                    "result": "92%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.4913322925567627,
                    "therapy_or_medication_correct": 0.5241872668266296,
                    "medical_outcome_correct": 0.7378678321838379,
                    "result_correct": 0.6294560432434082,
                    "outcome_category_correct": 0.7687371969223022,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.151580572128296
                }
            },
            {
                "pred_row": {
                    "id": 88,
                    "pubmed_id": 60404,
                    "paper": "Advances in Chronic Kidney Disease",
                    "authors": "Patel, Raj; Singh, Maya",
                    "journal": "Nephrology Today",
                    "publication_date": "2023-09-01",
                    "disease": "Kidney disease",
                    "medication_group": "Patients with advanced kidney disease",
                    "therapy_or_medication": "SGLT2 inhibitors",
                    "medical_outcome": "eGFR improvement",
                    "result": "15%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.4913322925567627,
                    "therapy_or_medication_correct": 0.9999999403953552,
                    "medical_outcome_correct": 0.9999998807907104,
                    "result_correct": 0.7188842296600342,
                    "outcome_category_correct": 0.7687371969223022,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.97895348072052
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 60505,
            "papername": "Emerging Therapies in Alzheimer’s Disease",
            "authors": "Taylor, Richard; Morris, Jessica",
            "publication_date": "2023-12-10 00:00:00",
            "journal": "Journal of Neurology and Psychiatry",
            "disease": "Alzheimer's",
            "medication_group": "Randomised group",
            "therapy_or_medication": "Anticholinesterases",
            "medical_outcome": "Cognitive Stabilization",
            "result": 0.12,
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 89,
            "pubmed_id": 60505,
            "paper": "Emerging Therapies in Alzheimer’s Disease",
            "authors": "Taylor, Richard; Morris, Jessica",
            "journal": "Journal of Neurology and Psychiatry",
            "publication_date": "2023-12-10",
            "disease": "Alzheimer's disease",
            "medication_group": "400 patients with mild to moderate Alzheimer's disease",
            "therapy_or_medication": "Anticholinesterases",
            "medical_outcome": "Cognitive stabilization",
            "result": "12%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 0.8405335545539856,
            "medication_group_correct": 0.4093342423439026,
            "therapy_or_medication_correct": 1.0,
            "medical_outcome_correct": 1.0000001192092896,
            "result_correct": 0.6908031105995178,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 5.940670967102051
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 89,
                    "pubmed_id": 60505,
                    "paper": "Emerging Therapies in Alzheimer’s Disease",
                    "authors": "Taylor, Richard; Morris, Jessica",
                    "journal": "Journal of Neurology and Psychiatry",
                    "publication_date": "2023-12-10",
                    "disease": "Alzheimer's disease",
                    "medication_group": "400 patients with mild to moderate Alzheimer's disease",
                    "therapy_or_medication": "Anticholinesterases",
                    "medical_outcome": "Cognitive stabilization",
                    "result": "12%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.8405335545539856,
                    "medication_group_correct": 0.4093342423439026,
                    "therapy_or_medication_correct": 1.0,
                    "medical_outcome_correct": 1.0000001192092896,
                    "result_correct": 0.6908031105995178,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.940670967102051
                }
            },
            {
                "pred_row": {
                    "id": 90,
                    "pubmed_id": 60505,
                    "paper": "Emerging Therapies in Alzheimer’s Disease",
                    "authors": "Taylor, Richard; Morris, Jessica",
                    "journal": "Journal of Neurology and Psychiatry",
                    "publication_date": "2023-12-10",
                    "disease": "Alzheimer's disease",
                    "medication_group": "400 patients with mild to moderate Alzheimer's disease",
                    "therapy_or_medication": "Memantine",
                    "medical_outcome": "Symptom management",
                    "result": "18%",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.8405335545539856,
                    "medication_group_correct": 0.4093342423439026,
                    "therapy_or_medication_correct": 0.48853600025177,
                    "medical_outcome_correct": 0.5965433120727539,
                    "result_correct": 0.6647222638130188,
                    "outcome_category_correct": 0.6335793137550354,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 4.633248507976532
                }
            },
            {
                "pred_row": {
                    "id": 91,
                    "pubmed_id": 60505,
                    "paper": "Emerging Therapies in Alzheimer’s Disease",
                    "authors": "Taylor, Richard; Morris, Jessica",
                    "journal": "Journal of Neurology and Psychiatry",
                    "publication_date": "2023-12-10",
                    "disease": "Alzheimer's disease",
                    "medication_group": "400 patients with mild to moderate Alzheimer's disease",
                    "therapy_or_medication": "Beta amyloid antibodies",
                    "medical_outcome": "Reduction in plaque load",
                    "result": "30%",
                    "outcome_category": "Physiological Measure",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.8405335545539856,
                    "medication_group_correct": 0.4093342423439026,
                    "therapy_or_medication_correct": 0.6829484105110168,
                    "medical_outcome_correct": 0.6104415059089661,
                    "result_correct": 0.6782591342926025,
                    "outcome_category_correct": 0.7687371969223022,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 4.9902538657188416
                }
            },
            {
                "pred_row": {
                    "id": 92,
                    "pubmed_id": 60505,
                    "paper": "Emerging Therapies in Alzheimer’s Disease",
                    "authors": "Taylor, Richard; Morris, Jessica",
                    "journal": "Journal of Neurology and Psychiatry",
                    "publication_date": "2023-12-10",
                    "disease": "Alzheimer's disease",
                    "medication_group": "400 patients with mild to moderate Alzheimer's disease",
                    "therapy_or_medication": "Lifestyle interventions",
                    "medical_outcome": "Quality of life improvement",
                    "result": "25%",
                    "outcome_category": "Quality of Life",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.8405335545539856,
                    "medication_group_correct": 0.4093342423439026,
                    "therapy_or_medication_correct": 0.5001537799835205,
                    "medical_outcome_correct": 0.6417022943496704,
                    "result_correct": 0.6582980155944824,
                    "outcome_category_correct": 0.6459974050521851,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 4.696019113063812
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 60505,
            "papername": "Emerging Therapies in Alzheimer’s Disease",
            "authors": "Taylor, Richard; Morris, Jessica",
            "publication_date": "2023-12-10 00:00:00",
            "journal": "Journal of Neurology and Psychiatry",
            "disease": "Alzheimer's",
            "medication_group": "Randomised group",
            "therapy_or_medication": "Memantine",
            "medical_outcome": "Symptom Management",
            "result": 0.18,
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 90,
            "pubmed_id": 60505,
            "paper": "Emerging Therapies in Alzheimer’s Disease",
            "authors": "Taylor, Richard; Morris, Jessica",
            "journal": "Journal of Neurology and Psychiatry",
            "publication_date": "2023-12-10",
            "disease": "Alzheimer's disease",
            "medication_group": "400 patients with mild to moderate Alzheimer's disease",
            "therapy_or_medication": "Memantine",
            "medical_outcome": "Symptom management",
            "result": "18%",
            "outcome_category": "Symptom Intensity and Relief",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 0.8405335545539856,
            "medication_group_correct": 0.4093342423439026,
            "therapy_or_medication_correct": 1.0000001192092896,
            "medical_outcome_correct": 0.9999999403953552,
            "result_correct": 0.704075038433075,
            "outcome_category_correct": 0.6335793137550354,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 5.587522029876709
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 89,
                    "pubmed_id": 60505,
                    "paper": "Emerging Therapies in Alzheimer’s Disease",
                    "authors": "Taylor, Richard; Morris, Jessica",
                    "journal": "Journal of Neurology and Psychiatry",
                    "publication_date": "2023-12-10",
                    "disease": "Alzheimer's disease",
                    "medication_group": "400 patients with mild to moderate Alzheimer's disease",
                    "therapy_or_medication": "Anticholinesterases",
                    "medical_outcome": "Cognitive stabilization",
                    "result": "12%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.8405335545539856,
                    "medication_group_correct": 0.4093342423439026,
                    "therapy_or_medication_correct": 0.48853600025177,
                    "medical_outcome_correct": 0.5965433120727539,
                    "result_correct": 0.687973141670227,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.022920191287994
                }
            },
            {
                "pred_row": {
                    "id": 90,
                    "pubmed_id": 60505,
                    "paper": "Emerging Therapies in Alzheimer’s Disease",
                    "authors": "Taylor, Richard; Morris, Jessica",
                    "journal": "Journal of Neurology and Psychiatry",
                    "publication_date": "2023-12-10",
                    "disease": "Alzheimer's disease",
                    "medication_group": "400 patients with mild to moderate Alzheimer's disease",
                    "therapy_or_medication": "Memantine",
                    "medical_outcome": "Symptom management",
                    "result": "18%",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.8405335545539856,
                    "medication_group_correct": 0.4093342423439026,
                    "therapy_or_medication_correct": 1.0000001192092896,
                    "medical_outcome_correct": 0.9999999403953552,
                    "result_correct": 0.704075038433075,
                    "outcome_category_correct": 0.6335793137550354,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.587522029876709
                }
            },
            {
                "pred_row": {
                    "id": 91,
                    "pubmed_id": 60505,
                    "paper": "Emerging Therapies in Alzheimer’s Disease",
                    "authors": "Taylor, Richard; Morris, Jessica",
                    "journal": "Journal of Neurology and Psychiatry",
                    "publication_date": "2023-12-10",
                    "disease": "Alzheimer's disease",
                    "medication_group": "400 patients with mild to moderate Alzheimer's disease",
                    "therapy_or_medication": "Beta amyloid antibodies",
                    "medical_outcome": "Reduction in plaque load",
                    "result": "30%",
                    "outcome_category": "Physiological Measure",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.8405335545539856,
                    "medication_group_correct": 0.4093342423439026,
                    "therapy_or_medication_correct": 0.4837106764316559,
                    "medical_outcome_correct": 0.6880582571029663,
                    "result_correct": 0.6830683946609497,
                    "outcome_category_correct": 0.7687371969223022,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 4.873442143201828
                }
            },
            {
                "pred_row": {
                    "id": 92,
                    "pubmed_id": 60505,
                    "paper": "Emerging Therapies in Alzheimer’s Disease",
                    "authors": "Taylor, Richard; Morris, Jessica",
                    "journal": "Journal of Neurology and Psychiatry",
                    "publication_date": "2023-12-10",
                    "disease": "Alzheimer's disease",
                    "medication_group": "400 patients with mild to moderate Alzheimer's disease",
                    "therapy_or_medication": "Lifestyle interventions",
                    "medical_outcome": "Quality of life improvement",
                    "result": "25%",
                    "outcome_category": "Quality of Life",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.8405335545539856,
                    "medication_group_correct": 0.4093342423439026,
                    "therapy_or_medication_correct": 0.6771700978279114,
                    "medical_outcome_correct": 0.6626919507980347,
                    "result_correct": 0.6714625954627991,
                    "outcome_category_correct": 0.6459974050521851,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 4.907189667224884
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 60505,
            "papername": "Emerging Therapies in Alzheimer’s Disease",
            "authors": "Taylor, Richard; Morris, Jessica",
            "publication_date": "2023-12-10 00:00:00",
            "journal": "Journal of Neurology and Psychiatry",
            "disease": "Alzheimer's",
            "medication_group": "Randomised group",
            "therapy_or_medication": "Beta Amyloid Antibodies",
            "medical_outcome": "Reduction in Plaque Load",
            "result": 0.3,
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 91,
            "pubmed_id": 60505,
            "paper": "Emerging Therapies in Alzheimer’s Disease",
            "authors": "Taylor, Richard; Morris, Jessica",
            "journal": "Journal of Neurology and Psychiatry",
            "publication_date": "2023-12-10",
            "disease": "Alzheimer's disease",
            "medication_group": "400 patients with mild to moderate Alzheimer's disease",
            "therapy_or_medication": "Beta amyloid antibodies",
            "medical_outcome": "Reduction in plaque load",
            "result": "30%",
            "outcome_category": "Physiological Measure",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 0.8405335545539856,
            "medication_group_correct": 0.4093342423439026,
            "therapy_or_medication_correct": 1.0,
            "medical_outcome_correct": 0.9999999403953552,
            "result_correct": 0.7367587685585022,
            "outcome_category_correct": 0.7687371969223022,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 5.7553635239601135
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 89,
                    "pubmed_id": 60505,
                    "paper": "Emerging Therapies in Alzheimer’s Disease",
                    "authors": "Taylor, Richard; Morris, Jessica",
                    "journal": "Journal of Neurology and Psychiatry",
                    "publication_date": "2023-12-10",
                    "disease": "Alzheimer's disease",
                    "medication_group": "400 patients with mild to moderate Alzheimer's disease",
                    "therapy_or_medication": "Anticholinesterases",
                    "medical_outcome": "Cognitive stabilization",
                    "result": "12%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.8405335545539856,
                    "medication_group_correct": 0.4093342423439026,
                    "therapy_or_medication_correct": 0.6829484105110168,
                    "medical_outcome_correct": 0.6104415059089661,
                    "result_correct": 0.7393125295639038,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.28257018327713
                }
            },
            {
                "pred_row": {
                    "id": 90,
                    "pubmed_id": 60505,
                    "paper": "Emerging Therapies in Alzheimer’s Disease",
                    "authors": "Taylor, Richard; Morris, Jessica",
                    "journal": "Journal of Neurology and Psychiatry",
                    "publication_date": "2023-12-10",
                    "disease": "Alzheimer's disease",
                    "medication_group": "400 patients with mild to moderate Alzheimer's disease",
                    "therapy_or_medication": "Memantine",
                    "medical_outcome": "Symptom management",
                    "result": "18%",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.8405335545539856,
                    "medication_group_correct": 0.4093342423439026,
                    "therapy_or_medication_correct": 0.4837106764316559,
                    "medical_outcome_correct": 0.6880582571029663,
                    "result_correct": 0.7147877216339111,
                    "outcome_category_correct": 0.6335793137550354,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 4.770003587007523
                }
            },
            {
                "pred_row": {
                    "id": 91,
                    "pubmed_id": 60505,
                    "paper": "Emerging Therapies in Alzheimer’s Disease",
                    "authors": "Taylor, Richard; Morris, Jessica",
                    "journal": "Journal of Neurology and Psychiatry",
                    "publication_date": "2023-12-10",
                    "disease": "Alzheimer's disease",
                    "medication_group": "400 patients with mild to moderate Alzheimer's disease",
                    "therapy_or_medication": "Beta amyloid antibodies",
                    "medical_outcome": "Reduction in plaque load",
                    "result": "30%",
                    "outcome_category": "Physiological Measure",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.8405335545539856,
                    "medication_group_correct": 0.4093342423439026,
                    "therapy_or_medication_correct": 1.0,
                    "medical_outcome_correct": 0.9999999403953552,
                    "result_correct": 0.7367587685585022,
                    "outcome_category_correct": 0.7687371969223022,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.7553635239601135
                }
            },
            {
                "pred_row": {
                    "id": 92,
                    "pubmed_id": 60505,
                    "paper": "Emerging Therapies in Alzheimer’s Disease",
                    "authors": "Taylor, Richard; Morris, Jessica",
                    "journal": "Journal of Neurology and Psychiatry",
                    "publication_date": "2023-12-10",
                    "disease": "Alzheimer's disease",
                    "medication_group": "400 patients with mild to moderate Alzheimer's disease",
                    "therapy_or_medication": "Lifestyle interventions",
                    "medical_outcome": "Quality of life improvement",
                    "result": "25%",
                    "outcome_category": "Quality of Life",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.8405335545539856,
                    "medication_group_correct": 0.4093342423439026,
                    "therapy_or_medication_correct": 0.499574214220047,
                    "medical_outcome_correct": 0.6504931449890137,
                    "result_correct": 0.7206388115882874,
                    "outcome_category_correct": 0.6459974050521851,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 4.766571193933487
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 60505,
            "papername": "Emerging Therapies in Alzheimer’s Disease",
            "authors": "Taylor, Richard; Morris, Jessica",
            "publication_date": "2023-12-10 00:00:00",
            "journal": "Journal of Neurology and Psychiatry",
            "disease": "Alzheimer's",
            "medication_group": "Randomised group",
            "therapy_or_medication": "Lifestyle Interventions",
            "medical_outcome": "Quality of Life Improvement",
            "result": 0.25,
            "outcome_category": "Quality of Life",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 92,
            "pubmed_id": 60505,
            "paper": "Emerging Therapies in Alzheimer’s Disease",
            "authors": "Taylor, Richard; Morris, Jessica",
            "journal": "Journal of Neurology and Psychiatry",
            "publication_date": "2023-12-10",
            "disease": "Alzheimer's disease",
            "medication_group": "400 patients with mild to moderate Alzheimer's disease",
            "therapy_or_medication": "Lifestyle interventions",
            "medical_outcome": "Quality of life improvement",
            "result": "25%",
            "outcome_category": "Quality of Life",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 0.8405335545539856,
            "medication_group_correct": 0.4093342423439026,
            "therapy_or_medication_correct": 1.0,
            "medical_outcome_correct": 0.9999998807907104,
            "result_correct": 0.7425962090492249,
            "outcome_category_correct": 0.9999998807907104,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 5.9924635887146
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 89,
                    "pubmed_id": 60505,
                    "paper": "Emerging Therapies in Alzheimer’s Disease",
                    "authors": "Taylor, Richard; Morris, Jessica",
                    "journal": "Journal of Neurology and Psychiatry",
                    "publication_date": "2023-12-10",
                    "disease": "Alzheimer's disease",
                    "medication_group": "400 patients with mild to moderate Alzheimer's disease",
                    "therapy_or_medication": "Anticholinesterases",
                    "medical_outcome": "Cognitive stabilization",
                    "result": "12%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.8405335545539856,
                    "medication_group_correct": 0.4093342423439026,
                    "therapy_or_medication_correct": 0.5001537799835205,
                    "medical_outcome_correct": 0.6417022943496704,
                    "result_correct": 0.7138758897781372,
                    "outcome_category_correct": 0.6459974050521851,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 4.751596987247467
                }
            },
            {
                "pred_row": {
                    "id": 90,
                    "pubmed_id": 60505,
                    "paper": "Emerging Therapies in Alzheimer’s Disease",
                    "authors": "Taylor, Richard; Morris, Jessica",
                    "journal": "Journal of Neurology and Psychiatry",
                    "publication_date": "2023-12-10",
                    "disease": "Alzheimer's disease",
                    "medication_group": "400 patients with mild to moderate Alzheimer's disease",
                    "therapy_or_medication": "Memantine",
                    "medical_outcome": "Symptom management",
                    "result": "18%",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.8405335545539856,
                    "medication_group_correct": 0.4093342423439026,
                    "therapy_or_medication_correct": 0.6771700978279114,
                    "medical_outcome_correct": 0.6626919507980347,
                    "result_correct": 0.7072480916976929,
                    "outcome_category_correct": 0.5927481055259705,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 4.889725863933563
                }
            },
            {
                "pred_row": {
                    "id": 91,
                    "pubmed_id": 60505,
                    "paper": "Emerging Therapies in Alzheimer’s Disease",
                    "authors": "Taylor, Richard; Morris, Jessica",
                    "journal": "Journal of Neurology and Psychiatry",
                    "publication_date": "2023-12-10",
                    "disease": "Alzheimer's disease",
                    "medication_group": "400 patients with mild to moderate Alzheimer's disease",
                    "therapy_or_medication": "Beta amyloid antibodies",
                    "medical_outcome": "Reduction in plaque load",
                    "result": "30%",
                    "outcome_category": "Physiological Measure",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.8405335545539856,
                    "medication_group_correct": 0.4093342423439026,
                    "therapy_or_medication_correct": 0.499574214220047,
                    "medical_outcome_correct": 0.6504931449890137,
                    "result_correct": 0.7246699929237366,
                    "outcome_category_correct": 0.5712728500366211,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 4.695877820253372
                }
            },
            {
                "pred_row": {
                    "id": 92,
                    "pubmed_id": 60505,
                    "paper": "Emerging Therapies in Alzheimer’s Disease",
                    "authors": "Taylor, Richard; Morris, Jessica",
                    "journal": "Journal of Neurology and Psychiatry",
                    "publication_date": "2023-12-10",
                    "disease": "Alzheimer's disease",
                    "medication_group": "400 patients with mild to moderate Alzheimer's disease",
                    "therapy_or_medication": "Lifestyle interventions",
                    "medical_outcome": "Quality of life improvement",
                    "result": "25%",
                    "outcome_category": "Quality of Life",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 0.8405335545539856,
                    "medication_group_correct": 0.4093342423439026,
                    "therapy_or_medication_correct": 1.0,
                    "medical_outcome_correct": 0.9999998807907104,
                    "result_correct": 0.7425962090492249,
                    "outcome_category_correct": 0.9999998807907104,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 5.9924635887146
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 80101,
            "papername": "Efficacy of Migraine Treatments in Different Groups",
            "authors": "Smith, A.; Johnson, B.",
            "publication_date": "2024-05-12 00:00:00",
            "journal": "Journal of Neurology",
            "disease": "Migraine",
            "medication_group": "Women group",
            "therapy_or_medication": "Erenumab",
            "medical_outcome": "Reduction in MMD",
            "result": 0.55,
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 93,
            "pubmed_id": 80101,
            "paper": "Efficacy of Migraine Treatments in Different Groups",
            "authors": "Smith, A.; Johnson, B.",
            "journal": "Journal of Neurology",
            "publication_date": "2024-05-12",
            "disease": "Migraine",
            "medication_group": "Women group",
            "therapy_or_medication": "Erenumab",
            "medical_outcome": "percentage reduction in MMD",
            "result": "55%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0000001192092896,
            "medication_group_correct": 1.0,
            "therapy_or_medication_correct": 0.9999997615814209,
            "medical_outcome_correct": 0.9122943878173828,
            "result_correct": 0.7011827826499939,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 6.613476991653442
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 93,
                    "pubmed_id": 80101,
                    "paper": "Efficacy of Migraine Treatments in Different Groups",
                    "authors": "Smith, A.; Johnson, B.",
                    "journal": "Journal of Neurology",
                    "publication_date": "2024-05-12",
                    "disease": "Migraine",
                    "medication_group": "Women group",
                    "therapy_or_medication": "Erenumab",
                    "medical_outcome": "percentage reduction in MMD",
                    "result": "55%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 1.0,
                    "therapy_or_medication_correct": 0.9999997615814209,
                    "medical_outcome_correct": 0.9122943878173828,
                    "result_correct": 0.7011827826499939,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.613476991653442
                }
            },
            {
                "pred_row": {
                    "id": 94,
                    "pubmed_id": 80101,
                    "paper": "Efficacy of Migraine Treatments in Different Groups",
                    "authors": "Smith, A.; Johnson, B.",
                    "journal": "Journal of Neurology",
                    "publication_date": "2024-05-12",
                    "disease": "Migraine",
                    "medication_group": "Men group",
                    "therapy_or_medication": "Erenumab",
                    "medical_outcome": "percentage reduction in MMD",
                    "result": "50%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.8459748029708862,
                    "therapy_or_medication_correct": 0.9999997615814209,
                    "medical_outcome_correct": 0.9122943878173828,
                    "result_correct": 0.7174963355064392,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.475765347480774
                }
            },
            {
                "pred_row": {
                    "id": 96,
                    "pubmed_id": 80101,
                    "paper": "Efficacy of Migraine Treatments in Different Groups",
                    "authors": "Smith, A.; Johnson, B.",
                    "journal": "Journal of Neurology",
                    "publication_date": "2024-05-12",
                    "disease": "Migraine",
                    "medication_group": "Men group",
                    "therapy_or_medication": "Erenumab",
                    "medical_outcome": "Discontinuation rate",
                    "result": "7%",
                    "outcome_category": "Adverse Events and Side Effects",
                    "outcome_evaluation": "significantly worse"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.8459748029708862,
                    "therapy_or_medication_correct": 0.9999997615814209,
                    "medical_outcome_correct": 0.6279245615005493,
                    "result_correct": 0.704086184501648,
                    "outcome_category_correct": 0.6407684087753296,
                    "outcome_evaluation_correct": 0.790851891040802,
                    "score": 5.6096057295799255
                }
            },
            {
                "pred_row": {
                    "id": 95,
                    "pubmed_id": 80101,
                    "paper": "Efficacy of Migraine Treatments in Different Groups",
                    "authors": "Smith, A.; Johnson, B.",
                    "journal": "Journal of Neurology",
                    "publication_date": "2024-05-12",
                    "disease": "Migraine",
                    "medication_group": "Women group",
                    "therapy_or_medication": "Erenumab",
                    "medical_outcome": "Discontinuation rate",
                    "result": "5%",
                    "outcome_category": "Adverse Events and Side Effects",
                    "outcome_evaluation": "significantly worse"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 1.0,
                    "therapy_or_medication_correct": 0.9999997615814209,
                    "medical_outcome_correct": 0.6279245615005493,
                    "result_correct": 0.7153939008712769,
                    "outcome_category_correct": 0.6407684087753296,
                    "outcome_evaluation_correct": 0.790851891040802,
                    "score": 5.774938642978668
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 80101,
            "papername": "Efficacy of Migraine Treatments in Different Groups",
            "authors": "Smith, A.; Johnson, B.",
            "publication_date": "2024-05-12 00:00:00",
            "journal": "Journal of Neurology",
            "disease": "Migraine",
            "medication_group": "Women group",
            "therapy_or_medication": "Erenumab",
            "medical_outcome": "Discontinuation Rate",
            "result": 0.05,
            "outcome_category": "Adverse Events and Side Effects",
            "outcome_evaluation": "significantly worse"
        },
        "pred_row": {
            "id": 95,
            "pubmed_id": 80101,
            "paper": "Efficacy of Migraine Treatments in Different Groups",
            "authors": "Smith, A.; Johnson, B.",
            "journal": "Journal of Neurology",
            "publication_date": "2024-05-12",
            "disease": "Migraine",
            "medication_group": "Women group",
            "therapy_or_medication": "Erenumab",
            "medical_outcome": "Discontinuation rate",
            "result": "5%",
            "outcome_category": "Adverse Events and Side Effects",
            "outcome_evaluation": "significantly worse"
        },
        "best_similarity": {
            "disease_correct": 1.0000001192092896,
            "medication_group_correct": 1.0,
            "therapy_or_medication_correct": 0.9999997615814209,
            "medical_outcome_correct": 1.0,
            "result_correct": 0.6513631939888,
            "outcome_category_correct": 0.9999999403953552,
            "outcome_evaluation_correct": 1.0,
            "score": 6.651363015174866
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 93,
                    "pubmed_id": 80101,
                    "paper": "Efficacy of Migraine Treatments in Different Groups",
                    "authors": "Smith, A.; Johnson, B.",
                    "journal": "Journal of Neurology",
                    "publication_date": "2024-05-12",
                    "disease": "Migraine",
                    "medication_group": "Women group",
                    "therapy_or_medication": "Erenumab",
                    "medical_outcome": "percentage reduction in MMD",
                    "result": "55%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 1.0,
                    "therapy_or_medication_correct": 0.9999997615814209,
                    "medical_outcome_correct": 0.5799520015716553,
                    "result_correct": 0.5913848876953125,
                    "outcome_category_correct": 0.6407684087753296,
                    "outcome_evaluation_correct": 0.790851891040802,
                    "score": 5.60295706987381
                }
            },
            {
                "pred_row": {
                    "id": 94,
                    "pubmed_id": 80101,
                    "paper": "Efficacy of Migraine Treatments in Different Groups",
                    "authors": "Smith, A.; Johnson, B.",
                    "journal": "Journal of Neurology",
                    "publication_date": "2024-05-12",
                    "disease": "Migraine",
                    "medication_group": "Men group",
                    "therapy_or_medication": "Erenumab",
                    "medical_outcome": "percentage reduction in MMD",
                    "result": "50%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.8459748029708862,
                    "therapy_or_medication_correct": 0.9999997615814209,
                    "medical_outcome_correct": 0.5799520015716553,
                    "result_correct": 0.6449295878410339,
                    "outcome_category_correct": 0.6407684087753296,
                    "outcome_evaluation_correct": 0.790851891040802,
                    "score": 5.5024765729904175
                }
            },
            {
                "pred_row": {
                    "id": 96,
                    "pubmed_id": 80101,
                    "paper": "Efficacy of Migraine Treatments in Different Groups",
                    "authors": "Smith, A.; Johnson, B.",
                    "journal": "Journal of Neurology",
                    "publication_date": "2024-05-12",
                    "disease": "Migraine",
                    "medication_group": "Men group",
                    "therapy_or_medication": "Erenumab",
                    "medical_outcome": "Discontinuation rate",
                    "result": "7%",
                    "outcome_category": "Adverse Events and Side Effects",
                    "outcome_evaluation": "significantly worse"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.8459748029708862,
                    "therapy_or_medication_correct": 0.9999997615814209,
                    "medical_outcome_correct": 1.0,
                    "result_correct": 0.6390331983566284,
                    "outcome_category_correct": 0.9999999403953552,
                    "outcome_evaluation_correct": 1.0,
                    "score": 6.48500782251358
                }
            },
            {
                "pred_row": {
                    "id": 95,
                    "pubmed_id": 80101,
                    "paper": "Efficacy of Migraine Treatments in Different Groups",
                    "authors": "Smith, A.; Johnson, B.",
                    "journal": "Journal of Neurology",
                    "publication_date": "2024-05-12",
                    "disease": "Migraine",
                    "medication_group": "Women group",
                    "therapy_or_medication": "Erenumab",
                    "medical_outcome": "Discontinuation rate",
                    "result": "5%",
                    "outcome_category": "Adverse Events and Side Effects",
                    "outcome_evaluation": "significantly worse"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 1.0,
                    "therapy_or_medication_correct": 0.9999997615814209,
                    "medical_outcome_correct": 1.0,
                    "result_correct": 0.6513631939888,
                    "outcome_category_correct": 0.9999999403953552,
                    "outcome_evaluation_correct": 1.0,
                    "score": 6.651363015174866
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 80101,
            "papername": "Efficacy of Migraine Treatments in Different Groups",
            "authors": "Smith, A.; Johnson, B.",
            "publication_date": "2024-05-12 00:00:00",
            "journal": "Journal of Neurology",
            "disease": "Migraine",
            "medication_group": "Men group",
            "therapy_or_medication": "Erenumab",
            "medical_outcome": "Reduction in MMD",
            "result": 0.5,
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 94,
            "pubmed_id": 80101,
            "paper": "Efficacy of Migraine Treatments in Different Groups",
            "authors": "Smith, A.; Johnson, B.",
            "journal": "Journal of Neurology",
            "publication_date": "2024-05-12",
            "disease": "Migraine",
            "medication_group": "Men group",
            "therapy_or_medication": "Erenumab",
            "medical_outcome": "percentage reduction in MMD",
            "result": "50%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0000001192092896,
            "medication_group_correct": 0.9999999403953552,
            "therapy_or_medication_correct": 0.9999997615814209,
            "medical_outcome_correct": 0.9122943878173828,
            "result_correct": 0.7118043899536133,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 6.624098539352417
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 93,
                    "pubmed_id": 80101,
                    "paper": "Efficacy of Migraine Treatments in Different Groups",
                    "authors": "Smith, A.; Johnson, B.",
                    "journal": "Journal of Neurology",
                    "publication_date": "2024-05-12",
                    "disease": "Migraine",
                    "medication_group": "Women group",
                    "therapy_or_medication": "Erenumab",
                    "medical_outcome": "percentage reduction in MMD",
                    "result": "55%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.8459748029708862,
                    "therapy_or_medication_correct": 0.9999997615814209,
                    "medical_outcome_correct": 0.9122943878173828,
                    "result_correct": 0.6546006202697754,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.41286963224411
                }
            },
            {
                "pred_row": {
                    "id": 94,
                    "pubmed_id": 80101,
                    "paper": "Efficacy of Migraine Treatments in Different Groups",
                    "authors": "Smith, A.; Johnson, B.",
                    "journal": "Journal of Neurology",
                    "publication_date": "2024-05-12",
                    "disease": "Migraine",
                    "medication_group": "Men group",
                    "therapy_or_medication": "Erenumab",
                    "medical_outcome": "percentage reduction in MMD",
                    "result": "50%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.9999999403953552,
                    "therapy_or_medication_correct": 0.9999997615814209,
                    "medical_outcome_correct": 0.9122943878173828,
                    "result_correct": 0.7118043899536133,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.624098539352417
                }
            },
            {
                "pred_row": {
                    "id": 96,
                    "pubmed_id": 80101,
                    "paper": "Efficacy of Migraine Treatments in Different Groups",
                    "authors": "Smith, A.; Johnson, B.",
                    "journal": "Journal of Neurology",
                    "publication_date": "2024-05-12",
                    "disease": "Migraine",
                    "medication_group": "Men group",
                    "therapy_or_medication": "Erenumab",
                    "medical_outcome": "Discontinuation rate",
                    "result": "7%",
                    "outcome_category": "Adverse Events and Side Effects",
                    "outcome_evaluation": "significantly worse"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.9999999403953552,
                    "therapy_or_medication_correct": 0.9999997615814209,
                    "medical_outcome_correct": 0.6279245615005493,
                    "result_correct": 0.7187364101409912,
                    "outcome_category_correct": 0.6407684087753296,
                    "outcome_evaluation_correct": 0.790851891040802,
                    "score": 5.778281092643738
                }
            },
            {
                "pred_row": {
                    "id": 95,
                    "pubmed_id": 80101,
                    "paper": "Efficacy of Migraine Treatments in Different Groups",
                    "authors": "Smith, A.; Johnson, B.",
                    "journal": "Journal of Neurology",
                    "publication_date": "2024-05-12",
                    "disease": "Migraine",
                    "medication_group": "Women group",
                    "therapy_or_medication": "Erenumab",
                    "medical_outcome": "Discontinuation rate",
                    "result": "5%",
                    "outcome_category": "Adverse Events and Side Effects",
                    "outcome_evaluation": "significantly worse"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.8459748029708862,
                    "therapy_or_medication_correct": 0.9999997615814209,
                    "medical_outcome_correct": 0.6279245615005493,
                    "result_correct": 0.748306930065155,
                    "outcome_category_correct": 0.6407684087753296,
                    "outcome_evaluation_correct": 0.790851891040802,
                    "score": 5.653826475143433
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 80101,
            "papername": "Efficacy of Migraine Treatments in Different Groups",
            "authors": "Smith, A.; Johnson, B.",
            "publication_date": "2024-05-12 00:00:00",
            "journal": "Journal of Neurology",
            "disease": "Migraine",
            "medication_group": "Men group",
            "therapy_or_medication": "Erenumab",
            "medical_outcome": "Discontinuation Rate",
            "result": 0.07,
            "outcome_category": "Adverse Events and Side Effects",
            "outcome_evaluation": "significantly worse"
        },
        "pred_row": {
            "id": 96,
            "pubmed_id": 80101,
            "paper": "Efficacy of Migraine Treatments in Different Groups",
            "authors": "Smith, A.; Johnson, B.",
            "journal": "Journal of Neurology",
            "publication_date": "2024-05-12",
            "disease": "Migraine",
            "medication_group": "Men group",
            "therapy_or_medication": "Erenumab",
            "medical_outcome": "Discontinuation rate",
            "result": "7%",
            "outcome_category": "Adverse Events and Side Effects",
            "outcome_evaluation": "significantly worse"
        },
        "best_similarity": {
            "disease_correct": 1.0000001192092896,
            "medication_group_correct": 0.9999999403953552,
            "therapy_or_medication_correct": 0.9999997615814209,
            "medical_outcome_correct": 1.0,
            "result_correct": 0.623311460018158,
            "outcome_category_correct": 0.9999999403953552,
            "outcome_evaluation_correct": 1.0,
            "score": 6.623311221599579
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 93,
                    "pubmed_id": 80101,
                    "paper": "Efficacy of Migraine Treatments in Different Groups",
                    "authors": "Smith, A.; Johnson, B.",
                    "journal": "Journal of Neurology",
                    "publication_date": "2024-05-12",
                    "disease": "Migraine",
                    "medication_group": "Women group",
                    "therapy_or_medication": "Erenumab",
                    "medical_outcome": "percentage reduction in MMD",
                    "result": "55%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.8459748029708862,
                    "therapy_or_medication_correct": 0.9999997615814209,
                    "medical_outcome_correct": 0.5799520015716553,
                    "result_correct": 0.5718334317207336,
                    "outcome_category_correct": 0.6407684087753296,
                    "outcome_evaluation_correct": 0.790851891040802,
                    "score": 5.429380416870117
                }
            },
            {
                "pred_row": {
                    "id": 94,
                    "pubmed_id": 80101,
                    "paper": "Efficacy of Migraine Treatments in Different Groups",
                    "authors": "Smith, A.; Johnson, B.",
                    "journal": "Journal of Neurology",
                    "publication_date": "2024-05-12",
                    "disease": "Migraine",
                    "medication_group": "Men group",
                    "therapy_or_medication": "Erenumab",
                    "medical_outcome": "percentage reduction in MMD",
                    "result": "50%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.9999999403953552,
                    "therapy_or_medication_correct": 0.9999997615814209,
                    "medical_outcome_correct": 0.5799520015716553,
                    "result_correct": 0.6190842986106873,
                    "outcome_category_correct": 0.6407684087753296,
                    "outcome_evaluation_correct": 0.790851891040802,
                    "score": 5.63065642118454
                }
            },
            {
                "pred_row": {
                    "id": 96,
                    "pubmed_id": 80101,
                    "paper": "Efficacy of Migraine Treatments in Different Groups",
                    "authors": "Smith, A.; Johnson, B.",
                    "journal": "Journal of Neurology",
                    "publication_date": "2024-05-12",
                    "disease": "Migraine",
                    "medication_group": "Men group",
                    "therapy_or_medication": "Erenumab",
                    "medical_outcome": "Discontinuation rate",
                    "result": "7%",
                    "outcome_category": "Adverse Events and Side Effects",
                    "outcome_evaluation": "significantly worse"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.9999999403953552,
                    "therapy_or_medication_correct": 0.9999997615814209,
                    "medical_outcome_correct": 1.0,
                    "result_correct": 0.623311460018158,
                    "outcome_category_correct": 0.9999999403953552,
                    "outcome_evaluation_correct": 1.0,
                    "score": 6.623311221599579
                }
            },
            {
                "pred_row": {
                    "id": 95,
                    "pubmed_id": 80101,
                    "paper": "Efficacy of Migraine Treatments in Different Groups",
                    "authors": "Smith, A.; Johnson, B.",
                    "journal": "Journal of Neurology",
                    "publication_date": "2024-05-12",
                    "disease": "Migraine",
                    "medication_group": "Women group",
                    "therapy_or_medication": "Erenumab",
                    "medical_outcome": "Discontinuation rate",
                    "result": "5%",
                    "outcome_category": "Adverse Events and Side Effects",
                    "outcome_evaluation": "significantly worse"
                },
                "similarity": {
                    "disease_correct": 1.0000001192092896,
                    "medication_group_correct": 0.8459748029708862,
                    "therapy_or_medication_correct": 0.9999997615814209,
                    "medical_outcome_correct": 1.0,
                    "result_correct": 0.6252670288085938,
                    "outcome_category_correct": 0.9999999403953552,
                    "outcome_evaluation_correct": 1.0,
                    "score": 6.471241652965546
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 80202,
            "papername": "Diabetes Treatment in Different European Populations",
            "authors": "Müller, H.; Schmidt, T.",
            "publication_date": "2023-10-22 00:00:00",
            "journal": "European Journal of Endocrinology",
            "disease": "Diabetes",
            "medication_group": "Western Europeans group",
            "therapy_or_medication": "Metformin",
            "medical_outcome": "Reduction in A1C",
            "result": "1.8%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "no significant differences"
        },
        "pred_row": {
            "id": 97,
            "pubmed_id": 80202,
            "paper": "Diabetes Treatment in Different European Populations",
            "authors": "Müller, H.; Schmidt, T.",
            "journal": "European Journal of Endocrinology",
            "publication_date": "2023-10-22",
            "disease": "Diabetes",
            "medication_group": "Western Europeans",
            "therapy_or_medication": "Metformin",
            "medical_outcome": "A1C reduction",
            "result": "1.8%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0,
            "medication_group_correct": 0.851679265499115,
            "therapy_or_medication_correct": 0.9999998807907104,
            "medical_outcome_correct": 0.7979474067687988,
            "result_correct": 0.9999998807907104,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 0.632323145866394,
            "score": 6.281949698925018
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 97,
                    "pubmed_id": 80202,
                    "paper": "Diabetes Treatment in Different European Populations",
                    "authors": "Müller, H.; Schmidt, T.",
                    "journal": "European Journal of Endocrinology",
                    "publication_date": "2023-10-22",
                    "disease": "Diabetes",
                    "medication_group": "Western Europeans",
                    "therapy_or_medication": "Metformin",
                    "medical_outcome": "A1C reduction",
                    "result": "1.8%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.851679265499115,
                    "therapy_or_medication_correct": 0.9999998807907104,
                    "medical_outcome_correct": 0.7979474067687988,
                    "result_correct": 0.9999998807907104,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.632323145866394,
                    "score": 6.281949698925018
                }
            },
            {
                "pred_row": {
                    "id": 98,
                    "pubmed_id": 80202,
                    "paper": "Diabetes Treatment in Different European Populations",
                    "authors": "Müller, H.; Schmidt, T.",
                    "journal": "European Journal of Endocrinology",
                    "publication_date": "2023-10-22",
                    "disease": "Diabetes",
                    "medication_group": "Eastern Europeans",
                    "therapy_or_medication": "Metformin",
                    "medical_outcome": "A1C reduction",
                    "result": "1.5%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.8305103778839111,
                    "therapy_or_medication_correct": 0.9999998807907104,
                    "medical_outcome_correct": 0.7979474067687988,
                    "result_correct": 0.9698979258537292,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.632323145866394,
                    "score": 6.230678856372833
                }
            },
            {
                "pred_row": {
                    "id": 99,
                    "pubmed_id": 80202,
                    "paper": "Diabetes Treatment in Different European Populations",
                    "authors": "Müller, H.; Schmidt, T.",
                    "journal": "European Journal of Endocrinology",
                    "publication_date": "2023-10-22",
                    "disease": "Diabetes",
                    "medication_group": "Southern Europeans",
                    "therapy_or_medication": "Metformin",
                    "medical_outcome": "A1C reduction",
                    "result": "1.6%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.8446043133735657,
                    "therapy_or_medication_correct": 0.9999998807907104,
                    "medical_outcome_correct": 0.7979474067687988,
                    "result_correct": 0.984549880027771,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.632323145866394,
                    "score": 6.2594247460365295
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 80202,
            "papername": "Diabetes Treatment in Different European Populations",
            "authors": "Müller, H.; Schmidt, T.",
            "publication_date": "2023-10-22 00:00:00",
            "journal": "European Journal of Endocrinology",
            "disease": "Diabetes",
            "medication_group": "Eastern Europeans group",
            "therapy_or_medication": "Metformin",
            "medical_outcome": "Reduction in A1C",
            "result": "1.5%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "no significant differences"
        },
        "pred_row": {
            "id": 98,
            "pubmed_id": 80202,
            "paper": "Diabetes Treatment in Different European Populations",
            "authors": "Müller, H.; Schmidt, T.",
            "journal": "European Journal of Endocrinology",
            "publication_date": "2023-10-22",
            "disease": "Diabetes",
            "medication_group": "Eastern Europeans",
            "therapy_or_medication": "Metformin",
            "medical_outcome": "A1C reduction",
            "result": "1.5%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0,
            "medication_group_correct": 0.8746082186698914,
            "therapy_or_medication_correct": 0.9999998807907104,
            "medical_outcome_correct": 0.7979474067687988,
            "result_correct": 0.9999998807907104,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 0.632323145866394,
            "score": 6.304878652095795
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 97,
                    "pubmed_id": 80202,
                    "paper": "Diabetes Treatment in Different European Populations",
                    "authors": "Müller, H.; Schmidt, T.",
                    "journal": "European Journal of Endocrinology",
                    "publication_date": "2023-10-22",
                    "disease": "Diabetes",
                    "medication_group": "Western Europeans",
                    "therapy_or_medication": "Metformin",
                    "medical_outcome": "A1C reduction",
                    "result": "1.8%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.8152076005935669,
                    "therapy_or_medication_correct": 0.9999998807907104,
                    "medical_outcome_correct": 0.7979474067687988,
                    "result_correct": 0.9698979258537292,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.632323145866394,
                    "score": 6.215376079082489
                }
            },
            {
                "pred_row": {
                    "id": 98,
                    "pubmed_id": 80202,
                    "paper": "Diabetes Treatment in Different European Populations",
                    "authors": "Müller, H.; Schmidt, T.",
                    "journal": "European Journal of Endocrinology",
                    "publication_date": "2023-10-22",
                    "disease": "Diabetes",
                    "medication_group": "Eastern Europeans",
                    "therapy_or_medication": "Metformin",
                    "medical_outcome": "A1C reduction",
                    "result": "1.5%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.8746082186698914,
                    "therapy_or_medication_correct": 0.9999998807907104,
                    "medical_outcome_correct": 0.7979474067687988,
                    "result_correct": 0.9999998807907104,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.632323145866394,
                    "score": 6.304878652095795
                }
            },
            {
                "pred_row": {
                    "id": 99,
                    "pubmed_id": 80202,
                    "paper": "Diabetes Treatment in Different European Populations",
                    "authors": "Müller, H.; Schmidt, T.",
                    "journal": "European Journal of Endocrinology",
                    "publication_date": "2023-10-22",
                    "disease": "Diabetes",
                    "medication_group": "Southern Europeans",
                    "therapy_or_medication": "Metformin",
                    "medical_outcome": "A1C reduction",
                    "result": "1.6%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.8367538452148438,
                    "therapy_or_medication_correct": 0.9999998807907104,
                    "medical_outcome_correct": 0.7979474067687988,
                    "result_correct": 0.977742612361908,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.632323145866394,
                    "score": 6.244767010211945
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 80202,
            "papername": "Diabetes Treatment in Different European Populations",
            "authors": "Müller, H.; Schmidt, T.",
            "publication_date": "2023-10-22 00:00:00",
            "journal": "European Journal of Endocrinology",
            "disease": "Diabetes",
            "medication_group": "Southern Europeans group",
            "therapy_or_medication": "Metformin",
            "medical_outcome": "Reduction in A1C",
            "result": "1.6%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "no significant differences"
        },
        "pred_row": {
            "id": 99,
            "pubmed_id": 80202,
            "paper": "Diabetes Treatment in Different European Populations",
            "authors": "Müller, H.; Schmidt, T.",
            "journal": "European Journal of Endocrinology",
            "publication_date": "2023-10-22",
            "disease": "Diabetes",
            "medication_group": "Southern Europeans",
            "therapy_or_medication": "Metformin",
            "medical_outcome": "A1C reduction",
            "result": "1.6%",
            "outcome_category": "Efficacy Measures",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0,
            "medication_group_correct": 0.8690279126167297,
            "therapy_or_medication_correct": 0.9999998807907104,
            "medical_outcome_correct": 0.7979474067687988,
            "result_correct": 0.9999999403953552,
            "outcome_category_correct": 1.0000001192092896,
            "outcome_evaluation_correct": 0.632323145866394,
            "score": 6.299298405647278
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 97,
                    "pubmed_id": 80202,
                    "paper": "Diabetes Treatment in Different European Populations",
                    "authors": "Müller, H.; Schmidt, T.",
                    "journal": "European Journal of Endocrinology",
                    "publication_date": "2023-10-22",
                    "disease": "Diabetes",
                    "medication_group": "Western Europeans",
                    "therapy_or_medication": "Metformin",
                    "medical_outcome": "A1C reduction",
                    "result": "1.8%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.7981134057044983,
                    "therapy_or_medication_correct": 0.9999998807907104,
                    "medical_outcome_correct": 0.7979474067687988,
                    "result_correct": 0.984549880027771,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.632323145866394,
                    "score": 6.212933838367462
                }
            },
            {
                "pred_row": {
                    "id": 98,
                    "pubmed_id": 80202,
                    "paper": "Diabetes Treatment in Different European Populations",
                    "authors": "Müller, H.; Schmidt, T.",
                    "journal": "European Journal of Endocrinology",
                    "publication_date": "2023-10-22",
                    "disease": "Diabetes",
                    "medication_group": "Eastern Europeans",
                    "therapy_or_medication": "Metformin",
                    "medical_outcome": "A1C reduction",
                    "result": "1.5%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.797629177570343,
                    "therapy_or_medication_correct": 0.9999998807907104,
                    "medical_outcome_correct": 0.7979474067687988,
                    "result_correct": 0.977742612361908,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.632323145866394,
                    "score": 6.205642342567444
                }
            },
            {
                "pred_row": {
                    "id": 99,
                    "pubmed_id": 80202,
                    "paper": "Diabetes Treatment in Different European Populations",
                    "authors": "Müller, H.; Schmidt, T.",
                    "journal": "European Journal of Endocrinology",
                    "publication_date": "2023-10-22",
                    "disease": "Diabetes",
                    "medication_group": "Southern Europeans",
                    "therapy_or_medication": "Metformin",
                    "medical_outcome": "A1C reduction",
                    "result": "1.6%",
                    "outcome_category": "Efficacy Measures",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.8690279126167297,
                    "therapy_or_medication_correct": 0.9999998807907104,
                    "medical_outcome_correct": 0.7979474067687988,
                    "result_correct": 0.9999999403953552,
                    "outcome_category_correct": 1.0000001192092896,
                    "outcome_evaluation_correct": 0.632323145866394,
                    "score": 6.299298405647278
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 80303,
            "papername": "Asthma Control in Various Demographics",
            "authors": "Chang, L.; Brown, M.",
            "publication_date": "2024-01-15 00:00:00",
            "journal": "Respiratory Medicine",
            "disease": "Asthma",
            "medication_group": "Children group",
            "therapy_or_medication": "Inhalers",
            "medical_outcome": "Symptom Reduction",
            "result": 0.3,
            "outcome_category": "Symptom Intensity and Relief",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 100,
            "pubmed_id": 80303,
            "paper": "Asthma Control in Various Demographics",
            "authors": "Chang, L.; Brown, M.",
            "journal": "Respiratory Medicine",
            "publication_date": "2024-01-15",
            "disease": "Asthma",
            "medication_group": "Children group",
            "therapy_or_medication": "Inhalers",
            "medical_outcome": "Reduction in asthma symptoms",
            "result": "30%",
            "outcome_category": "Symptom Intensity and Relief",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0,
            "medication_group_correct": 0.9999998211860657,
            "therapy_or_medication_correct": 1.0,
            "medical_outcome_correct": 0.7763745784759521,
            "result_correct": 0.7367587685585022,
            "outcome_category_correct": 1.0,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 6.513132989406586
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 100,
                    "pubmed_id": 80303,
                    "paper": "Asthma Control in Various Demographics",
                    "authors": "Chang, L.; Brown, M.",
                    "journal": "Respiratory Medicine",
                    "publication_date": "2024-01-15",
                    "disease": "Asthma",
                    "medication_group": "Children group",
                    "therapy_or_medication": "Inhalers",
                    "medical_outcome": "Reduction in asthma symptoms",
                    "result": "30%",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.9999998211860657,
                    "therapy_or_medication_correct": 1.0,
                    "medical_outcome_correct": 0.7763745784759521,
                    "result_correct": 0.7367587685585022,
                    "outcome_category_correct": 1.0,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.513132989406586
                }
            },
            {
                "pred_row": {
                    "id": 102,
                    "pubmed_id": 80303,
                    "paper": "Asthma Control in Various Demographics",
                    "authors": "Chang, L.; Brown, M.",
                    "journal": "Respiratory Medicine",
                    "publication_date": "2024-01-15",
                    "disease": "Asthma",
                    "medication_group": "Elderly group",
                    "therapy_or_medication": "Inhalers",
                    "medical_outcome": "Reduction in asthma symptoms",
                    "result": "25%",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.8724028468132019,
                    "therapy_or_medication_correct": 1.0,
                    "medical_outcome_correct": 0.7763745784759521,
                    "result_correct": 0.7206388115882874,
                    "outcome_category_correct": 1.0,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.369416058063507
                }
            },
            {
                "pred_row": {
                    "id": 101,
                    "pubmed_id": 80303,
                    "paper": "Asthma Control in Various Demographics",
                    "authors": "Chang, L.; Brown, M.",
                    "journal": "Respiratory Medicine",
                    "publication_date": "2024-01-15",
                    "disease": "Asthma",
                    "medication_group": "Adult group",
                    "therapy_or_medication": "Inhalers",
                    "medical_outcome": "Reduction in asthma symptoms",
                    "result": "35%",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.815295398235321,
                    "therapy_or_medication_correct": 1.0,
                    "medical_outcome_correct": 0.7763745784759521,
                    "result_correct": 0.6916147470474243,
                    "outcome_category_correct": 1.0,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.283284544944763
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 80303,
            "papername": "Asthma Control in Various Demographics",
            "authors": "Chang, L.; Brown, M.",
            "publication_date": "2024-01-15 00:00:00",
            "journal": "Respiratory Medicine",
            "disease": "Asthma",
            "medication_group": "Adult group",
            "therapy_or_medication": "Inhalers",
            "medical_outcome": "Symptom Reduction",
            "result": 0.35,
            "outcome_category": "Symptom Intensity and Relief",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 101,
            "pubmed_id": 80303,
            "paper": "Asthma Control in Various Demographics",
            "authors": "Chang, L.; Brown, M.",
            "journal": "Respiratory Medicine",
            "publication_date": "2024-01-15",
            "disease": "Asthma",
            "medication_group": "Adult group",
            "therapy_or_medication": "Inhalers",
            "medical_outcome": "Reduction in asthma symptoms",
            "result": "35%",
            "outcome_category": "Symptom Intensity and Relief",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0,
            "medication_group_correct": 1.0000001192092896,
            "therapy_or_medication_correct": 1.0,
            "medical_outcome_correct": 0.7763745784759521,
            "result_correct": 0.7251928448677063,
            "outcome_category_correct": 1.0,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 6.501567363739014
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 100,
                    "pubmed_id": 80303,
                    "paper": "Asthma Control in Various Demographics",
                    "authors": "Chang, L.; Brown, M.",
                    "journal": "Respiratory Medicine",
                    "publication_date": "2024-01-15",
                    "disease": "Asthma",
                    "medication_group": "Children group",
                    "therapy_or_medication": "Inhalers",
                    "medical_outcome": "Reduction in asthma symptoms",
                    "result": "30%",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.815295398235321,
                    "therapy_or_medication_correct": 1.0,
                    "medical_outcome_correct": 0.7763745784759521,
                    "result_correct": 0.7438833713531494,
                    "outcome_category_correct": 1.0,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.335553169250488
                }
            },
            {
                "pred_row": {
                    "id": 102,
                    "pubmed_id": 80303,
                    "paper": "Asthma Control in Various Demographics",
                    "authors": "Chang, L.; Brown, M.",
                    "journal": "Respiratory Medicine",
                    "publication_date": "2024-01-15",
                    "disease": "Asthma",
                    "medication_group": "Elderly group",
                    "therapy_or_medication": "Inhalers",
                    "medical_outcome": "Reduction in asthma symptoms",
                    "result": "25%",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.8265049457550049,
                    "therapy_or_medication_correct": 1.0,
                    "medical_outcome_correct": 0.7763745784759521,
                    "result_correct": 0.7282050251960754,
                    "outcome_category_correct": 1.0,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.331084370613098
                }
            },
            {
                "pred_row": {
                    "id": 101,
                    "pubmed_id": 80303,
                    "paper": "Asthma Control in Various Demographics",
                    "authors": "Chang, L.; Brown, M.",
                    "journal": "Respiratory Medicine",
                    "publication_date": "2024-01-15",
                    "disease": "Asthma",
                    "medication_group": "Adult group",
                    "therapy_or_medication": "Inhalers",
                    "medical_outcome": "Reduction in asthma symptoms",
                    "result": "35%",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 1.0000001192092896,
                    "therapy_or_medication_correct": 1.0,
                    "medical_outcome_correct": 0.7763745784759521,
                    "result_correct": 0.7251928448677063,
                    "outcome_category_correct": 1.0,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.501567363739014
                }
            }
        ]
    },
    {
        "real_row": {
            "pubmed_id": 80303,
            "papername": "Asthma Control in Various Demographics",
            "authors": "Chang, L.; Brown, M.",
            "publication_date": "2024-01-15 00:00:00",
            "journal": "Respiratory Medicine",
            "disease": "Asthma",
            "medication_group": "Elderly group",
            "therapy_or_medication": "Inhalers",
            "medical_outcome": "Symptom Reduction",
            "result": 0.25,
            "outcome_category": "Symptom Intensity and Relief",
            "outcome_evaluation": "significantly improved"
        },
        "pred_row": {
            "id": 102,
            "pubmed_id": 80303,
            "paper": "Asthma Control in Various Demographics",
            "authors": "Chang, L.; Brown, M.",
            "journal": "Respiratory Medicine",
            "publication_date": "2024-01-15",
            "disease": "Asthma",
            "medication_group": "Elderly group",
            "therapy_or_medication": "Inhalers",
            "medical_outcome": "Reduction in asthma symptoms",
            "result": "25%",
            "outcome_category": "Symptom Intensity and Relief",
            "outcome_evaluation": "significantly improved"
        },
        "best_similarity": {
            "disease_correct": 1.0,
            "medication_group_correct": 1.0,
            "therapy_or_medication_correct": 1.0,
            "medical_outcome_correct": 0.7763745784759521,
            "result_correct": 0.7425962090492249,
            "outcome_category_correct": 1.0,
            "outcome_evaluation_correct": 0.9999998211860657,
            "score": 6.518970608711243
        },
        "all_runs": [
            {
                "pred_row": {
                    "id": 100,
                    "pubmed_id": 80303,
                    "paper": "Asthma Control in Various Demographics",
                    "authors": "Chang, L.; Brown, M.",
                    "journal": "Respiratory Medicine",
                    "publication_date": "2024-01-15",
                    "disease": "Asthma",
                    "medication_group": "Children group",
                    "therapy_or_medication": "Inhalers",
                    "medical_outcome": "Reduction in asthma symptoms",
                    "result": "30%",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.8724028468132019,
                    "therapy_or_medication_correct": 1.0,
                    "medical_outcome_correct": 0.7763745784759521,
                    "result_correct": 0.7246699929237366,
                    "outcome_category_correct": 1.0,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.373447239398956
                }
            },
            {
                "pred_row": {
                    "id": 102,
                    "pubmed_id": 80303,
                    "paper": "Asthma Control in Various Demographics",
                    "authors": "Chang, L.; Brown, M.",
                    "journal": "Respiratory Medicine",
                    "publication_date": "2024-01-15",
                    "disease": "Asthma",
                    "medication_group": "Elderly group",
                    "therapy_or_medication": "Inhalers",
                    "medical_outcome": "Reduction in asthma symptoms",
                    "result": "25%",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 1.0,
                    "therapy_or_medication_correct": 1.0,
                    "medical_outcome_correct": 0.7763745784759521,
                    "result_correct": 0.7425962090492249,
                    "outcome_category_correct": 1.0,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.518970608711243
                }
            },
            {
                "pred_row": {
                    "id": 101,
                    "pubmed_id": 80303,
                    "paper": "Asthma Control in Various Demographics",
                    "authors": "Chang, L.; Brown, M.",
                    "journal": "Respiratory Medicine",
                    "publication_date": "2024-01-15",
                    "disease": "Asthma",
                    "medication_group": "Adult group",
                    "therapy_or_medication": "Inhalers",
                    "medical_outcome": "Reduction in asthma symptoms",
                    "result": "35%",
                    "outcome_category": "Symptom Intensity and Relief",
                    "outcome_evaluation": "significantly improved"
                },
                "similarity": {
                    "disease_correct": 1.0,
                    "medication_group_correct": 0.8265049457550049,
                    "therapy_or_medication_correct": 1.0,
                    "medical_outcome_correct": 0.7763745784759521,
                    "result_correct": 0.6750593185424805,
                    "outcome_category_correct": 1.0,
                    "outcome_evaluation_correct": 0.9999998211860657,
                    "score": 6.277938663959503
                }
            }
        ]
    }
]